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Alzheimer’s disease (AD) affects a considerable, and increasing, part of the population.  Early 
diagnosis of AD is very important to permit effective therapy, and minimize AD’s social and 
economic burden.  The goal of our research is to evaluate the changes of cerebral perfusion (i.e., 
blood flow) in the early stages of AD and the effects from hypertension. 
We studied volunteers with Mild Cognitive Impairment (MCI) and early AD from the 
Pittsburgh cohort of the Cardiovascular Health Study (CHS) Cognitive Study during a four-year 
follow-up.  Previously, studies used referral patients who typically have more advanced AD.  No 
perfusion data concerning the early and transitional disease stages are currently available from 
population studies (i.e., subjects who have been monitored longitudinally in time).  There are no 
common techniques for perfusion quantification and image analysis so that inconsistencies are 
observed between/within studies, modalities, and researchers.  
Several advancements were achieved in preparation for the cohort study.  First, we 
improved the accuracy and speed of brain perfusion quantification.  Second, we improved the 
accuracy of image registration to a reference brain using quantitative validation of a registration 
method and performance comparison with a popular registration method.  Third, we improved 
the method of statistical analysis for evaluating the changes of perfusion between groups.  Fourth, 
we evaluated the changes of cerebral perfusion between cognitive groups (controls, MCIs, ADs), 
and hypertension and normo-tensive subgroups. 
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Individual perfusion maps were improved by measuring and incorporating individual 
arrival time, saturation effects, and individual inversion efficiency.  A fully deformable 
registration technique was shown to be more accurate than standard techniques like statistical 
parametric mapping to detect local perfusion changes.  All of the published literature for 
perfusion up-to-date reported decreased perfusion in AD, but we found hyperperfusion in some 
regions.  The regional findings imply that a hemodynamic process, at the capillary level, 
accompanied the neurodegenerative process.  Hypertensive normal cognitive controls 
demonstrated hypoperfusion in regions usually involved in AD pathology.  However, the effect 
of hypertension was attenuated after the onset of the pathological cognitive process. 
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1.0  INTRODUCTION 
Alzheimer’s disease (AD) is a serious health problem facing the United States and ranks as the 
fourth leading cause of death in the United States 1.  The prevalence of Alzheimer’s disease (AD) 
ranges from 3% to 10% in subjects ages 65 and older, and from 20% to more than 30% in those 
ages 85 and older2-4.  The incidence and prevalence of AD will continue to rise as the population 
ages and longevity increases.  Prevalence is projected to increase from  8 to 13.5 million cases 
over the next 50 years in the U. S. 5, 6, creating a significant impact on the healthcare system and 
society.   
The clinical diagnosis of AD typically comes late in the disease progression.  This is 
primarily due to the lack of sensitive markers of early AD because of the similarities between 
normal aging and abnormal cognitive impairments that are a forerunner of AD 7.  Disease 
markers are important to devise effective treatments to prevent the onset of symptoms.   
 However, there is currently no cure for AD.  The U. S. Food and Drug Administration 
(FDA) claimed no evidence for any candidate drugs that have an effect on the underlying 
progression of the disease, although there are some symptomatic treatments, such as 
acetylcholinesterase inhibitors 8.  One principle goal of AD research is to develop highly 
effective tools capable of identifying individuals who will eventually progress to AD to permit 
early diagnosis and therapeutic intervention.   
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There have been significant efforts from the medical community to understand the 
pathophysiology of the disease, especially the transition from normalcy to dementia.  The 
transitional state has been called mild cognitive impairment (MCI) 9, 10, and its proper clinical 
identification is the key to devising effective therapies that can prevent, or delay, the onset of 
dementia.  Similarly, the early diagnosis of AD is critical for the introduction of disease-
modifying treatments.   
1.1 THE MOTIVATION FOR RESEARCH SUBJECTS  
Neuroimaging studies have provided valuable in vivo information of AD pathophysiology.  
Functional imaging techniques using positron emission tomography (PET) and single photon 
emission computed tomography (SPECT) showed decreased cerebral blood flow (CBF) or 
glucose metabolism in the temporal, parietal, and frontal heteromodal association areas, and 
mesial temporal lobe 11-17, and in the posterior cingulate gyrus 15, 16, 18-20 in AD subjects 
compared to normal individuals.  MRI volumetric studies17, 21-25, and continuous arterial spin 
labeling (CASL) perfusion MRI 26, 27 have shown atrophy and diminished CBF, respectively, in 
the same areas detected with functional methods.   
Functional studies conducted in MCI subjects showed decreased metabolism in 
temporoparietal regions, especially in the posterior cingulate gyrus12, 28-32.  MRI studies using 
region-of-interest analyses have shown that the volume of the hippocampus, entorhinal cortex 
and amygdala was reduced in MCI subjects compared to controls 33-39.  Studies based on whole 
brain techniques found that MCI subjects also had temporal, parietal, and frontal (including the 
subcallosal region of the anterior cingulate gyrus) volume loss 33, 40-42.  Taken together, these 
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studies showed that the MCI patients had cerebral changes not only in the mesial temporal lobe, 
but also in the heteromodal association areas.  However, the majority of these studies were 
conducted in referral clinics 26, 27 with subjects that had advanced disease, especially MCIs.   
Very little is known about CBF changes in MCI and early dementia in subjects from 
population cohorts.  Neuroimaging studies in these subjects, especially those in early disease 
stages, are extremely important since the severity of symptoms may not have reached the 
threshold that usually initiates a referral to specialists.  Therefore, neuroimaging of population 
cohorts provides an ideal opportunity to examine the incipient pathophysiological changes in AD, 
several years before they are enrolled in memory clinic imaging studies.   
1.2 THE MOTIVATION FOR RESEARCH METHODOLOGY  
 
MRI methods are able to provide the resolution comparable with, or superior to, nuclear 
medicine techniques such as PET and SPECT.  First, MRI does not require the injection of 
radioactive tracers.  Second, MRI is much cheaper and more widely available than PET.  Third, 
it is easier to produce spatially registered structural information from MRI compared to SPECT 
or PET.   
Two MRI techniques claim to provide a quantitative assessment of perfusion.  The first 
of the techniques, dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI), 
requires the injection of a contrast agent for which the acceptable maximum dose is limited.  
There are also quantification issues with DSC-MRI: 1) the relationship of changes in regional 
signal intensity to contrast agent concentration is complex; 2) an accurate quantification of 
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Artery Input Function (AIF) is difficult because the measured AIF may be affected by both a 
delay and dispersion between the artery where it was estimated and the volume of interest (VOI) 
43, 44.   
The second method, arterial spin labeling (ASL), employs radiofrequency (RF) pulses to 
invert naturally existing water proton spins (i.e., nuclear angular momentum) in the flowing 
blood prior to their arrival at VOI.  ASL is commonly subdivided into two categories: continuous 
ASL (CASL) and pulsed ASL (PASL).  CASL uses a continuous adiabatic RF pulse to invert 
blood water spins flowing through the carotids of the neck 45.  PASL uses a short RF pulse to 
invert blood water spins and minimize the distance between the labeling region and the image 
slice.  Compared to CASL, PASL cannot cover the whole cerebrum in a single acquisition due to 
the smaller tracer bolus.  We used the CASL technique in order to obtain the quantitative 
perfusion for the whole cerebrum.  In addition, CASL can provide an improved signal-to-noise 
ratio (SNR) versus PASL46.   
1.3 THE CHALLENGE OF CASL MRI 
CASL was first proposed by Detre et al. 47, who suggested the use of a train of RF pulses to 
repeatedly saturate blood water spins flowing throw the neck.  The saturated spins flow into the 
brain and, assuming water is a freely diffusible tracer, exchange completely with brain tissue 
water, thus reducing the overall tissue magnetization.  Soon after CASL was proposed, Williams 
et al.45 improved the technique by using adiabatic fast passage (AFP) to label via spin inversion 
the arterial water spins 48, 49.  In AFP, an RF pulse is applied for several seconds to a plane in the 
neck of a subject, inflowing arterial water spins are inverted during this period, and a flow-
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related steady state is achieved.  The advantage of labeling arterial spins by inversion rather than 
saturation is an increase in the difference between the labeled and unlabeled states.    
However, CASL has four well-recognized major problems in measuring tissue perfusion.  
First, the arrival time taken for spins to travel between the labeling plane and image slice voxels 
(sometimes referred to as the arrival time) is nonzero, and therefore spin relaxation occurs during 
the period.  In the rat experiments, the short arrival time and the long T1 of blood at the higher 
(4.7 Tesla) field strength reduced the impact of arrival times on the CBF quantification 50.  For 
human perfusion, however, arrival time dependence of the measured CBF represents a major 
obstacle to accurate quantification.  Different people have different arrival times.  Different 
regions of the brain have different arrival times, depending on the distance from the labeling 
plane and the cerebrovascular anatomy.  These effects must be taken into account for accurate 
perfusion quantification.   
Second, the application of a long (i.e., several seconds) off-resonance RF pulse in a single 
RF coil used for both labeling and imaging causes a decrease in the water signal resulting from 
magnetization transfer (MT) effects.  No direct saturation of the observed water magnetization in 
the imaging slice occurs because of the narrow line width of the free water peak.  However, off-
resonance saturation of macromolecular spins does occur, resulting in attenuation of the free 
water signal through magnetization transfer 51.  The off-resonance saturation effects can mask the 
perfusion-dependent signal.    
Third, multi-slice CASL imaging is complicated since the off-resonance saturation 
effects must be matched between both label and control acquisitions.  Originally, the control 
plane was placed symmetrically opposite to the label plane with respect to the imaging slice and 
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only one slice was acquired.  Several multi-slice techniques were developed to minimize the 
difference between off-resonance saturation effects in the label and control irradiations.   
Fourth, the inversion (or labeling) efficiency (the measure of how efficiently the blood is 
inverted from the label and control plane) is not constant.  Different people may experience 
different inversion efficiencies depending on the B1 field at the label plane and the arterial blood 
velocity.   
Researchers have worked to solve these issues.  To account for the nonzero arrival time 
effect, one could measure the arrival time on a voxel-by-voxel basis and incorporate it into the 
original model (Bloch equation, will be introduced later) 52.  However, in most situations, SNR is 
found to be insufficient to estimate the arrival time with high spatial resolution 53.  Alsop and 
Detre 54 inserted a long time delay into the sequence between the end of the labeling period and 
the image acquisition and showed that if this delay is greater than the arterial arrival times across 
the image, then the resulting perfusion maps will be insensitive to variations in arrival time.  
However, the long postlabeling delay reduces the signal differences between control and labeled 
images, and the length of the delay is limited by T1 relaxation and SNR.  Furthermore, the long 
delay increases the experimental repeat time (TR) and constrains the acquisition volume.   
The magnetization transfer (MT) effects decrease the MRI signal of both the label and 
control images, that are sensitive to the off-resonance saturation.  The labeling plane is 
positioned in a transverse plane which is orthogonal to the supplying arteries.  Even within a 
subject, all the imaging slices experience different off-resonance frequencies because those 
imaging slices are placed at varying distances from the labeled plane.  For different subjects, the 
labeling planes may have varying distances from the center of the imaging section.  Therefore, 
the MT effects vary regionally and between experiments, and so the effects must be properly 
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corrected.  The MT effects need to be characterized for accurate perfusion quantification.  MT 
effects were modeled and interpreted 55-58, but these MT models described the MT effects in 
steady-state, which is not necessarily the case in our CASL experiments.    
Three methods were proposed to tackle multi-slice CASL imaging.  First, an RF surface 
coil with a small spatial range was placed on the neck and used to perform spin labeling 59.  The 
BB1 field generated by the coil does not reach the imaging slices and thus causes no off-resonance 
saturation in the imaging volume.   
Second, simultaneous proximal and distal irradiation (SPDI) 60 was developed to generate 
a small imaging volume in which the residual off-resonance saturation effects (i.e., the difference 
in saturation effects between control and label irradiations) are minimized.  Equal RF power was 
applied proximal and distal to the slices to be imaged.  Two-site irradiation applied in the 
presence of a gradient served as the labeling, while the same RF power in the absence of the 
gradient served as the control.  Off-resonance saturation effects are similar with and without the 
gradient for the slices within the flat portion of the MT profile.  However, the residual off-
resonance effects are small relative to the CASL (difference) signal only for a few middle slices 
(usually 3-5 slices).  The coverage of the whole cerebrum cannot be performed using a single 
experiment.   
Third, Alternating Single adiabatic inversion (SAI) label and Double adiabatic inversion 
(DAI) control pulses (ASD) was developed to cover the whole cerebrum 61.  ASD used a pair of 
narrowly separated inversion planes to serve as the control.  As spins flow through the first 
inversion plane, they are inverted and then immediately uninverted.  The control RF pulse was 
designed to achieve identical off-resonance saturation effects throughout the brain.  However, 
ASD suffers from inefficiencies in both the control and label.  The inefficiencies may reduce the 
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perfusion SNR 62, 63 relative to the conventional single-slice CASL using alternating proximal 
and distal irradiations (APDI) 45 given the same labeling conditions. 
The inversion efficiency may vary significantly between subjects since it is flow-velocity 
dependent 46 and the labeling and control planes tend to lie in the inhomogeneous region of the 
RF coil.  Previous researchers cited relative ASD and APDI efficiencies obtained from the earlier 
in vivo measurements without compensating for varying clinical condition.  The relative 
efficiencies based on comparisons of ASD and APDI signals are subject to significant errors 
from MT asymmetry 64 and residual MT gradient associated with APDI.  There was no standard 
method for estimating the inversion efficiencies specifically for each experiment.  Yet, 
knowledge of the inversion efficiency is key to the accurate quantification of perfusion.   
Another important problem that has been neglected so far is the slice acquisition order.  
Researchers usually acquire the slice from inferior to superior order.  But this image acquisition 
order can perturb the tracer and exacerbate off-resonance saturation effects.    
1.4 THE CHALLENGE OF ELDERLY BRAIN NORMALIZATION 
Statistical comparison of the perfusion changes between subject groups requires geometrical 
alignment (or registration) of the subject image to a reference image, i.e. brain normalization.  
The brain normalization is to remove the anatomical variability of different brains.  The match of 
fine cortical structures between subject image and the reference image is a natural requirement 
for accurate normalization. 
The widely used reference images are 1) Montreal Neurological Institute (MNI) template 
ICBM152, which was created from the average of 152 young templates, 2) Colin27 brain, in 
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which the brain of Colin Holmes (one of the MNI lab members) was scanned 27 times; the scans 
were coregistered and averaged to create a very high detail MRI dataset of one brain; the average 
was also registered to the MNI305 (the first MNI template).  However, both reference images are 
the templates from young people.   
Spatial normalization of elderly brains is a challenging issue.  Whole brain volume and 
fine cortical structures have large variability between individuals that may change at different 
atrophy rates as people age.  Individual brain image voxels may deform or warp at different rates 
during the brain normalization.  The deformation variability across cortical structures requires an 
accurate normalization method to match the cortical structures between individual brain and the 
template.  A poor normalization method will bias group comparisons.  Therefore, the 
performance of spatial normalization on elderly brains has an important effect on group 
comparisons when applied to functional and structural imaging. 
Two popular automated brain normalization packages for brain analysis are automated 
image registration (AIR) and statistical parametric mapping (SPM).  However, both methods 
have limited dimensions in brain deformation.  AIR adopts a polynomial basis function of low 
dimension,  SPM uses a geometric transformation model with low-dimensional discrete cosine 
transformation (DCT) basis functions.   
However, Chen proposed a high-dimensional method 65 (referred to as the fully 
deformable normalization method), which combines the piecewise linear registration and dense 
voxel-by-voxel geometric transformations, and allows each voxel to move without any constraint.  
The fully deformable method has the potential precision to match each cortical feature with 
substantial fine-scale deformation.  Therefore, the normalization method may be very important 
in studying AD since only fine brain cortical structures may be affected for the disease especially 
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like AD.  But the accuracy of the normalization methods needed to be evaluated and to be 
applied in the CASL brain normalization.   
1.5 THE CHANLLENGE OF STATISTICAL ANALYSIS 
Most neuroscience imaging researchers use SPM to perform the statistical analysis of functional 
MRI (fMRI) data.   The SPM package assumes that all the voxels which are used to make 
statistical inferences contain valid data.  However, the statistical inference may make no sense 
without justifying the valid data assumption from all subjects for each analyzed voxel.   
There are some practical considerations in regard to the valid data assumption if complete 
brain coverage is not adopted.  First, there are variations in brain acquisition coverage.  It is 
difficult to get exactly the same slice coverage even if the same person is scanned twice.  It is not 
possible for some elderly subjects to put their head in the predetermined direction or orientation 
(e.g. due to some disease).  Second, there are large variations in brain dimensions.  Even if the 
head is put in the scanner parallel to one direction perfectly and the slice starts from the same 
anatomical structure with the same slice thickness and interslice spacing, it will not end at the 
equivalent anatomical structure due to the variance of longitudinal length.  These practical issues 
make the SPM data processing package invalid to apply directly.   
Another alternative approach is to apply the SPM data processing package to a common 
brain volume for all subjects.  However, this approach may leave out large areas of cortical 
region.  To get larger cortical regions analyzed statistically, one can choose to exclude brain data 
of some subjects which have less overlap with others.  However, researchers normally suffer 
 
 
10
  
with small samples.  Based on those considerations, we implemented the voxel-level statistical 
analysis in separate code to analyze the valid data only and utilize the available data maximally.   
1.6 RESEARCH DESIGN  
To resolve the above research issues, we summarize our research design for the issues in Table 
1.1.  The significance of our research design is also listed in the Table. 
Table 1.1.  Summary of research issues, research designs and significance   
Topics Issues from Previous 
Studies 
Research Design Significance 
Subjects Studied only normal 
controls and very 
diseased AD subjects.   
Studied normal 
controls, MCI and early 
AD patients.   
Examine the incipient 
perfusion changes in 
MCI and AD patients 
for early diagnosis and 
therapy.   
Postlabeling 
Delay 
Used long delay: reduces 
the signal amplitude and 
SNR, time cost is large, 
need two 8-minute 
acquisitions to cover the 
brain, and is limited by 
tracer T1 relaxation.   
Used shortened delay: 
only need one 
acquisition to cover the 
whole brain.   
 
Increased perfusion 
signal amplitude and 
SNR; time cost is 
reduced to almost half; 
whole brain in one 
acquisition reduced 
possible motion; 
Increased complexity of 
quantification. 
MT Effects 
& Residual 
Off-resonance 
Saturation 
Effects 
Assumed negligible 
residual off-resonance 
saturation effects. 
 
Established a dual-
Lorentzian MT model 
to fit the experimental 
data and model the 
residual effects from in 
vivo measurements.  
Apply models to correct 
individual data sets 
based on their 
experiment conditions 
(B1, label distance) 
MT, residual off-
resonance saturation, 
and nonadiabatic effects 
vary between subjects 
and experiments.  These 
effects can be 
significant especially 
for short postlabeling 
delays.   
Inversion 
Efficiency 
Assumed that it is 
constant.   
Established an 
analytical model and 
validated with the 
experiments.   
Varies between subjects 
and experiments 
significantly.  Offer the 
researcher the ability to 
correct the perfusion 
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quantification due to the 
variance of clinical 
conditions.       
Arrival Time Assumed the inserted 
postlabeling delay is long 
enough for the labeling 
blood to be delivered to 
the imaging slice.   
Measured the arrival 
time indirectly for each 
individual subject.   
Get the arrival time of 
each individual subject 
measured at the mean 
time.  Avoid wasted 
time after tracer arrival 
(early arrivals of tracer) 
or insufficient 
postlabeling delay (e.g. 
for diseased subjects)  
Acquisition 
Order 
From inferior to superior  From superior to 
inferior.   
Keep the blood tracer 
intact and alleviate the 
off-resonance saturation 
effects and crosstalk.    
Brain 
Normalization 
Corrected for global brain 
shape differences.   
Allowed transformation 
of each voxel 
unconstrained for fine 
matches of cortical 
features.   
Better detection of 
perfusion abnormalities 
of fine cortical 
structures.   
Statistical 
Analysis 
Only analyzed the voxels 
in which all subjects have 
valid data.   
Analyze the voxels in 
which the majority of 
the subjects have valid 
data.   
Maximize the brain 
volume that is 
evaluated.   
  
1.7 RESEARCH STATEMENT  
The first objective of this research is to improve the accuracy and speed of cerebral blood flow 
(CBF) measurements acquired using CASL, a non-invasive endogenous tracer technique.  We 
achieved this by characterizing or modeling kinetic variables and improving image analysis 
techniques. 
The second objective is to evaluate perfusion changes using CASL among age-matched 
normal controls, MCI and early Alzheimer’s disease (AD) subjects, and probe the hypothesis 
that perfusion drops as dementia progresses.  We achieve this objective by applying the fully 
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deformable normalization method to warp the improved perfusion maps to the standard space 
and using image-based voxel-by-voxel analysis and cluster-level statistical analysis to detect 
regional perfusion abnormalities.   
One recent study suggests that people with hypertension or hypercholesterolemia are 
more likely to develop Alzheimer's disease.  Therefore, the third objective of this research is to 
compare the perfusion changes related to hypertension to evaluate risk factors of hypertension 
and cardiovascular disease to dementia.   
1.8 RESEARCH OUTLINE 
Chapter 1 provides a high level motivation for the dissertation research to be conducted, and 
outlines the research objectives.  Chapter 2 presents basic concepts of CASL and further exposes 
the issues surrounding CASL.  Chapter 3 establishes the dual-Lorentzian model of off-resonance 
saturation.  Chapter 4 introduces and verifies an analytical model for inversion efficiency.  
Chapter 5 discusses the CASL kinetic model for perfusion quantification.  Chapter 6 adopts a 
fully deformable registration technique to CASL perfusion analysis.  Chapter 7 applies these 
quantitative techniques to the study of CBF in the progression of dementia.  Chapter 8 evaluates 
risk factors of hypertension and cardiovascular disease to dementia.   
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2.0  FOUNDATION 
2.1 INTRODUCTION OF MRI BASIC CONCEPTS 
2.1.1 What is MRI? 
MRI is a tomographic imaging technique that produces images using nuclear magnetic resonance 
(NMR) signals 66.   
MRI formation can be described as follows: First, nuclear spin angular magnetic 
moments (collectively called magnetization) are polarized by a main static magnetic (B0).  
Second, the orientation of the magnetization is tipped or nutated by tuning RF (B1) to the 
resonant (precession) frequency and measured using magnetic field induction.  Third, a magnetic 
field gradient is used to spatially encode and readout the magnetization by creating linearly-
varying precessional frequencies.  The MRI signal is readout or sampled in conjugate k-space 
and converted into an image typically using Fourier transformation. 
2.1.2 Magnetized nuclear spin system 
A physical object is composed of nuclei and electrons.  These nuclei possess a spin angular 
momentum.  At room temperature, the spin orientations are completely random in the absence of 
an external magnetic field, due to thermal random motion.   
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The nuclear spin vectors μ is lined up to activate macroscopic magnetism from an object 
by exposing the object to a strong external magnetic field B0.  For spin-1/2 nuclei (normally 
referred to as a nuclear spin system) like 1H, 13C, 19F and 31P, a spin takes one of two possible 
orientations: parallel or antiparallel to the B0 direction, as shown in Fig 2.1.  The angle θ between 
μ and B0 is 54044’ based on the relation of magnetic moment number and spin quantum number.  
The angular frequency of nuclear precession is  
000 2 Bf γπω ==          (2.1) 
where γ is physical constant known as the gyromagnetic ratio.  ω0 is known as the Larmor 
precession rate and f0 is called the Larmor frequency.   
θ 
B0 
Parallel 
Antiparallel
(a) (b) 
 
Figure 2.1. Nuclear magnetic moment vectors. (a) pointing in random directions and (b) aligned 
in the direction of an external magnetic field.  
  
Quantum theory indicates that the parallel state is the lower energy state, while the 
antiparallel state is the higher energy state.  The Boltzmann relationship is: 
)exp(
santi
para
kT
E
N
N Δ=     (2.2) 
where Npara  is the number of spins parallel to B0, Nanti is the number of spins antiparallel to B0, 
Ts is the temperature of the spin system (in Kelvin), ΔE = γhB0/(2π) is the energy difference 
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between the two states, k is the Boltzmann constant, γ is the spin gyromagnetic ratio, h is the 
Planck constant.  Equation (2.2) indicates that there is small excess of a spins in the low-energy 
state near room temperature (Ts=300K).  The population difference between the two spin states 
generates an observable macroscopic magnetization pointing along the direction of B0 from a 
spin system.  Such a spin system is said to be magnetized or polarized.   
2.1.3 RF excitations 
For a polarized spin system, the observable bulk magnetization is pointing along the direction of 
BB0.  There is no net transverse component of the bulk magnetization at equilibrium because each 
microscopic magnetic moment vector has a random phase.  Establishment of a phase coherence 
among these randomly precessing spins in a polarized spin system is referred to as resonance.   
An external force, an oscillating magnetic field denoted as B1, is added into the magnetized 
spin system to generate the resonance condition.  The resonance condition based on classical 
physics is that B1 rotates in the same manner as the precessing spins.  i.e., the radiation frequency 
ωrf of B1 is equal to the Larmor frequency ω0.  
0ωω =rf           (2.3) 
Equation (2.3) is known as the resonance condition.   
The B1 field is typically applied as an RF pulse, which is normally turned on for a few 
microseconds or milliseconds.  Morever, the B1 field is much weaker compared with the static B0 
field. 
The change of bulk magnetization M with time after applying magnetic field B1(t) is 
described quantitatively by the Bloch equation, ignoring relaxation.   
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BM
dt
Md vr
r
×= γ           (2.4) 
As a result of the RF pulse, the bulk magnetization is tipped away from the B0 direction, creating 
a measurable transverse magnetization component.  The flip angle is defined as the resulting 
angle between M and the B0 direction.  The flip angle depends on both the magnitude of B1(t) 
and the duration that B1 is applied on.  When 0ωω ≠rf , the RF excitation is called off-resonance 
excitation.   
2.1.4 Free precession and relaxation 
The tipped magnetization after an RF pulse will return to its thermal equilibrium state according 
to the laws of thermodynamics if given sufficient time and the RF pulse is removed.  This 
process is characterized by a precession of M about the B0 field, called free precession; a 
recovery of the longitudinal magnetization Mz, called longitudinal precession; and the 
destruction of the transverse magnetization Mxy, called transverse relaxation.  The Bloch 
equation takes the general form after adding the relaxation process: 
 
1
0
2
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T
kMM
T
jMiM
BM
dt
Md zzyx
rrvvrr −−+−×= γ      (2.5) 
where T1 and T2 are time constants characterizing the longitudinal and transverse relaxation 
process of the spin system, respectively, after it has been disturbed from its thermal equilibrium 
state.  Both the decay of transverse magnetization and the recovery of longitudinal magnetization 
after an RF perturbation follow an exponential function from Equation (2.5).   
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2.2 PERFUSION AS PHYSIOLOGICAL STATUS 
The term perfusion describes the amount of blood delivered to the capillary beds of a block of 
tissue in a certain period of time.  Its units are nominally milliliter of blood per 100 g of tissue 
per minute.  Perfusion is blood flow at the capillary level, different from bulk blood flow which 
occurs along major arteries and veins.   It reflects the delivery of oxygen and other nutrients to 
the tissue, and so is related to the energy status or metabolism of the tissue.    
2.2.1 Measurement (Models) of Perfusion & current status 
Researchers have put much effort into the measurement of perfusion since perfusion is an 
essential hemodynamic parameter.  Numerous diagnostic imaging techniques (such as PET, 
SPECT, and MRI) have been devised to measure tissue perfusion.  Some of the studies targeted 
relative perfusion.  However, this research will only concentrate on the quantification of absolute 
perfusion.  Each technique is based on the principles of tracer kinetics.    
PET quantitative measurement of perfusion involves the intravenous injection of a 
radioactive tracer (such as H215O).  Perfusion was calculated using either the time-weighted 
integral method 67, a method not requiring arterial blood data 68, or a method based on tracer-
washout rate 69.  The three methods are based on the one-tissue compartment model for H215O 
represented by the differential equation:   
)()()( 21 tCktCKdt
tdC
a −=        (2.6) 
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where C(t) denotes tissue activity concentration.  Ca(t) is the measured arterial input function 
(AIF), K1 is the influx rate constant for washin (regional perfusion) and k2 is the outflux rate 
constant for washout (regional perfusion/partition coefficient).   Assuming no tissue activity 
before tracer application at time zero, the solution of Eq. (2.6) is given by: 
∫ −− =⊗= t tukatka dueuCKetCKtC
0
)(
11
22 )()()(      (2.7) 
SPECT perfusion also uses an intraveneous radiolabeled tracer (such as 99mTc-ECD).  A 
three-compartment model was used to describe the tracer kinetics 70-72 (Fig. 2.2).  The following 
equation can be used to describe the model: 
ττττ τ deCa
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kKdCa
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kKtC tkk
tt
b
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31 32)()()( −+∫∫ +×++×=    (2.8) 
where Ca(t) and Cb(t) are the respective concentrations of the tracer in arterial blood and brain 
tissue corrected for physical decay.  K1 is the influx rate constant for washin (regional perfusion) 
and k2 is the outflux rate constant for washout (regional perfusion/partition coefficient).  k3 is the 
lipophilic-to-hydrophilic conversion constant and k4 is the hydrophilic-to-lipophilic conversion 
constant.  The reverse conversion constant, k4, is hypothetic, and its value is assumed to be zero 
in these studies.   It is not difficult to see that the SPECT three-compartment model (Equation 
2.8) can be simplified into the PET one-tissue compartment model assuming k3 to be zero. 
Two main MRI approaches for perfusion quantification have been developed: dynamic 
susceptibility contrast (DSC) MRI and arterial spin labeling (ASL).  DSC MRI involves the 
injection of a bolus of contrast agent.  Since the arrival time of the bolus through the tissue is 
only a few seconds, a fast imaging technique is required to obtain sequential images during the 
washin and washout of the contrast material.  Single-shot echo planar imaging (EPI) or spiral 
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acquisitions, a fast imaging technique, allows an improved characterization of the passage of the 
bolus and facilitates the acquisition of multislice data, thus increasing the regional coverage of 
the technique.  The DSC model relies on the assumption that in the presence of an intact BBB, 
the contrast material remains intravascular.  The concentration CVOI(t) of tracer in given volume 
of interest (VOI) can be described by the following equation 73: 
))()(()()( tRtCF
k
tC aVOI
H
VOI ⊗= ρ       (2.9) 
where Ca(t) is the concentration of contrast agent entering VOI at time t.  R(t) is the residue 
function, the fraction of injected tracer still present in the VOI at time t following an ideal 
instantaneous unit bolus injection at time t = 0.  FVOI is the perfusion in the VOI, ρ is the density 
of brain tissue and kH accounts for the difference in haematocrit (H) between capillaries and 
large vessels.    
 
 
 
 
 
 
 
 
BBB
k4
k3K1
k2
Hydrophilic Lipophilic Lipophilic 
Tracer in plasma 
Ca(t) 
 
Figure 2.2.  Kinetic model of the tracer with three compartments and four parameters.  K1 to k4 
are rate constants for transport of tracer between compartments.  Ca(t) and Cb(t) are respective 
concentrations of the tracer in arterial blood and brain tissue corrected for physical decay.  BBB 
= blood-brain barrier. 
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ASL employs endogenous blood water as the tracer.  An MR image can be made 
sensitive to the effect of inflowing blood spins if those spins are polarized differently than the 
tissue water spins.  ASL fulfills this idea by saturating or inverting the magnetization of the 
arterial blood 45, 47.  Blood water carrying the labeled magnetization flows into the image slice 
and exchanges with tissue water.  Perfusion is directly related to the subtraction of an image in 
which inflowing blood spins have been labeled from an image (the labeled image) in which 
inflowing spins are intact (the control image).  The tissue model for quantification of perfusion 
with ASL can be derived from the Bloch equation for longitudinal relaxation when it is modified 
to include the effects of flow 47: 
)()(
)()(
1
0
tMftfM
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−=        (2.10) 
where Mb(t) is the longitudinal magnetization per gram of brain tissue water, Mz0 is the 
magnetization of fully relaxed tissue, T1 is the longitudinal relaxation time, f is the perfusion 
(converted to ml /100g-min), Ma(t) is the magnetization of the inflowing arterial blood per ml, λ  
is the blood:brain partition coefficient.  The first term [fMa(t)] represents the gain of 
magnetization by the tissue caused by inflows, and the second term )(tMf bλ  accounts for the 
loss of magnetization due to outflow.  This tissue model can be subsumed into the general kinetic 
model as a special case with appropriate assumptions (1. the arrival of labeled blood at a 
particular voxel is via uniform plug flow; 2. the kinetics of water exchange between tissue and 
blood is described by a single-compartment; 3. the water is completely extracted from the 
vascular space.)74.  The general model for quantitative perfusion imaging with ASL is described 
as: 
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where is the difference in control and labeled longitudinal magnetization due to blood that 
entered the voxel during the interval [0, t] and still present in the voxel; M
)(tMΔ
0b is the magnetization 
of fully relaxed arterial blood; α is the inversion efficiency, a fraction accounts for the imperfect 
inversion;  f is the perfusion rate; c(t) is the arterial delivery function, i.e. the normalized arterial 
concentration of magnetization arriving at the voxel at time t; r(t, t’) is the residue function, the 
fraction of labeled water that arrived at time t’ and is still in the voxel at time t; m(t, t’) is the 
magnetization relaxation function, i.e. the fraction of original longitudinal magnetization carried 
by water that arrives at time t’ that remains at time t.  Assuming that the physiological state of 
the tissue is not changing, then r(t, t’) and m(t, t’) are functions of just the interval t-t’, and are 
written as r(t) and m(t).  is constructed as a sum over the history of delivery of 
magnetization to the tissue weighted with the fraction of that magnetization that remains in the 
voxel.  After the inversion pulse, the arterial magnetization difference is ideally 2M
)(tMΔ
0b but 
practically 2αM0b due to the imperfect inversion.  The amount of magnetization delivered to a 
particular voxel between t’ and t’+ dt’ is ')'(2 0 dttfcM bα , the fraction of that magnetization that 
remains at time t is .  The kinetic model takes into account a finite arrival time 
and limited bolus width.   
)'()'( ttmttr −−
In all of these perfusion models, the tracer concentration at time t can be expressed as a 
superposition of the tracer arterial input function weighted with the residue function over the 
time interval [0, t], which we see in convolution form in the models; the perfusion is proportional 
to the tracer concentration and inversely proportional to the convolution.   
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2.2.2 Measurement of perfusion using ASL 
In ASL, arterial magnetization is usually achieved by spin inversion.  The various ASL 
techniques can be distinguished by different ways in which the spin inversion is achieved.  Two 
techniques have been developed: CASL and PASL.   
CASL: The first CASL proposed by Detre et al. 47 used a train of RF pulses to 
continuously saturate (or label) the blood water as it flowed into the brain for several seconds.  A 
steady state of brain tissue magnetization developed and a labeled image was acquired.  A 
control image was acquired without labeling the arterial water.  The difference between these 
two images led to the perfusion map from Equation (2.10) 45: 
cont
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where and  were the steady state control and labeled tissue magnetizations 
respectively, was the longitudinal relaxation time of brain tissue including the effect of flow: 
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Equation (2.13) describes the relationship of the apparent longitudinal relaxation time to 
perfusion.   
Willams et al. 45 improved the first CASL technique by replacing the spin saturation with 
adiabatic first passage (AFP).  The blood water proton spins flowing through magnetic field 
gradient G at velocity v are inverted if the adiabatic condition 48 is satisfied, i.e. 
1121 )/1(/1,/1 BGvBTT aa γ<<<<       (2.14) 
where T1a, T2a are the longitudinal and transverse relaxation times of arterial blood water; BB1 is 
the amplitude of the RF pulse; G is the amplitude of the field gradient; v is the blood velocity; 
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and γ  is the gyromagnetic ratio of the nuclei.  In practice, this means that inversion must take 
place in a major artery where the blood velocity is sufficient to satisfy the above condition.  
Some of the velocities may not meet the adiabatic condition since a range of velocities may be 
present, resulting in imperfect inversion of arterial blood magnetization.  The inversion 
efficiency α was introduced to Equation (2.11) and (2.12) to account for the imperfect inversion 
effect.  α is 1 if all flowing water spins are inverted and 0 if no spins are inverted at all.   
Several additional factors affect the accuracy of perfusion quantification using CASL.  
The most important of these are addressed below.  The first factor is the arterial arrival time.  
Equation (2.12) assumes that blood water reaches the tissue of interest in a state defined by α, the 
inversion efficiency.  However, the blood spin takes time to travel from the place where the spin 
is originally inverted to where it reaches the tissue, and the degree of blood spin inversion 
decreases during the arrival time due to the T1 relaxation.  Zhang et al. 52  took this effect in 
account by measuring the arrival time and incorporating it into the Bloch equation analysis.  An 
arrival time map on a voxel-by-voxel basis is necessary since a range of arrival times will exist 
across an image.  However, SNR and time restrictions do not typically allow the accurate 
estimate of arrival time on a voxel-by-voxel basis.  Alsop and Detre modified the standard CASL 
technique by putting a delay between the end of labeling period and the image acquisition 54.  
They showed this approach prevents the quantification of perfusion from being sensitive to 
differences in arrival time, as long as the delay is longer than arrival times for the whole image.  
However, the long delay will cause a loss of SNR and is limited by the T1 relaxation.   
The second factor affecting perfusion accuracy is magnetization transfer (MT).  The long 
off-resonance RF pulse used to invert the arterial blood water, results in off-resonance saturation 
of water.  Although no direct saturation of the observed water magnetization occurs in the 
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imaging slice due to the narrow resonance peak of free water and several kHz off-resonance of 
the RF pulse, the magnetization of water bound to macromolecules is affected because of the 
very wide resonance peak of this group of spins.  MT through chemical exchange or coupled 
cross-relaxation between free water and water bound to macromolecules causes the observed 
MRI signal to drop.   
MT effects decrease the signal magnitude of both label and control images.  If the off-
resonance saturation effects are matched for the label and control, the residual MT (ΔMT) is zero.  
If the saturation effects are not matched, ΔMT can mask the perfusion signal.  MT effects need to 
be removed from the control-label difference signal for accurate quantification of perfusion 52, 75.   
The CASL control image must experience exactly the same MT effects as the labeled 
image.  One can place the control plane above brain either by changing Δf polarity or gradient 
polarity, The former is preferable to maintain the same gradient-induced eddy current effects 
between the label and control.  Certainly no blood inversion occurs in this case, but only a single 
slice could satisfy the MT matching condition, making this method hard to extend to multislice 
acquisition (Figure 2.3a).   
A two-coil setup can be used to prevent the saturation of macromolecules 76.  A small 
surface coil is placed on the neck for arterial blood labeling, and no off-resonance saturation 
effects are noticed in the brain since the B1 of the small coil is only limited in the neck region.  A 
separate RF coil is used for imaging.  This approach can be extended to multislice perfusion 
imaging since there is no off-resonance saturation effect in either the control image or the labeled 
image.  However, this method requires specialized hardware that is not available from 
commercial scanners.  In addition, macromolecules are not saturated so chemical exchange of 
labeled spins becomes a significant concern in perfusion kinetics.  
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The third factor affecting perfusion accuracy is the intravascular signal contamination.  
Both MRI ASL perfusion models describe the relation between perfusion and tissue water 
magnetization.  However, a MRI voxel signal may come from capillaries and from large vessels.  
The signal in large vessels will contribute to a signal difference between control and labeled 
image, which is not desirable for the perfusion calculation.  If a significant amount of signal 
emanates from the large vessels, perfusion will be overestimated.  Flow-sensitive crusher 
gradients have been used to eliminate signal from these large vessels 47, 53, but these tend to 
reduce the perfusion signal resulting in an underestimation of perfusion.    
Another alternative approach is the arrival time insensitive sequence as mentioned above 
from Alsop and Detre.  The long postlabeling delays allow most of the labeled blood to either 
exchange with the tissue or wash through the large vessels.  However, the resulting difference 
signal is smaller or the tracer may relax altogether resulting in an underestimation of perfusion. 
In addition, it is unclear how to ensure the postlabeling delay is larger than the transit time if the 
latter is unknown.   
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Figure 2.3.  Off-resonance saturation effects of control and label planes of CASL: (a) single-slice 
alternating proximal and distal irradiation (APDI), (b) multislice simultaneous proximal and 
distal irradiation (SPDI), (c) multi-slice alternating single adiabatic inversion and double 
adiabatic inversion (ASD).     
2.2.3 Advantages and disadvantages of perfusion MR techniques 
Although neither ASL nor DSC-MRI requires ionizing radiation, ASL has the extra benefit of 
using an endogenous contrast agent.  Therefore, multiple measurements can be performed, in 
principle, without any restriction.  The complete noninvasive character of ASL makes it superior 
to DSC for research studies.  Although multiple bolus injections of contrast agent can be 
performed, the acceptable maximum dose is typically limited to 0.3 mmol/kg per exam.  A lower 
dose which must be administered in multiple measurements reduces the sensitivity of the 
technique.  An advantage of DSC is that the change in signal intensity is generally 10-50%.  In 
ASL, the intrinsic perfusion signal is normally only 0.5-3% so that excellent SNR is required for 
accurate perfusion measurements.   
 Although both MRI techniques behave reasonably well in the range of normal perfusion 
values, they have difficulties in dealing with very high or very low perfusion.  With very low 
flow, the first obvious limitation is the low SNR of the measurement.  This can be improved in 
the ASL technique by increasing the number of averages, which is not optional in typical single 
DSC studies because of its dynamic character.   
The second problem is related to the presence of long arrival delays for the arterial blood 
to the region of interest, which is the case for collateral circulation in stroke regions.  Extra 
delays of up to several seconds can be observed in the ischemic tissue.  The very long arrival 
delays are one of the fundamental limitations of the ASL technique for measuring perfusion 46, 52-
54, 77.  It may be impossible to have the tagged tracer arriving at the tissue before relaxation and, 
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therefore, no effect will be observed.  For DSC studies, the presence of long bolus arrival times 
is also a problem.  The transit of the bolus from the site of injection (typically a vein) to the VOI 
can introduce a delay, as well as dispersion (spread of the bolus shape).  If one does not account 
for this delay and dispersion, it may cause an underestimation of the perfusion 43, 44, 73, 78.  
Although one can account for the dispersion from the site of injection (vein) to the artery where 
AIF is measured, the extra dispersion from the artery to the input of the VOI (where the true AIF 
should be obtained) cannot be ascertained easily.  The extra dispersion is particularly significant 
in cases of collateral flow to ischemic areas.  To address this problem, a mathematical vascular 
model has been incorporated into the DSC analysis 43.  However, further validation is needed for 
a large number of patients with cerebrovascular diseases.   
The case of very high flows can be problematic for both MRI techniques.  For ASL, the 
assumption of complete exchange may not be valid for high CBF 79, 80.  If this incomplete 
exchange is not taken into account, the perfusion will be underestimated since only a fraction of 
the arterial magnetization is exchanged.  For DSC, the response curve is narrowed, resulting in 
potential difficulty to accurately characterize perfusion for a given time resolution.  However, 
dispersion from the site of injection causes the bolus to be widely spread even when the 
perfusion is high.   
Both ASL and DSC techniques ca n be used in a multislice protocol, although there is a 
limitation to the maximum number of slices in each case.  In DSC, coverage is given by a 
compromise between the number of slices and the time sampling resolution.  For typical 
repetition time values (TR) of 1-2 s, a coverage of 10 to 15 slices can be achieved using EPI.  In 
ASL, the maximum number of slices is limited by arrival times and the relaxation of the 
endogenous tracer.  Typically a coverage of 5 to 10 slices can be obtained depending on the 
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spatial resolution, yet we get 19 slices.  Another possibility for the whole brain coverage is 3D 
image acquisition 81, 82, though the spatial resolution tends to be reduced. 
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3.0  A MODEL OF MAGNETIZATION TRANSFER IN SINGLE-COIL CASL 
3.1 INTRODUCTION 
The magnetization of macromolecular protons cannot be easily measured directly with MRI 
since the T2 of the macromolecules in biological tissues is too short (i.e. less than 1 ms).  
However, the magnetization of macromolecular spins can be transferred to the free water spins 
through the exchange of magnetization by either chemical exchange or cross-relaxation.  As 
shown in Fig. 2.3, one can choose to saturate the macromolecular spins by using off-resonance 
radio frequency adiabatic pulses because the macromolecular spins have a much broader line 
shape than the free water spins.  Only macromolecular spins are saturated and further their 
magnetization is transferred to the water spins which can be detected with MRI.   
Single-coil CASL techniques employ the same RF coil for labeling and imaging.  
Examples include the traditional single-slice Alternating Proximal and distal Irradiation (APDI) 
45, multi-slice Simultaneous Proximal and Distal Irradiation (SPDI) 60, and multi-slice CASL 
with Alternating single adiabatic inversion (SAI) label and double adiabatic inversion (DAI) 
control irradiations (ASD) 61 (see Fig. 2.3).  Although there are some variances about the design 
of their label and control sequences, all of them suffer off-resonance saturation effects from the 
RF pulses employed for the label and control sequences.   
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The off-resonance saturation causes the loss of MRI control and label signals, on which 
quantification of perfusion is based.   Therefore the signal difference of control and label images 
includes both perfusion and residual MT signals.  The MT effects must be quantified and 
accounted for to permit accurate quantification of perfusion.   
A quantitative analysis of off-resonance saturation has been developed by a number of 
investigators using a two-pool model consisting of a free water pool and a semi-solid 
macromolecular pool with restricted mobility.  Various line shapes have been used to describe 
the absorption probability of the semi-solid pool: Lorentzian 83, Gaussian 55, superLorentzian 56, 
“Kubo-Tomita” 84, 85 and a flexible line shape 86.  Each line shape was shown to have quantitative 
correspondence to experimental measurements.   
In previous in vitro MT experiments 55, 56, 86, off-resonance irradiation was applied using 
a long continuous wave irradiation (~ 7 s) to ensure a steady state.  For practical in vivo imaging 
experiments, the continuous-wave irradiation is not yet widely available because imaging RF 
transmitters are currently designed for pulsed RF, not continuous, operation.  Pulsed off-
resonance irradiation is necessary because of limitations in RF driver performance to keep the 
power deposition (SAR) within acceptable limits.  MT effects with pulsed RF irradiation were 
also studied 87.   
In CASL experiments, the off-resonance adiabatic RF pulses are used in conjunction with 
a gradient to label the inflowing blood spins.  The pulses saturate the macromolecules based on 
their resonance offset from the labeling plane.  The RF pulses cannot be performed continuously 
due to hardware limitations and therefore a pulse RF train with high duty cycle (~90%) was 
achieved in our experiments.  The duration of the RF train (3.7 s) may be too short to reach the 
steady state.  Therefore, off-resonance saturation effects associated with CASL have to be 
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characterized separately since saturation is heavily dependent on the specific details of the pulse 
sequence and scanner imaging hardware.   
3.2 THEORY 
 A tissue may be modeled by a pair of proton spin pools, named as pool A and B.  Pool A is a 
free water pool.  Pool B is a semi-solid macromolecular pool.  Pools A and B interact via dipole-
dipole interaction.  These coupled pools can be described by the set of Bloch equations in the 
presence of an RF field 83: 
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where M0a,b is the equilibrium longitudinal magnetization in the absence of any RF field from 
pools A and B respectively.  Mx,y,za,b are the x, y, z components of the magnetization of pools.  
T2a,b is the transverse relaxation time.  Ra,b is the longitudinal relaxation rate (1/T1a,b).  Rba is a 
pseudo-first-order cross-relaxation rate constant from pool B to pool A.  ω1 is the amplitude of 
off-resonance saturation pulse.  Δ is the frequency offset of saturation pulse.  f is the ratio of the 
number of B spins and the number of A spins.  The steady-state solution gives a Lorentzian line 
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shape for both free water and macromolecular pools.  The experiment was demonstrated in 
samples of bovine serum albumin 83.   
Henkelman et al., 55 modified the model by keeping the model symmetric with respect to 
the two pools.  Noticing Rab = Rba/f and f = M0b/M0a, we know that Rba/Rab = M0b/M0a.  So 
Henkelman et al. introduced a fundamental rate constant R such that Rba = RM0b and Rab = RM0a.  
Therefore (3.1) and (3.2) can be written symmetrically as: 
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The steady state solution was solved by making all time derivatives equal to zero of Eq. (3.6) - 
(3.9).  By noting that 1)2( 2 >>Δ aTπ , the solution can be simplified as: 
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As seen from Eq. (3.8), the pool B is of Lorentzian line shape.  However, they showed that a 
Lorentzian line shape is not adequate to describe their MT data acquired from agar gel.  They 
proposed a Gaussian line shape for pool B: 
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The Gaussian line shape was shown to agree well with their agar gel data.  Morrison et al., 
found the superLorentzian line shape can adequately describe the in vitro MT data of the tissues 
from bovine: 
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However, Li et al., showed that a nonparametric flexible line shape improves the fits noticeably 
by using the same bovine tissues.  All these methods utilized steady state off-resonance 
continuous wave (CW) saturation techniques with variable offset saturation frequencies and 
amplitudes.   
Due to the restriction of specific absorption rate (SAR) and the inability to generate CW 
irradiation on most clinical scanners, this technique is difficult to implement in vivo for humans.  
Holt et al. 88, proposed off-resonance pulsed irradiation.  However, the steady-state Bloch model 
does not provide an adequate theoretical description of pulsed MT.  A general mathematical 
description of the time-dependent pulsed MT was proposed, but the data processing was very 
complicated.   
Sled and Pike developed 87 an approximated signal equation for a spoiled gradient-echo 
imaging sequence.  Sled and Pike 57 demonstrated this method in uncooked beef and in vivo in 
human.  The superLorentzian yielded a close fit compared to Gaussian or Lorentzian line shape 
for their uncooked beef experiment.  The superLorentzian line shape is then used to derive 
parameters for in vivo measurements.  However, the experiment protocol includes a large 
number of MT-weighted scans and time-consuming acquisitions.  Moreover, the model still 
remains complicated since it requires a numerical solution of the Bloch equations to estimate a 
direct saturation. 
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Our CASL experiment utilized off-resonance saturation using pulsed trains.  We derive 
the CASL-related non-steady state model from the Eq. (3.3) - (3.6).  The pulse duration of our 
CASL experiments was 3.7 s, which is equal to more than 3 times T1 (approximately 1 s) of Gray 
matter, but more than 5 times T2 ( approximately 100 ms) of Gray matter.  The transverse 
magnetization should be in the steady state; the longitudinal magnetization may not reach the 
steady state.  Therefore, we need to introduce two constant, (Ca and Cb) to describe the 
instantaneous longitudinal relaxation rate.   
For transverse steady state, the time derivatives from Eq. (3.3) and (3.4) must be zero.  
We can express Mya and Myb by Mza and Mzb respectively.  From the assumed longitudinal 
relaxation rate, we replace the above obtained expression of Mya and Myb into Eq. (3.5) and (3.6) : 
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 Mza can be solved by eliminating Mzb: 
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For the comparison of parameters, we simplify the Eq. (3.13) by using 1)2( 2 >>Δ aTπ  condition 
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There are seven parameters to be determined: R~ , Rb, , 1/Ra
b RRM /0 aT2a, T2b, Ca/RaM0
a and 
Cb/RaM0a. 
To account for the use of a pulse train, we defined the CW power equivalent amplitude of 
the MT pulse, which is equal to the mean saturating power of a pulse 58, 89.    
3.3 MATERIALS AND METHODS 
All data were acquired using a 1.5 T GE Signa system (Milwaukee, WI, LX).   The GE 
quadrature head coil was used for labeling as well as image acquisition.   Human subjects were 
scanned in accordance with approved Institutional Review Board (IRB) protocols after providing 
informed consent and passing MRI screenings.   MT measurements were acquired in healthy 
normal volunteers (ages 20-50).    
Off-resonance saturation measurements: A modified CASL sequence was used to measure 
off-resonance saturation (Fig. 3).   Because of hardware limitations associated with the clinical 
scanner (e.g., RF amplifier and transmit/receive switch), the irradiations were applied using a 
train of 44 pulses, each pulse with an 85 ms period and 93% duty cycle for AM frequencies 0 
and 125 Hz.   The maximum input RF amplitude was limited to 51 mG.    
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Except where noted, each off-resonance RF excitation was followed by the same 15 slice echo 
planar imaging (EPI) acquisition (64×64 matrix, 20 cm FOV, 5 mm thick, 0 spacing, MinFull 
(28 ms) TE, 62.5kHz receiver bandwidth (rBW), 1 s acquisition time, 900 Flip angle), with a 
sequential superior to inferior slice acquisition order.   A 100 ms delay was placed between the 
off-resonance saturation and image.  In this research, slice 1 corresponds to the superior slice; 
slice 15 corresponds to the inferior slice.    
Off-resonance saturation was characterized using three experiments described below.   
First, the dependence of the z-spectra on Bl was measured using variable RF amplitudes and 
offset frequencies (250 Hz - 17 kHz) to simulate APDI (fAM=0) and DAI (fAM=125 Hz) RF 
waveforms.   Images were also acquired without off-resonance saturation for normalization of 
the MT data.   A minimum of 15 repetitions was acquired for each frequency and amplitude.   A 
different individual was used to characterize each fAM because each exam typically lasted 90 
minutes (including structural images, and T1 and B1 maps).  A strong crushing gradient was used 
to eliminate any residual transverse magnetization between repetitions.   
BB1 maps: Multi-slice B1 map data were acquired for the image slices using EPI (8 s TR 
and MinFull 28ms TE, 62.5 kHz rBW) with varying nutations (20 different input flip angles 
varying from 18-189  in increments of 9 ) .  B0 0 90 1 maps were used to calibrate data acquired from 
the different experiments and determine the mean amplitude of the saturation RF for each image 
plane (designated herein as B1sat).     
Structural Images: Coronal T1-weighted spoiled gradient-recalled echo (SPGR) images 
covering the whole brain were acquired (124 slices with Matrix: 256 × 192; 1.5 mm thick and 
zero spacing, MinFull TE, 25 ms TR, 24 x 18 cm FOV, 16 kHz rBW).    The structural images 
were used in gray and white matter segmentation of the image data.   
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3.4 IMAGE PROCESSING AND DATA ANALYSIS 
Image processing:  Statistical Parametric Mapping (SPM) (Wellcome Department of Imaging 
Neuroscience) was used for EPI motion correction, gray and white matter segmentation, and co-
registration with the SPGR images.   MATLAB (The MathWorks, Inc.) programs were used to 
perform the statistical analysis of the EPI data.   
BB1 maps: B1 map data were fitted voxel-by-voxel to the three-parameter model: 
    )sin()( jjz CBAM φφ +=     (3.16) 
using a nonlinear algorithm, where φj is the incremented nutation angle; and A, B, and C are the 
fitting coefficients.   Each B1 field map was converted to B1sat based on the ratio of the saturating 
RF amplitude to the prescan calibration reference B1, corrected for any changes in transmit gains 
between the RF saturation and B1 map sequences.    
Saturation curves:  Saturation spectra were calculated separately for gray and white 
matter.   For each image plane, the signal distribution was fit to a Gaussian curve to determine 
the mean (Mz) and standard deviation for each offset frequency, and then normalized to the mean 
equilibrium signal (M0): 
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All of the saturation curves were corrected for signal increases caused by T1 relaxation that 
occurred during the delay between off-resonance saturation and image slice acquisition using: 
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where τ is the RF saturation period, w is the post-saturation delay, tacq is the acquisition time with 
respect to the beginning of the acquisition window, and T1t is the relaxation time of the tissue 
(1.065 and 0.800 s for gray and white matter, respectively, based on our 1.5 T brain studies).     
Equation (3.15) was fitted to the experimental results using a least squares technique.  A set of 
seven parameters (Rb, T2b, R
~ , [RM0b/Ra], [1/RaT2a], Ca/RaM0a and Cb/RaM0a) can be obtained.  
Henkelman et al., suggested that parameter Rb be fixed since Rb is insensitive to the residual sum 
of squares and its accurate value cannot be determined.  The parameter was also fixed in our 
work to save the time of fitting for an unnecessary parameter (Rb = 1 s-1).   
One off-resonance irradiation power measurement was not sufficient for uniquely 
determining the fitting parameters for the model.  The experiment was performed at three 
different irradiation amplitudes 1ω /2π (78Hz, 110Hz and 156Hz for APDI, 128Hz, 181Hz and 
256Hz for DAI).  For CASL, irradiation amplitudes of ~110Hz for APDI and ~180Hz for DAI 
are typically used.  We used 12 different offset frequenciesΔ , distributed from 0.25 to 15 kHz.     
We performed a global fit to Equation (3.14) of each data set with 12 different offset frequencies 
and 3 irradiation powers with the superLorentzian, Gaussian, and Lorentzian line shapes.  
Unique sets of seven model parameters cannot be obtained from the experimental data.  However, 
for each initial value of the pair of (Ca, Cb), unique sets of five model parameters can be 
determined.  Each initial value of (Ca, Cb) reaches a local minimum.  The right initial value of 
pair (Ca, Cb) would lead to the minimum average residual deviation from the experimental data.  
Therefore, we chose the initial value of pair (Ca, Cb) that minimizes the average residual 
deviation for a global fit.   
Quality of the fit was evaluated as the average residual deviation per point between the fit and 
experiment, Nssq /=σ  86 (where ssq is the sum of squares, N is the number of data points).  
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The error of fitted parameters was determined by finding the maximum and minimum value of 
the parameters for an increase of 1 in , while keeping all other parameters fixed 2χ 91.   
3.5 RESULTS & DISCUSSION 
Average residual derivation σ values for the fits to the two-pool model using superLorentzian, 
Gaussian and Lorentzian line shapes are shown in Table 3.1.  For both gray and white matter 
with different RF waveforms, the average residual deviation with the Lorentzian fit is reduced 
60% compared with the Gaussian fit, and 92% compared with the superLorentzian fit.  The 
average residual deviation (average 0.0125) from the parametric fit is comparable with the best 
reported value from nonparametric fit (average 0.013) 86.  Figure 3.2 shows the comparison of 
representative fits (human gray matter saturation curve at f = 0 Hz) using the superLorentzian, 
the Gaussian, and the Lorentzian line shapes.  The fits with superLorentzian line shape deviate 
significantly from the experiment.  The Gaussian line shape does not result in as good a fit as the 
Lorentzian line shape.  There is overall improvement in the fit using Lorentzian line shape 
compared with either the Gaussian or superLorentzian line shape. 
For steady-state off-resonance continuous-wave irradiation, researchers have suggested 
that the Gaussian line shape is appropriate for solids and gels 55; superLorentzian is suitable for 
tissues 56.  However, Li et al., suggested a non-parametric flexible line shape because the average 
behavior of a variety of macromolecular types may not be adequately represented by any 
analytical line shape.  Another disparity between our study and previous studies is that we used 
all gray and white matter tissues from one axial slice instead of sampling several points or 
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drawing a region.  The heterogeneity of the gray and white matter will affect the line shape of the 
semi-solid pool.   
Both Tozer et al. 58 and Ramani et al. 89, reported that the Gaussian line shape provides a 
superior fit than the superLorentzian for the tissue off-resonance non-steady state (14.6 ms MT 
pulse) saturation data in their pulsed RF sequence.  They indicated that the tissue off-resonance 
saturation may have different line shapes for different pulse sequences and imaging hardware.  
The non-steady state may affect the line shape of off-resonance saturation.  
Figure 3.3 shows the fit of gray matter and white matter saturation data of human brain 
for APDI and DAI RF waveforms to the two-pool model with a Lorentzian line shape for the 
semi-solid pool.  The two-pool model with Lorentzian line shape for the semi-solid pool is very 
good for even different RF waveforms.  All the fitted parameters for the gray and white matter at 
two different modulation frequencies are shown in Table 3.2.   
The differences of parameters between APDI and DAI further prove that the off-
resonance saturation is also heavily sequence-dependent, as we mentioned in the introduction.  
The values of Ca/RaM0a and Cb/RaM0a less than 10-6 indicate that the saturation pulse achieves a 
condition very close to the steady state.  We compared the average residual derivation σ by 
setting both Ca/RaM0a and Cb/RaM0a to zero. The average residual derivation σ only increases 
1.6% for the RF saturation data of white matter at f = 125 Hz if we set both Ca/RaM0a and 
Cb/RaM0a to zero. We cannot assert whether these two parameters are truly zeros or not. The T2 
times for the gray and white matter semisolid pools are short (~40 sμ ), and are in the range of T2 
that was measured by Tozer et al. for tissue white matter (18 sμ ) 58 and reported by Caines et al.  
for rat muscle (58 sμ ) 92.  The values of 1/RaT2a of white matter are in the range of 1/RaT2a 
measured by Sled and Pike for white matter tissue 57(16) and reported by Tozer et al. for white 
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matter tissue (44) 58.  The values of RM0b/Ra for gray and white matter are in the range [1.7-3.5] 
and [1.5-3.7] respectively, calculated within the error range 57.  The exchange rate R of the 
saturation data (f = 0) is also comparable to those measured for human gray matter (33 ) and 
white matter (27 ) 
1−s
1−s 57.  The heterogeneity of the gray and white matter from the large region of 
interests will contribute to the variance of the parameters. 
The CASL MT Lorentzian model offers us the ability to calculate the off-resonance 
saturation effects for different frequency offsets corresponding to each slice.  The pure perfusion 
signal can be separated from the signal difference between the control and label images.  The 
signal from the control images can also be compensated back to the original signal for the signal 
drop from the CASL off-resonance saturation model.  The detailed compensation formula is list 
on Equation (5.16).  Therefore, the quantification of perfusion will be improved by predicting 
off-resonance saturation effects for each of our experiments. 
Table 3.1. Essential particles Average residual derivation σ for the best fits using superLorentzian, 
Gaussian, Lorentzian line shape for the semi-solid pool 
            Data Source   SuperLorentzian σ Gaussian σ Lorentzian σ 
Gray matter at f = 0 Hz 0.15 0.030 
 
0.0124 
White matter at f = 0 Hz 0.15 0.034 
 
0.0124 
Gray matter at f = 125 Hz 0.16 0.030 
 
0.0140 
White matter at f = 125 Hz 0.14 0.034 
 
0.0111 
 
Table 3.2.  Parameters for the Fit of Eq.[3.14] to the magnetization transfer data.(Rb = 1s-1) 
 
bT2 ( )sμ  R( ) 1−s
a
b
R
RM 0  
aaTR 2
1
 
a
a
a
MR
C
0
 b
b
b
MR
C
0
 
σ 
Gray at f = 0 Hz 34.2 ± 1.0 31.9 ± 0.6 2.44 ± 0.04 28.3 ± 1.2 <10-6 <10-6 0.0124 
White at f = 0 Hz 41.6 ± 1.1 28.4 ± 0.5 3.02 ± 0.04 28.1 ± 1.4 <10-6 <10-6 0.0124 
Gray at f  = 125 Hz 34.1 ± 1.2 45.1 ± 1.0 1.90 ± 0.03 15.3 ± 0.8 <10-6 <10-6 0.0140 
White at f = 125 Hz 44.8 ± 1.1 46.7 ± 1.1 2.69 ± 0.04 17.6 ± 1.0 1.8 × 10-6 1.9× 10-6 0.0111 
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  RF Saturation   
Image Acquisition 
 τ =3.7 s   w=0.1 s 1 s 
Crusher
  ··· 
 
Figure 3.1. Saturation Pulse Sequence and Timing. Crushers are applied after the RF saturation 
during the delay. 
 
 
 
SuperLorentzain 
σ = 0.16 
Gaussian 
σ = 0.03 Lorentzian σ = 0.01 
Figure 3.2. RF saturation data and fits for human gray matter at f = 0 Hz.  Data are shown for 
three different RF amplitudes ( πω 2/1 =78Hz (◊), 110Hz (□), 156Hz (*) Hz) and 12 different 
offset frequencies.  (a) The data fitted to Eq. (3.14) with a superLorezian line shape; (b) the same 
data fitted with a Gaussian line shape (c) the same data fitted with a Lorezian line shape for the 
semi-solid pool.  The average residual deviations per point (σ) are 0.16, 0.03, and 0.01, 
respectively, for the three fits. 
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(a) 
(c) (d) 
(b) 
f = 0 Hz 
f = 125 Hz f = 125 Hz 
f = 0 Hz 
Figure 3.3. (a) RF saturation data and fits for human (a) gray matter at f = 0 Hz; (b) white matter 
at f = 0 Hz; (c) gray matter at f = 125 Hz; (d) white matter at f = 125 Hz.  Solid red lines result 
from a global fit to Eq. (3.14) with the Lorentzian line shape for semi-solid pool.  In graphs (a) 
and (b), the marked points are the data for three different RF amplitudes ( πω 2/1 =78Hz (◊), 
110Hz (□), 156Hz (*) Hz) and 12 different offset frequencies.  In graphs C and D, the marked 
points are the data for three different RF amplitudes ( πω 2/1 =128Hz (◊), 181Hz (□), 256Hz (*) 
Hz) and 12 different offset frequencies.   
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4.0  A SIMPLE MODEL OF CASL INVERSION EFFICIENCY 
4.1 BACKGROUND 
Multi-slice continuous arterial spin labeling (CASL) using Alternating single adiabatic inversion 
(SAI) label and double adiabatic inversion (DAI) control acquisitions (ASD) has become a 
valuable noninvasive technique for measuring cerebral perfusion in the normal and diseased 
brain 61, 62, 93-95.   The advantages of ASD are: 1) the technique uses conventional hardware (i.e., 
single RF head coil) and is simple to employ in a clinical setting and 2) its residual 
magnetization transfer (MT) characteristics permit the perfusion in the entire cerebrum to be 
sampled.   However, one disadvantage of ASD is that the DAI control suffers from inefficiencies 
that reduce the perfusion signal-to-noise ratio (SNR) 62, 63 relative to conventional single-slice 
CASL using alternating proximal and distal irradiations (APDI) (i.e., SAI label and control 
acquisitions) 45 or multi-slice simultaneous proximal and distal irradiation (SPDI) 60.   
Two published studies have considered the improvement of the efficiency of the DAI 
control by computer simulations of the Bloch equations.  One focused on assessing the influence 
of each pulse parameter (RF pulse amplitude, B1; phase, φ and frequency, f ), spin velocity, and 
spin relaxation on the performance of DAI control 96.  However, no quantitative measurement or 
verification was provided for the derivation of optimal parameters.   The other work 97 
introduced a dimensionless parameter α, which is obtained from the labeling parameters (RF 
 
 
45
  
gradient strength G, RF pulse amplitude B1, and frequency f ) and the flow velocity.  The 
parameter provided a simple measurement for distinguishing three separate regimes, each 
characterized by a different magnetization trajectory, and therefore gained extra insight to derive 
optimal parameters for the DAI control.  However, Utting et al., 96 pointed out that unless f 
>2πBB1, φ determines the performance of the DAI control, but this relation has not been included 
in the optimization of parameters.  Therefore, more adequate measurements may be needed for 
the optimization of DAI control. 
The efficiencies for the SAI label and DAI control are required in calculating absolute 
perfusion rates from the CASL signals.   Currently, there is no standard method for estimating 
the DAI efficiency specific to each experiment.   Previously, researchers cited relative ASD and 
APDI efficiencies from earlier in vivo measurements, without compensation for varying clinical 
conditions.   Given that DAI and SAI planes tend to lie in the inhomogeneous region of the RF 
head coil for brain studies, the actual DAI and SAI efficiencies may vary significantly between 
subjects.   Relative efficiencies based on comparing ASD and APDI signals are subject to 
significant errors from MT asymmetry 64 and residual MT gradients associated with APDI.   
Accurate in vivo measurements of absolute adiabatic inversion efficiency are challenging 
because of the small arterial lumen size, the presence of pulsatile flow, and the need to minimize 
the exam time.   Simulations based on the Bloch equations have been employed for SAI 98-100 and 
DAI 96, 97 based on adiabatic fast passage (AFP) but implementation is time-consuming and may 
not adequately describe the behavior of in vitro or in vivio experiments.   Instead, simple models 
for inversion efficiencies are desirable.   The efficiency of SAI has been previously measured 
and modeled using the simple Zhernovoi model 101, 102.   Herein, we extend the Zhernovoi model 
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to DAI.   The primary advantage of these models over relative measurements is the ability to 
calculate the absolute inversion efficiency for each experiment with minimal scan time.   
4.2 THEORY 
ASD and APDI use a constant amplitude adiabatic RF envelope for SAI.   The envelope for the 
DAI control is amplitude-modulated at a low frequency (fAM < 500 Hz), thus creating two closely 
spaced sidebands separated in frequency by 2fAM, with each sideband receiving half of the 
envelope’s amplitude.   The envelope for SPDI is amplitude modulated at a high frequency (fAM 
> 10 kHz) to create two widely spaced sidebands, one of which is typically used for SAI.   These 
waveforms are further modulated at the desired Larmor frequency to adiabatically invert the 
arterial blood as it passes through the prescribed inversion region(s).   The labeling field 
amplitudes at the respective inversion region will depend on the B1 distribution of the coil, the 
input SAI and DAI RF amplitude settings, and the RF transmit gain.    
4.2.1 DAI Efficiency 
For a single inversion region, the adiabatic condition for a spin moving at velocity v, is: 
  l
l
l B
B
G
TT
γ<<•<< v1,1
21
rr
    (4.1) 
where BBl is the labeling RF amplitude measured at the inversion region (designated herein as 
BlSAIB  for SAI and BBlDAI for DAI), Gl is the labeling gradient amplitude, T1 and T2 are the 
respective spin-lattice and spin-spin relaxation times, and γ is the spin gyromagnetic ratio.   The 
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root-mean-square (rms) amplitudes of the SAI label and DAI control should be equal to 
minimize residual MT in the imaging volume .   Therefore, BlDAI46, 61 B  = BBlSAI/√2 for each of the 
two DAI inversion regions.   
Previously, we presented a general expression for the mean inversion efficiency in AFP 
based on Zhernovoi 102, 103: 
2
'
1
πβ
α −−= e     (4.2) 
where β’ is the effective adiabaticity factor based on the mean flow velocity <v> measured 
across the channel or artery: 
v
2
' rr •= l
l
G
Bγβ      (4.3) 
 
In general, the relationship between the final (Mf) and initial (Mi) magnetic moment 
associated with one or more inversions is: 
( ) ( )nij
nj
jif MwMM αα 2121 −≈−∏= =    (4.4) 
where αj is the inversion efficiency for each inversion indexed by j, wj is a weighting factor that 
accounts for relaxation and other losses that occur between successive inversions, n is the 
number of inversions [typically n=1 for SAI, n=2 for DAI for steady or biphasic (positive 
velocity) flow].   The approximation (right side of equation) assumes minimal losses between 
inversions (wj = 1) and a constant efficiency (αj = α).   These assumptions may not hold for 
cycled RF pulse trains (i.e., duty cycle less than 100%), fluids with short relaxation times relative 
to the inversion time 98, insufficient distance between inversion sites, or triphasic flows 
(containing positive and negative velocities).   
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Our simple model assumes that DAI is simply two successive adiabatic inversions, each 
with inversion efficiency αC.   The efficiency of DAI is then given by: 
2221 CC ααχ +−=     (4.5) 
Note that the definition of efficiency is different between SAI and DAI.   The SAI efficiency (α) 
represents the ratio of inverted spins to the equilibrium magnetization.   The DAI efficiency (χ) 
represents the ratio of uninverted spins to the equilibrium magnetization.   The SAI and DAI 
efficiencies do not include relaxation between the inversion and imaging regions.   For other 
CASL techniques (e.g., APDI, SPDI, or decoupled labeling and imaging coils 104) that do not 
suffer from control inefficiencies, αC is 0 and χ is 1. 
4.2.2 Calculation of Aggregate Efficiency for CASL 
Using Equation (4.4), the aggregate efficiency for CASL with SAI label and DAI control is: 
( ) LC
e
SAIDAI
eff CM
MM αααα +−≈−= 22
2
   (4.6) 
where αL is the inversion efficiency of the SAI label, and αC is the inversion efficiency of each 
DAI labeling site (sideband).    
The labeling field (Bl) can be measured in vivo using the B1 map sequence described 
above in less than 3 minutes.   The B1 field map is converted to BlSAI and BBlDAI based on the ratio 
of the SAI and DAI labeling amplitudes to the prescan calibration reference B1, corrected for any 
changes in transmit gains between the CASL and B1 map sequences.   Bl should be measured in 
the labeling plane adjacent to the artery, not inside the lumen, to avoid flow-induced errors.   
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The arterial velocities can be measured using a commercial phase contrast (PC) Cine 
velocity mapping sequence, with a scan time under 30 seconds.   The image plane should be co-
planar to the labeling plane, preferably transverse to the supply arteries for effective labeling and 
visualization of the lumen.   The sequence should measure the velocity component that is parallel 
to Gl.   We typically acquire 20 cardiac phases using peripheral gating to sample the arterial 
velocity as a function of time, averaged across the vessel lumen.   αC and αL should be calculated 
for each cardiac phase, and then averaged across the cardiac cycle to determine <αeff> for the 
experiment.    
4.2.3 DAI Amplitude Modulation Frequency 
Ideally, the DAI sidebands should be spaced such that the spins can be inverted by the first 
sideband and uninverted by the second sideband.   The spatial separation of the DAI sidebands is 
proportional to fAM and inversely proportional to Gl.   Both the spin inversion time and distance 
are proportional to Bl, and inversely proportional to Gl 105.   If the sidebands are spaced too close 
together relative to the spin inversion distance, the spins may be incompletely inverted by the 
first sideband and then incompletely uninverted by the second sideband.   By contrast, if the 
sideband spacing is too large, the spins are susceptible to relaxation effects in transit between 
sidebands that will also prevent the spins from returning to their equilibrium state.   
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4.3 MATERIALS AND METHODS 
All MRI experiments were conducted on a 1.5 T GE whole-body Signa LX MRI (Milwaukee, 
WI).    
4.3.1 Phantom Experiments 
The flow phantom and imaging methods used in this experiment have been previously described 
for similar SAI efficiency measurements 102.   The T1 and T2 of the flowing fluid (30 mM saline) 
were measured to be 2.36 s and 1.50 s, respectively.   
The gradients were fixed at either 0.25 or 0.5 G/cm for both the label (herein defined 
using DAI RF for our experiments) and control (herein defined without adiabatic RF) to match 
eddy currents.   The RF duty cycle was either 90 or 93% using a train of 44 pulses.   Each pulse 
was 80 ms in duration.   The center between the inversion regions was located 6 cm upstream of 
the axial image plane (i.e., oriented transverse to the direction of flow).    No transit delay was 
used and only a single echo-planar image slice was acquired.   
DAI efficiencies were measured in three experiments for different values of the DAI 
amplitude (AC) and: 1) labeling gradient (Gl); 2) flow velocity (<v>); and 3) DAI AM frequency 
(fAM).   Note: AC is defined herein as 2·BlDAI.   We assumed that BlDAI was equal between the two 
DAI inversion regions based on their close proximity.   
For the first experiment, we maintained laminar flow with a mean velocity of 18 cm/s in 
the flow apparatus and used two different values of labeling gradient (0.25 and 0.5 G/cm) while 
varying the DAI amplitude from 0 to a maximum of 60 mG.   In the second experiment, DAI 
efficiencies were measured for four flow velocities (mean velocities of 18, 26, 35, 44 cm/s) while 
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AC was varied from 0 to a maximum of 80 mG.   Gl was fixed at 0.25 G/cm.   In the third 
experiment, the DAI efficiency was measured for four different DAI AM frequencies (62.5, 125, 
250, 500 Hz) while BlDAI was varied from 0 to a maximum of 65 mG.   Gl was fixed at 0.25 
G/cm.   
BB1 maps: B1B  maps were used to calibrate data acquired from the different experiments 
and determine BlDAI at the DAI region.   Multi-slice B1 map data were acquired for the image and 
DAI slices using EPI (TR: 8 s and TE: MinFull 28ms, BW: 62.5 kHz) with varying nutations (20 
different input flip angles varying from 18-1890 in increments of 90) 90.   B1 map data were fitted 
voxel-by-voxel to the three-parameter model: 
    )sin()( jjz CBAM φφ +=     (4.7) 
using a nonlinear algorithm, where φj is the incremented nutation angle, A, B, and C are the 
fitting coefficients.   The mean B1 for the inversion region was used to calculate β’ using 
Equation (4.3).   
Image Processing: Interactive Data Language (IDL, Research Systems, Boulder 
Colorado) routines were used in image processing and analysis to select the flow region of 
interest (ROI) and to calculate the ROI statistics.   The DAI efficiency was measured by drawing 
a ROI within the flow tube lumen located downstream of the DAI region.   The DAI efficiency 
was calculated as:  
e
DAIe
measured MA
MM
2
1
−−=χ    (4.8) 
where the numerator is the magnitude of the complex difference between the unlabeled control 
(Me) and DAI image (MDAI) signals, and <A> represents the fraction of the signal remaining after 
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T1 relaxation during transit from the inversion regions to the measurement plane.   Models for 
<A> were presented previously for different flows 102.    
Computer Simulations: Numerical solutions of the Bloch equations including AFP were 
conducted using IDL in an effort to replicate the MRI results.   The simulations included 
different values of fAM (62.5, 125, 250, and 500 Hz), AC, <v> (9 – 35 cm/s in increments of 4.5 
cm/s) to replicate the dispersion in flow, and fluid relaxivities.   The results were averaged over 
the component spin velocities.   
4.3.2 In Vivo Measurements 
ASD and SPDI cerebral CASL data were acquired in 28 elderly subjects after informed consent, 
in accordance with the University of Pittsburgh Institutional Review Board (IRB).   Nineteen 
image slices were acquired using ramp-sampled EPI (64×64 matrix, 20 cm FOV, 5 mm thick, 0 
spacing, MinFull (21 ms) TE, 1 s acquisition time, 900 Flip angle) after a 700 ms transit delay.   
The ASD irradiations were applied using a 44 pulse train with an 85 ms period and 93% duty 
cycle.   SPDI used a 49 pulse train with a 76 ms period and 92% duty cycle.   The input RF 
amplitude was 35 mG for SAI (ASD label), and 49.5 mG for DAI (ASD control, fAM = 125 Hz) 
and 51 mG for SPDI (25.5 mG/sideband, fAM = 15.625 kHz).   ASD used a Gl of 0.25 G/cm 
while SPDI used a Gl of 0.37 G/cm.   The label was placed 10 cm below the center of the 
imaging volume, superior to the common carotid bifurcation.   Bl and arterial velocities were 
measured at the labeling planes using B1 map and conventional phase contrast (PC) cine 
velocimetry sequences.    
Statistical Parametric Mapping (SPM) (Wellcome Department of Imaging Neuroscience) 
was used for EPI motion correction, gray and white matter segmentation, and co-registration 
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with the high-resolution structural images.   MATLAB (The MathWorks, Inc.) programs were 
used to determine the mean gray matter CASL signals from the central image (10th) slice for the 
49 difference pairs (control – label) acquired for ASD, and 11 difference pairs acquired from 
SPDI.   Relative efficiencies were calculated using the ratio of the SPDI/ASD difference 
(control-label) signals.   A regression analysis was performed using the ratio of the aggregate 
SPDI/ASD efficiencies calculated from the efficiency models using the B1 map and PC Cine 
results.    
4.4 RESULTS  
Phantom Experiments 
The dependence of the percent difference signals (100·|Me-MDAI|/|Me|) on the labeling 
gradient is illustrated in Fig. 4.1 (top).   Difference signals were converted into DAI efficiencies 
(χ) and plotted as a function of β’ after correction for T1 relaxation attenuation in transit from the 
inversion regions to the imaging plane (Fig. 4.1 bottom) 102.   In general, the DAI efficiency 
starts from 1 at β’=0 (when the DAI control is turned off), drops to 0.5 at β’=0.5, then rises again 
to a peak at β’~3, and subsequently oscillates at higher β’ (Fig. 4.2).    
The effect of fAM can be observed in Fig. 4.3.  For the lowest fAM (62.5 Hz), χ inflects at 
β’~2.  The peak inflection point for 125 Hz is also noticeable at β’~3.6, indicating an oscillation 
as well.   The DAI efficiency drops as fAM is increased, presumably due to losses (e.g., relaxation 
and spin locking) that occur as the two inversion sites move apart.     
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The numerical solutions of the Bloch equations (Fig. 4.4) also demonstrate the oscillatory 
behavior of χ.   The simulations grossly mimic the behavior of our experimental results only 
when many different velocities are averaged together.    
In Vivo Measurements 
The in vivo measurements are summarized in Table 4.1.  The mean ratio of the 
SPDI/ASD difference signals measured in the gray matter was 1.16 +/- 0.05.   The mean ratio 
calculated from the simple efficiency models was 1.13 +/- 0.02.  Analysis of variance (ANOVA) 
yielded a correlation coefficient of 0.974.   
4.5 DISCUSSION 
The experimental data verify that χ is dependent on β’ (consisting of the BlDAI, Gl, and <v>), and 
fAM (i.e., the separation of inversion sidebands).   Bloch equation simulations and flow phantom 
and in vivo measurements are required to further assess the effects of the following on χ 98: RF 
pulse durations and duty cycles; different flow types (e.g., triphasic pulsatile flows) and 
velocities, fluids that simulate blood properties (T1 and T2 of 1.4 s and 0.24 s, respectively, 
measured at 1.5 T) 106; and pulse sequence parameters (AC, Gl, fAM).    
Adiabaticity 
The simple model provides an excellent fit for β’ less than 1, and remains accurate to 
within 10% for β’ less than 2.   Similar divergent behavior was also observed for the Zhernovoi-
based model of SAI 102 for β’ > 3 and was attributed to the increasing inversion time.    
DAI Modulation Frequency 
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Our experimental data show that the values of β’ at which χ inflects depends on fAM for 
62.5 and 125 Hz.    Numerical simulations (not shown) reveal that this behavior also occurs for 
fAM greater than 125 Hz.   Therefore, the oscillating behavior of the DAI efficiency appears to be 
related to the separation of the sidebands and is also dependent on the inversion time for the 
spins.   Oscillations in AFP were reported by Zhernovoi 107 to occur when the adiabatic sweep 
was truncated.   This condition may exist for DAI in the region between the two inversion planes.     
Bloch Equation Simulations 
Simulations of the Bloch equations are challenging for real flows since they must address 
the timing of the pulse train, the characteristics of the blood flow including the dispersion in flow 
velocities, and the scanner performance (e.g., gradient ramps, RF phase and amplitude stability).   
The results of the Bloch equation simulations grossly mimic the behavior of our experimental 
result only when many different velocities are averaged together.   So far, we have not found the 
Bloch equation numerical simulations to be useful in estimating either SAI or DAI efficiencies 
for real flows since the nonlinear equations are highly sensitive to the experimental conditions.      
In Vivo Measurements 
The high correlation coefficient indicates good agreement between relative efficiencies 
measured in the brain and the efficiency models.   Therefore, the models provide a valuable and 
simple method to calculate the experimental inversion efficiencies with less error and time 
associated with alternative techniques.  The aggregate efficiency calculated from Equation (4.6) 
for 60 elderly subjects can vary from 0.4597 to 0.9973 with mean 0.8392 and deviation 0.1106 
(which is 13% of the mean).  This further verifies that inversion efficiencies between subjects 
vary significantly. 
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In conclusion, the DAI model derived from AFP provides a reasonable estimate of our 
flow phantom data for β’<2, and a good estimate of relative in vivo efficiencies.  Therefore the 
model can be used to calculate the absolute inversion efficiency for the quantification of absolute 
perfusion rate of each CASL experiment.  The model does not distinguish between fAM, duty 
cycle, pulse duration, and fluid flow and relaxation properties.  Nevertheless, no other simple 
DAI efficiency model has yet been proposed.   
Two other studies based on computer simulations investigated the DAI efficiency to 
improve the performance of the DAI control.  One study 96 investigated the dependence of DAI 
control on each pulse sequence parameter, spin velocity and spin relaxation.  It was found that 
unless f > 2πBB1, φ determined the performance of the DAI control.  The other study  introduced 
a dimensionless parameter α, which divides magnetization trajectory into three separate regimes.  
By taking advantage of this phenomenon, they derive optimal parameters for the DAI control.  
However, conflicts appear between these two investigations: the dominance of phase φ to the 
AM control (if f < 2 πB1
97
B ) is not accounted for in the second optimization parameters α and β1/2, 
which indicates that the optimization strategy may not be adequate in some conditions.   
Our experimental design for the parameters of CASL is near optimal efficiency according 
to the optimization strategy 97.  It was pointed out that the assumed inversion efficiency (0.7 and 
0.8) overcompensates rCBF in some animals, which indicates the necessity of measuring the 
inversion efficiency in an individual basis 96.  An inconsistency was reported regarding the 
predicted magnetization between our model and their computer model.  However, computer 
simulations of Bloch equation only grossly mimic the behavior of our experimental results as we 
reported.  Therefore, the in vivo application of the computer model still needs further 
investigation.   
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Figure 4.1. Experimental DAI data measured for a Gl of 0.25 and 0.5 G/cm illustrates the 
advantage of lower labeling gradients for minimizing Bl.   The flow had a mean velocity of 18 
cm/s.   The percent differences between the unlabeled and DAI images are plotted versus AC 
(top).   Oscillation of the difference signal (for 0.25 G/cm) is apparent from the second inflection 
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point at AC ~ 45 mG.   The resulting DAI efficiencies (χ) are plotted versus the effective 
adiabaticity (β’ < 3) (bottom).   fAM was 125 Hz with a RF duty cycle of 90%.  
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Figure 4.2. Experimental χ for different mean flow rates versus β’<4 and β’<9 (inset).   The RF 
duty cycle was 93%.   Gl was 0.25 G/cm and fAM was 125 Hz.   The data were corrected for T1 
relaxation in transit. 
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Figure 4.3. Experimental DAI efficiencies for different fAM versus β’.   χ was measured  
using flow with a mean velocity of 18 cm/s, Gl of 0.25 G/cm, and a 90% RF duty cycle.  
The data were corrected for T1 relaxation in transit.   
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Figure 4.4. Simulated χ for four different fAM versus β’.   The efficiencies represent the  
mean from 7 component velocities for the laminar flow (<v> = 18 cm/s) used for the fAM  
measurements (0.5<v> – 2<v> in increments of 0.25<v>) and include losses due to T1
and T2 relaxation during DAI.   Gl was 0.25 G/cm.  
  
Table 4.1. In Vivo Study Results 
Experimental Parameter Mean Stdev Max Min 
<v(t)> (cm/s) 19.85 +/- 0.67 4.98 28.90 10.36 
BB1 at labeling plane (units of β1max) 0.72 +/- 0.02 0.08 0.88 0.54 
β’ SAI (SPDI) 1.31 +/- 0.09 0.49 2.85 0.63 
β’ SAI (ASD) 3.62 +/- 0.26 1.36 7.85 1.75 
β’ DAI (ASD) 1.82 +/- 0.13 0.68 3.95 0.88 
(SPDI/ASD)Gray Matter 1.16 +/- 0.05 0.28 1.81 0.78 
(SPDI/ASD)Model 1.13 +/- 0.02 0.09 1.31 1.00 
Correlation Coefficient 0.974 
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5.0  ADVANCED CASL MODEL IN PERFUSION 
5.1 BACKGROUND OF CASL PERFUSION MODEL 
Perfusion quantification using CASL requires a kinetic model to convert the CASL data to a 
perfusion map.  Williams et al.45, proposed a steady-state model based on Bloch equations in 
which macromolecules were saturated and there was no arrival delay between the end of labeling 
period and the image acquisition.  However, Williams’ model was applied to cerebral blood flow 
measurement in rats.  The endogenous tracer arrival times are short (the mean value is 266 ms 
108) in rats. Arrival times in humans are approximately 1 s. T1 relaxation of the labeled blood 
water occurs during the delay between the labeling blood at the labeling plane and its arrival at 
the vascular compartment.  Zhang et al., 52 made an initial attempt to account for the arrival time 
effect by incorporating a T1 relaxation attenuation factor into the inversion efficiency α.  In 
principle, the arrival time for each voxel is needed to produce quantitative perfusion maps.  
However, perfusion SNR and time restrictions for the exam may make the acquisition and 
estimation of the arrival time impractical.   
Alsop and Detre 54 proposed adding a transit delay between the end of labeling period 
and the image acquisition.  The transit delay makes the perfusion maps insensitive to arrival 
times as long as the delay is greater than the arterial arrival times across the image.  If the delay 
is greater than the arrival times, the flow model reduces to Williams’ perfusion model while 
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taking into account the arrival time effect.  However, both the Williams’ and Alsop’s kinetic 
models assume the duration of labeling to be infinitely long.   
An alternative perfusion general kinetic model was proposed by Buxton et al. 74.  The 
proposed model is more general than previously used models but reproduces the earlier models 
under the appropriate assumptions: 1. the arrival of labeled blood at a particular voxel is via 
uniform plug flow; 2. the water exchange between tissue and blood is described by single-
compartment kinetics; 3. the water is completely extracted from the vascular space.  The labeling 
duration τ is taken into account.  If the labeling duration is infinite, the perfusion model is 
reduced to Alsop’s kinetic model.   
Wang et al. 109 incorporated the labeling duration τ back into Alsop’s perfusion model.  
The model is consistent with Buxton’s model by replacing by T'1tT 1a in the case of aw δ> , which 
is equivalent to assuming that the time to pass through the vasculature and into the tissue is long 
compared with T1 and the labeling delay duration w, i.e., m(t) = exp(-t/T1a) in Buxton’s model.  
All above mentioned perfusion models are summarized in Table 5.1.  
Table 5.1. the developments of rCBF quantification models.  All equations are of the form 
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5.2 BUXTON’S CASL KINETIC MODEL 
The perfusion signal (Sf) is proportional to the cerebral perfusion rate (f ) from the general kinetic 
model 74:  
         (5.1) )(tkcfS f ⋅⋅=
where  and 02 aeff Mc α= )]()([)()( tmtrtatk •⊗=      (5.2) 
In the above equations, Ma0 is the equilibrium arterial blood magnetization, effα is the effective 
inversion efficiency, f is the perfusion rate, a(t) is the delivery function, i.e.,  the normalized 
arterial concentration of magnetization arriving at the voxel at time t.   r(t) is the residue function, 
i.e., the fraction of labeled water molecules that remains in the voxel after t time unit from the 
arrival time, m(t) is the magnetization relaxation function based on the T1 relaxation times, i.e., 
the fraction of longitudinal magnetization of labeled water that remains in the voxel after t time 
unit from the arrival time.  With the following assumptions, the factors of k(t) of the general 
kinetic model are simplified to previous standard models.   
Uniform plug flow assumption: The arrival of labeled blood at a particular voxel is 
assumed to occur via uniform plug flow.  After the blood is labeled, it has to experience a time 
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delay tz to arrive at the voxel in the image plane from the labeling plane.  Therefore, no labeled 
blood arrives before the delay tz.  During the time tz < t < tz +τ (where τ  is the labeling 
duration), the arriving blood is labeled uniformly; and after time tz +τ , the arriving blood is 
again unlabeled.  The arterial function a(t) is written as: 
tt
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)( 1      (5.3) 
where T1a is the blood longitudinal relaxation time.   
Single-compartment kinetics assumption: Water exchange between tissue and blood 
are assumed to be so rapid that their concentration ratios remain constant.  In particular, the ratio 
of total tissue concentration to the venous concentration is a constant equal to the equilibrium 
tissue/blood partition coefficient of water λ.  With this assumption, the residue function is: 
)/exp()( λfttr −=        (5.4) 
Immediate and complete extraction from the vascular space assumption: The water 
is completely extracted from the vascular space immediately after arrival in the voxel.  With this 
assumption, the relaxation function is: 
         (5.5) )/exp()( 1tTttm −=
5.3 OUR CASL KINETIC MODEL 
No-exchange assumption: There has been evidence that spin labeled water substantially relaxes 
prior to exchange with tissue water in humans at 1.5 T 95, 110-112. The inverted protons relax via T1 
before they leave the intravascular space, especially for white matter where the arrival times are 
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longer than gray matter.  The no-exchange hypothesis may not hold in animals models where the 
blood flows are typically higher and arrival times are typically lower than humans.   
Under the assumption of no-exchange, the residue function can be modeled as:  
1)(_ =tr exno         (5.6) 
since the labeled blood relaxes before exchanging with the tissue.  The labeled water protons are 
still in the vasculature when the protons relax, and so the assumption for immediate and 
complete extraction from the vascular space is invalid.  Therefore, the relaxation function m(t) 
needs to be modified to: 
)()/)(exp()( 1_ tuTtttm bzexno ⋅+−=      (5.7) 
where u(t) is the unit step function.  T1t is replaced by T1b in the Equation (5.5) since the 
magnetization still decays with the relaxation time of blood after an initial arrival time tz.  The 
arrival time tz is added to address the magnetization attenuation that occurs between labeling and 
the arrival time.  The arterial function a(t) must be similarly adjusted to include a nonzero arrival 
time tz.  a(t) can be modified accordingly.   
   )()()( zz ttuttuta −−−−= τ      (5.8) 
Hence, the definition of m(t) is the normalized magnetization after time t unit from the arrival 
time tz, and a(t) represents whether the label blood arrives at the voxel at time t or not.  The 
definitions of m(t) and a(t) are more logical and hemodynamically sound. 
Exchange assumption: There is also evidence that the labeled blood water exchanges 
with tissue water before it relaxes at fields greater than 1.5 T 113.  The water exchange between 
tissue and blood can be described by an equilibrium tissue/blood partition coefficient of water, λ.   
With this assumption, the residue function can be modeled as: 
)/exp()( λfttrex −=          (5.9) 
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The magnetization decays with the relaxation time of tissue after an initial arrival time tz if we 
assume that blood water exchanges with the tissue water immediately after its arrival.  In this 
case, the relaxation function can be modeled as: 
 )()//exp()( 11 tuTtTttm bztex ⋅−−=       (5.10) 
The theoretical curves of the arterial functions, the relaxation functions, and the residue functions 
for no-exchange model vs. exchange model are shown in Figure 5.1. 
Off-resonance saturation effects: In the above models, we have ignored the effects of 
off-resonance saturation on image intensity.  The off-resonance RF saturation at the imaging 
slices is minimal for a separate labeling RF coil 59.  For single-coil CASL, the RF saturation may 
be significant.  The application of off-resonance RF causes a decreased signal at the image slices 
even in the absence of perfusion.  The signal attenuation may not match perfectly between the 
control and labeling RF irradiation.   
The signal attenuation difference between the control and label images is referred to as 
residual MT (S∆MT) herein.  For a single-coil CASL, the difference signal (∆M) between control 
and label images is composed of the perfusion (Sf) and residual magnetization transfer (S∆MT) 
signals.   
MTf SStM Δ+=Δ )(        (5.11) 
By combining Equation (5.1), (5.2) and (5.11), the perfusion rate f can be calculated as: 
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5.4 ESTIMATION OF PARAMETERS IN OUR CASL PERFUSION MODEL  
Estimation of Ma0: For absolute quantification, the difference signal should be normalized to the 
blood magnetization and not the steady-state tissue signal.  However, Ma0 cannot be measured 
easily and directly.  Traditionally, the relationship between Ma0 and tissue magnetization Mt0was 
based on the partition coefficient λ 47, 54, 114: 
TE
TTt
a
ateMM
)11(0
0 *2
*
2
−= λ       (5.13) 
where the exponent corrects for imaging sequence effects (assumes a gradient-echo pulse 
sequence), ,brainλ GMλ and WMλ  having values of 0.90, 0.98 and 0.82 ml/g, respectively 115.  The 
T2 relaxation times (including B0 inhomogeneities) for tissue (T2t*) and blood (T2a*) are 55 ms 
and 100 ms 116 respectively at 1.5 T.  T2* depends on the actual magnet homogeneity and voxel 
size and may vary between systems.  However, Buxton 74 argues that the use of partition 
coefficient is not accurate.  The current standard is to calculate the blood magnetization (Ma0) 
from white matter magnetization (Mt0) 116: 
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      (5.14) 
where density of arterial blood (ρa) is 1.06 g/ml; density of  tissue (ρt) is 1.05 g/ml for both gray 
and white matter.  With these values and a TE of 21 ms for ramp-sampled EPI in our CASL 
experiments: 
    with Λ = 1.2      (5.15) 00 ta MM Λ≈
Tissue magnetization (Mt0): We normalize the difference signal (MC-ML) to the control 
image to correct for the RF inhomogeneity and system instability and save acquisition time by 
avoiding the separate acquisition of tissue magnetization.  The control image includes signal 
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losses from off-resonance RF saturation.  We can calculate the tissue magnetization Mt0 based on 
the control magnetization and our RF saturation model: 
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      (5.16) 
where w is the postlabeling delay, ∆tacq is the acquisition time measured from the start of the 
multi-slice acquisition in s.  T1t is the longitudinal relaxation time of the tissue.  Based on our 1.5 
T brain studies, mean gray and white T1 values of 1.065 and 0.800 s, respectively, were used for 
the T1 relaxation correction. MT is the signal loss )(, ΔnormzM , which can be calculated by 
Equation (3.4).   
By simple arithmetic from Equation (5.15) and (5.16), we have 
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Arrival time & convolution model: The arrival time (tz) of the labeled blood at the 
imaging plane from the labeling plane should be measured directly, by varying the transit delay.  
This time should not include the time for the tracer to exit the intravascular space and enter the 
extravascular space.  The arrival time varies for different individuals.  In the normal human 
brains, tz values typically range from 0.7 to 1.5s in gray matter and higher in white matter54, 95.  
We only calculate the gray matter perfusion map due to the long tracer arrival time and poor 
SNR in white matter.   
The convolution k(t) is directly related to the arrival time tz.  Let us take a look at the convolution 
k(t) more carefully to see the relation.  From Equation (5.2) and the definition of convolution, we 
have: 
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The convolution k(t) for the no-exchange model and exchange model can be written in an 
analytical format as Equation (5.19) and (5.20): 
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where  is the effective tissue relaxation time, by incorporating the effect of flow in TtT1′ 1 
shortening: 
λ
f
TT tt
+=′ 11
11          (5.21) 
t represents the slice acquisition time, measured from the beginning of the sequence: 
acqtwt Δ++= τ       (5.22) 
w is the postlabeling delay (typically 0.7 s for our experiments), ∆tacq is the acquisition time 
(measured from the start of the multi-slice acquisition in s): 
sliceacq TRnTEt ⋅−+=Δ )1(      (5.23) 
where TE is the echo time (0.021s in our rampsampled EPI, 0.028 s in our regular EPI, 0.008 ms 
for our single-shot spiral), n is the slice index (1 to 19 for rampsampled EPI, 1 to 15 for regular 
EPI), and TRslice is the acquisition time per slice (1/19 s (second) for rampsampled EPI, 1/15 s for 
regular EPI).    
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The graphs of kno_ex(t) and kex(t) with the effects of varying tz are shown in Figure 5.2.  
The maximum point of the convolution for both kno_ex (t) and kex(t) is  reached at time tz + τ 
(arrival time plus pulse labeling duration).  All the curves of kno_ex(t) with varying tz merge 
together if the acquisition time is larger than the pulse duration time plus the longest arrival time.  
If we acquire the image slices after all the labeled blood tracers arrives (t > tz + τ), kno_ex(t) for all 
the image voxels will be described by a mathematical formula without dependency on the arrival 
time variable tz (see t > tz + τ part of Equation 5.17).  As previously reported by Alsop and Detre 
54, acquiring the slices after tz + τ will make the perfusion maps completely insensitive to arrival 
times.  We can estimate the value of kno_ex(t) at any acquisition time t > tz + τ.  However, the 
value of kno_ex(t) depends on the arrival times of the image slices if tz < t < tz + τ.  (see tz < t < tz 
+ τ part of Equation 5.17). 
The convolution kex(t) is not completely insensitive to the arrival time after tz + τ.  The 
convolution depends on the difference in the blood relaxation time T1b and the tissue relaxation 
time T1t.  
1 
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Figure 5.1.  Depictions of (a) idealized artery delivery function a(t), (b) magnetization relaxation 
function m(t), and (c) residue function from no-exchange model vs. exchange model. Parameters 
for the curves are T1b = 1.3 s, tz = 0.7 s, f = 60 ml/100g/min corresponding to f = 0.01 s-1, and λ 
= 0.9. 
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Convolution curve: no-exchange vs. exchange
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Figure 5.2. Theoretical curves of the convolution k(t) of CASL versus time with varying arrival 
time for no-exchange model vs. exchange model.  Parameters for the three curves are T1b = 1.3 s, 
T1t = 1.0 s, τ = 3.7 s.  
5.5 THE ISSUE OF PREVIOUS CASL PERFUSION & OUR SOLUTION  
There are several issues in the quantification of CASL MRI perfusion bring concerns to us 
beside those described in Chapter 3 and 4.  First, the introduction of a long transit delay greatly 
decreases the sensitivity of the perfusion technique to the arrival time.  However, the 
insensitivity comes at the expense of decreased SNR and increased exam time. Moreover, the 
transit delay is limited by the T1 relaxation time and may not be adequate for subjects with 
cerebrovascular disease.   
Second, an assessment of cerebral perfusion between normal controls and AD subjects 
was performed by assuming that the blood tracer fully relaxes before it exchanges with the tissue 
water 26.   However, it is important to investigate whether the blood tracer exchange occurs and 
determine whether the no-exchange model or exchange model fits for the perfusion 
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quantification.  Third, the residual off-resonance saturation effects were previously assumed to 
be negligible 26.  Fourth, the inferior-to-superior acquisition was adopted in previous perfusion 
experiments.  The acquisition direction is same as the blood tracer flow orientation.  Hence, 
imaging may perturb the blood tracer and the difference signals.  Fifth, the multislice CASL 
difference signals contain information on the blood arrival time for each slice.  
5.5.1 The issue of acquisition direction 
An inferior-to-superior acquisition was used (shown in Figure 5.3(a)) in earlier perfusion 
experiments 26.  However, the acquisition order can perturb the blood tracer and exacerbate off-
resonance saturation effects.  A simulation was carried out to compare the off-resonance 
saturation effects between inferior-to-superior and superior-to-inferior acquisition order.  A 100 
ms delay was placed between the off-resonance saturation (for SAI) and image acquisition (with 
different acquisition order).  Images were also acquired without off-resonance saturation for 
normalization of the RF saturation data.  The RF saturation curves were corrected for signal 
increases caused by T1 relaxation that occurred during the delay between off-resonance 
saturation and image slice acquisition using Equation (3.17).  The simulation comparison of RF 
saturation effects between the two different acquisition orders is shown in Figure 5.3(b).  The 1.5 
s postlabeling delay reduces the degree of the RF saturation effects, but the saturation effects still 
vary ten percent (which can be calculated from the values in Figure 5.3(b).   
The RF saturation effects caused by the inferior-to-superior acquisition order are severe 
and vary from slice to slice.  The varying RF saturation effects from slice to slice affect the 
accuracy of three-dimensional motion correction.  The motion correction algorithm may fail 
because the algorithm may have difficulty in finding matching voxels due to large variance of 
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adjacent slices.  Even if the algorithm can proceed, the varying RF saturation effects from 
adjacent slices will contaminate the signals of the motion-affected voxels, and thus perfusion 
signals. 
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Figure 5.3. (a) Representation of blood flow and acquisition directions.  (b) The comparison of 
RF saturation effects measured in agar phantom between inferior-to-superior and superior-to-
inferior acquisition direction.   
 
5.5.2 The issues of long delay & our solution 
A long postlabeling delay (1.5 s) was adopted by Alsop et al. after the labeling period to reduce 
the arrival time sensitivity 26, 54.  The choice of postlabeling delay 1.5 s may not be long enough 
for some diseased subjects or white matter.  The arrival time can vary from 0.9363 to 1.6063 
with mean 1.1566 and standard deviation 0.1385 according to our CASL perfusion 
measurements in elderly subjects.  In order to get the perfusion maps of all subjects quantified 
accurately, the postlabeling delay needs to be longer than the longest arrival time in the 
population of the subjects, which is not known without direct measurements.  A longer 
postlabeling delay leaves less time for the brain image acquisition. In principle, two or more 
separate acquisitions are required to provide the complete coverage of the brain since the 
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endogeneous tracer is relaxing.  The length of the postlabeling delay, and thus the tolerance of 
long arrival time are limited by T1 relaxation and SNR.  The theoretical value of k(t) (which is 
proportional to the CASL signal) is decreased to 0.3862 at the time t = 1.5 + 3.7 s from Equation 
(5.19).  In summary, one must trade-off the insensitivity of the arrival time with perfusion SNR 
and brain coverage.      
A recent rat study 117 determined the arrival times as part of CASL measurements to 
choose the delay more efficiently for each subject.  This method helps to determine the delay but 
doubles the time cost of CASL measurements.  Large bipolar gradients were used to destroy 
signal from moving arterial water spins 53 instead of having postlabeling delay.  However, the 
inclusion of a bipolar gradients in the imaging sequence has been shown to reduce the perfusion 
signal and cause a lengthening of the measured arrival time 46.   
We acquire the image volume earlier by inserting a short postlabeling delay (700 ms) 
between labeling and imaging to gain more SNR for image slices.  The whole brain volume can 
be covered in one acquisition.  The total time for acquiring CASL perfusion images is less than 
10 minutes for 50 pairs of control and label images, which is half of the acquisition time used 
previously 61.  However, our approach will be sensitive to the arrival time, so the kinetic model 
related to arrival time needs to be considered. 
In our approach, we used a superior-to-inferior acquisition order.  Figure 5.4 illustrates 
the convolution curves with different arrival times, and the derived curve of convolution signal 
changes from superior to inferior slices.  At 700 ms postlabeling delay, the superior slice 
(assuming that the arrival time of the slice is 1.5 s for the illustration purpose) was sampled first, 
the average convolution signal intensity for the slice corresponds to a dot of the convolution 
curve with arrival time = 1.5 s at the time t = 3.7 + 0.7 s (the first yellow dot in Figure 5.4).  The 
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convolution signal intensities for the later slices correspond to the dots from other convolution 
signal curves with shorter arrival time (compared to the arrival time of the first superior slice).  
We obtained the theoretical curve of interslice convolution signal changes by connecting the 
convolution signals from all slices in the superior-to-inferior acquisition order (the pink line in 
Figure 5.4). We assumed that the superior slices have longer tracer arrival times.  
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Figure 5.4. The curve of interslice convolution signal with varying acquisition time.  The pink 
line stands for interslice signal changes from the superior-to-inferior acquisition order. 
 
For the maximum point of the interslice convolution curve, the slice acquisition time 
coincides with the tracer arriving at the slice (τ + tz).   
Our perfusion measurement is based on two key observations of the interslice 
convolution curve kIS (t): (I) When the slice acquisition time coincides with the arrival time (τ + 
tz), the maximum point of the interslice convolution curve is achieved; and (II) At the slice with 
coincident arrival time and acquisition time, the achieved maxima is same as the maxima of the 
convolution curve of the slice itself.  
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   The normalized interslice CASL difference signals have the same curve shape (only a 
constant factor 2αeff difference) as the interslice convolution curve, assuming the gray matter 
CBF is a global constant for each subject (i.e., in the absence of significant cerebrovascular 
disease) 46, 110, 116.  Therefore, CASL interslice signals reach the maxima at the same time as the 
interslice convolution signals.   
We can search for the time that the CASL interslice signals reach the maxima.  
According to the observation (I) of the interslice convolution curve, the calculated time is the 
summation of postlabeling delay and the tracer arrival time.  Thus, the tracer arrival time can be 
obtained by subtracting the postlabeling delay time from the calculated time tz0. 
According to the observation (II) of the interslice convolution curve, the maxima of the 
interslice convolution curve can be obtained by calculating the maxima of the convolution curve 
for the slice acquired at the above calculated tracer arrival time tz0.  The convolution curve is 
described by Equation (5.19) or (5.20) (please refer section 5.5.3 to choose which Equation).  
The maxima of the convolution equation for the slice is obtained at the time t = tz0 + τ.  The 
blood relaxation time T1b and  are needed to measure the maxima of the convolution equation.  
T
'
1tT
1b can be calculated based on individual hemotocrit.   can be calculated based on the average 
value of the gray matter T
'
1tT
1 map.   
The maxima of the interslice convolution curve can be obtained from the above 
calculation; the shape of the interslice convolution curve is same as the CASL interslice signal 
curve by assuming gray matter perfusion as a global constant.  Therefore, the practical interslice 
convolution curve can be obtained by shifting the CASL interslice signal curve by a factor so 
that the maxima matches with the above calculated theoretical value. 
 
 
77
  
A couple of issues are related to the perfusion quantification. The model assumes that 
gray matter perfusion is a global constant for each subject.  This is not likely to be true if the 
subject has significant cerebrovascular disease. However, cerebovascular disease is one of the 
exclusion criteria for the perfusion study.   
A potential inaccuracy can arise from the quantification of the interslice convolution 
curve.  The convolution curve is based on the average gray matter signals from the left/right half 
axial slices.  We used average arrival time for the left/right side of each axial slice.  However, the 
blood arrival times may have large variance, which will, in turn, lead to inaccuracies in perfusion 
measurements.      
 
5.5.3 Which model: exchange model versus no-exchange model? 
  The crucial task to figure out is whether the blood tracer exchanges with the gray matter tissue 
in elderly brains. This is equivalent to asking whether the no-exchange model or exchange model 
(Equation (5.19) or (5.20)) needs to be adopted for the perfusion model. 
CASL interslice data were analyzed to determine if tracer exchange occurs in gray matter 
in elderly brains.  CASL difference signal for each single slice was calculated based on an 
average difference signal for the whole gray matter volume.  From Equation (5.12) and (5.19), 
the CASL difference signal without exchange depends on the blood relaxation time T1b, 
acquisition time t and perfusion rate f.  From Equation (5.12) and (5.20), the CASL difference 
signal incorporates tissue relaxation time T1t besides the above mentioned three variables in the 
exchange model.  
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Based on the published values and our DSC data (averaged over the whole gray matter 
volume), the blood arrival time can be modeled as the power function of the distance from the 
labeling plane: 
b
z zzazt )()( 0−=        (5.24) 
where z0 is the location of the labeling plane, z is the slice location, and a and b are fitting 
parameters.  In a 2D CASL acquisition, each image plane contains both spatial and temporal 
information since each slice is acquired at a different time with respect to the beginning of the 
label generation.  The acquisition time t is linearly dependent on the slice location z by recalling 
the Eq. (5.22) and (5.23).  
The CASL difference signal is a function of blood relaxation time (T1b) (and tissue 
relaxation time T1t in the exchange case), the slice location (z, from the tz and acquisition time t), 
parameters of the power function (a and b) and perfusion f.  The left and right hemisphere 
perfusion were calculated separately by fitting the CASL signals with respect to the slice location 
to a spatio-temporal model based on the convolution tracer model, the signal acquisition timing, 
and the assumption that gray matter perfusion is a global constant 74.  Fitting was performed 
using the Levenburg-Marquardt method of least square.  Three fits were performed: 3-parameter 
fits (a, b, and f) with no tracer exchange, 4-parameter fits with (including T1t) and without 
exchange (including T1b as a variable).  T1b was calculated based on individual hemotocrit 118 
when not fitted as a variable (<T1b> = 1.41 ± 0.2 s).  Fifteen normal subjects (age 82 ± 3) were 
selected to study the tracer model. 
The representative fits of interslice CASL difference signals in gray matter with exchange 
(4-parameter) and without tracer exchange (3 parameters) are shown in Figure 5.5.  The 4-
parameter model with tracer exchange provides the best fit.  Summary of findings for 15 subjects 
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from the three models are shown (Table 5.3).  Average gray matter perfusion of 15 subjects were 
53 ± 13 ml/100g/min and 51 ± 14 ml/100g/min for left and right hemisphere, respectively.  
These values are slightly lower than the published PET perfusion of 67 ± 13 ml/100g/min for 
gray matter of young brain 119.  However, perfusion was shown to decrease with age 120.  The 
average fitted T1t was 1.06 ± 0.19 s.  The 4-parameter fit (no-exchange) overestimated the gray 
matter perfusion by 45% compared to PET while the fitted <T1b> of 0.93 ± 0.16 s was lower than 
the literature.  The results indicate that the tracer exchanges with the tissue water, before it 
decays, for the elderly brain gray matter at 1.5 T. 
 
exchange no-exchange 
Δ% Δ% 
Slice Position (cm) Slice Position (cm) 
 
Figure 5.5. Illustrative fits of interslice CASL difference [(control-label)/control] signals in gray 
matter with exchange and without tracer exchange.  T1b was calculated based on the subject’s 
hematocrit.  The exchange model provides a superior fit, indicating that the blood water is 
exchanging with the tissue water.  
 
Table 5.2. Summary of  Findings for 15 subjects. 
 
Model Gray matter 
perfusion 
(ml/100g/min) 
Mean R2 T1b (s) 
4-parameter 
(no-exchange) 
92 ± 40 (L) 
89 ± 39 (R) 
0.68 ± 0.15 
0.63 ± 0.17 
0.93 ± 0.16 
(Fitted) 
3-parameter 
(no-exchange) 
34 ± 6 (L) 
33 ± 7 (R) 
0.55 ± 0.18 
0.54 ± 0.13 
1.41 ± 0.02 
4-parameter 53 ±13(L) 0.72 ± 0.17 1.41 ± 0.02 
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(exchange) 50 ±14(R) 0.65 ± 0.19 
 
5.5.4 Inference of blood arrival time 
From section 5.5.3, the CASL difference signals should be fitted with respect to the slice location 
by the exchange model.  The fitted parameters (a and b) can be used to calculate the blood left 
and right arrival times of each slice separately by Equation (5.24).  The blood left and right 
arrival times of each slice can be inferred in the process of perfusion calculation with no extra 
time cost.  Furthermore, the method can be extended to infer the arrival times for smaller clusters 
if the SNR of images is large enough. 
One perfusion study was selected to investigate the differences of arrival times for each 
slice and its potential error in the perfusion calculation.  Four regions (upper left (ul), upper right 
(ur), lower left (ll), lower right (lr)) were divided for each axial slice.  The blood relaxation time 
of 1.4328 s is based on the hematocrit 118.  The fitted gray matter tissue relaxation time was 
1.0041 s in the original perfusion calculation (The gray matter T1 was 1.1260 s when calculated 
separately from the non-saturated T1 map).  The gray matter tissue relaxation time was fixed for 
the arrival time calculation of each region.   
The arrival time for each of four regions is listed on Table 5.3.  The arrival times heavily 
depend on the regions: the upper left and lower left sides only change 1.6%, but the upper right 
and lower right sides change 6.0%.  The global perfusions for the upper left and the lower left are 
58.7102 ml/100g·min and 57.3034 ml/100g·min, which is a 2.03% and 0.42% change from the 
global perfusion (57.5426 ml/100g·min) for the left side.  The global perfusions for the upper 
right and the lower right are 53.6945 ml/100g·min and 56.7990 ml/100g·min, which is a 2.66% 
and 2.96% change from the global perfusion (55.1641 ml/100g·min) for the right side.  The 
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perfusion changes due to the arrival time difference were calculated from Equation (5.12) and 
(5.20) (Table 5.4).  The differences of arrival times caused larger changes in perfusion for the 
superior slices.  The perfusion of the upper right region on slice 3 changes 7.5% from the 
original right side perfusion. 
The blood arrival times of four clusters (upper left, upper right, lower left, lower right) 
for each axial slice were calculated in this case.  The arrival times of clusters have large variance 
even within the slice.  We need to take the arrival time differences into account to improve the 
perfusion quantification.  The improved perfusion quantification can be achieved by dividing 
each axial slice into several small clusters in the same manner and calculating the perfusion map 
for each cluster by taking advantage of the interslice signals as mentioned in section 5.5.2.  
Moreover, the arrival time for each small cluster can be calculated the same as the arrival time of 
the four clusters in this section. Therefore, the cluster-wise arrival time map can be generated.   
Table 5.3. The difference of arrival times of four regions.  Δ stands for the relative changes of the arrival 
times (e.g. Δtz_ul = (tz_ul – tz_l)/tz_l. ul stands for upper left, ur for upper right, ll for lower left, lr for lower right ) 
Slice tz_l ∆tz_ul (%) ∆tz_ll (%) tz_r ∆tz_ur (%) ∆tz_lr (%) 
3 1.7903 -1.62 1.62 1.7073 -6.02 5.09 
4 1.5986 -1.62 1.62 1.536 -6.02 5.09 
5 1.4212 -1.63 1.62 1.3762 -6.02 5.09 
6 1.2574 -1.62 1.61 1.2275 -6.01 5.09 
7 1.1067 -1.63 1.62 1.0896 -6.02 5.08 
8 0.9685 -1.62 1.62 0.962 -6.02 5.09 
9 0.8423 -1.61 1.63 0.8445 -6.02 5.09 
10 0.7276 -1.61 1.62 0.7366 -6.01 5.09 
11 0.6239 -1.62 1.62 0.6381 -6.02 5.08 
12 0.5305 -1.62 1.6 0.5484 -6.02 5.09 
13 0.4469 -1.63 1.61 0.4673 -6.03 5.07 
14 0.3726 -1.64 1.61 0.3943 -6.01 5.1 
15 0.307 -1.63 1.6 0.3291 -6.02 5.07 
16 0.2496 -1.64 1.6 0.2713 -6.04 5.09 
17 0.1998 -1.6 1.65 0.2204 -5.99 5.08 
18 0.1572 -1.65 1.59 0.1761 -6.02 5.11 
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Table 5.4. The change of perfusion due to the change of arrival times.  
N Δf_ul(%) Δf_ll(%) Δf_ur(%) Δf_lr(%) 
3 2.2 -2.25 -7.5 6.87
4 1.93 -1.97 -6.66 6.05
5 1.69 -1.72 -5.92 5.32
6 1.48 -1.5 -5.24 4.68
7 1.3 -1.31 -4.64 4.1
8 1.12 -1.14 -4.08 3.6
9 0.97 -0.99 -3.57 3.13
10 0.83 -0.85 -3.11 2.71
11 0.72 -0.72 -2.7 2.33
12 0.61 -0.61 -2.31 2
13 0.52 -0.51 -1.98 1.69
14 0.43 -0.43 -1.66 1.43
15 0.35 -0.35 -1.39 1.19
16 0.29 -0.28 -1.15 0.98
17 0.23 -0.23 -0.93 0.79
18 0.18 -0.18 -0.74 0.64
5.5.5 The issue of residual off-resonance saturation effects 
The residual off-resonance saturation effects are typically assumed to be negligible 26, 61 in CASL 
experiments.  However, our residual off-resonance saturation measurements (including non-
adiabatic effects) demonstrate that it can vary from 0.0501% to 0.2821% with mean 0.1596% 
and standard deviation 0.0781%, which is around 15% of the signal with an insertion of 700 ms 
postlabeling delay (Figure 5.6).  The residual off-resonance saturation effects will decay to 
several percents for the 1.5 s postlabeling delay used by other investigators, but it will vary with 
different frequency offsets.  Therefore, the residual effects need to be characterized and 
corrected, or it will introduce error in the CBF quantification. 
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Figure 5.6. The effects of residue off-resonance saturation with different frequency offsets and 
700 ms postlabeling delay from human data.  
  
 
5.6 ENHANCEMENTS TO CASL PERFUSION MODEL  
5.6.1 Materials and Methods 
All data were acquired using a 1.5T GE Signa system (Milwaukee, WI, LX).   The standard GE 
quadrature head coil was used for labeling as well as image acquisition in humans and flow 
phantoms.   Human subjects were scanned in accordance with approved Institutional Review 
Board (IRB) protocols after providing informed consent and passing MRI screenings.  
Measurements of residual RF saturation were acquired in healthy normal volunteers (ages 20-50) 
while perfusion data were acquired in elderly volunteers (aged 70 and higher) as part of an NIH 
study of cognitive deterioration.  Patients were divided into normal controls, MCIs and early 
ADs according to the classification standard 121, 122 from the clinical doctors.   
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Our exclusion criteria to maximize case reliability and validity were: radiological 
evidence of structural CNS lesions (e.g., brain infarcts, CNS neoplasms, prior brain surgery), 
history of strokes or head trauma encephalopathy, consumption of caffeine within 8 hours prior 
to exam, inability to segment images using semi-automated tools, placement of the labeling 
plane was not orthogonal to both carotid arteries and/or the difference between left and right 
carotid arterial mean velocities exceeded 20%, excessive patient motion as evidenced in 
structural images, excessive image artifact (e.g., hair oil or dental implant), poor scanner 
performance (e.g. instability or noise).   
5.6.2 Magnetic Resonance Imaging 
The imaging protocol is described below: 
Sagittal Localizer:  A rapid sagittal T1-weighted image was performed to determine 
patient position.   
Multi-slice CASL: Multi-slice CASL used Alternating Single and Double adiabatic 
inversions (ASD) 61.  Due to the hardware limitations associated with the clinical scanner, the 
irradiations were applied using a 44 pulse train with an 85 ms period and 94% duty cycle for 
ASD,  In addition, the maximum Bl was limited to 50 mG.   Amplitude modulation of DAI 
waveforms caused the Bl for each site (or sideband) to be half of the waveform amplitude.   The 
DAI control was amplitude modulated (AM) at 125 Hz.    The label was typically applied 10 cm 
below the center of the imaging volume, near the cervicomedullary junction, based on a coronal 
MRA to ensure the labeling plane orthogonal to carotid flow.   
ASD employed a 19-slice EPI acquisition (64×64 matrix, 20 cm FOV, 5 mm thick, 0 
spacing, TE: MinFull 21 ms TE with ramp-sampling, 76kHz effective receiver bandwidth (rBW), 
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1 s acquisition time, 700 ms transit delay, 900 flip angle), with a sequential superior to inferior 
slice acquisition order.   The pulse sequence was repeated 50 times for ASD for signal averaging.   
Residual MT: Residual off-resonance RF saturation used the modified muti-slice CASL 
sequence except the ASD inversions were applied above the center of the imaging volume (the 
offsets were from 7 cm to 10 cm) to obtain the same saturation effects but avoid labeling the 
blood (see the details from Chapter 3).  These measurements were performed separately from the 
regular elderly perfusion measurements.    
BB1 maps: Multislice B1 map data were acquired for 20 slices (the same 19 slices as in the 
CASL, plus the labeling plane) using regular EPI (TR: 8 s and TE: MinFull 28ms, rBW: 62.5 
kHz) with varying nutations (20 different flip angles varying from 18-189  in increments of 9 ) .   0 0 90
Velocimetry: Phase Contrast (PC) Cine data were acquired at the labeling plane using a 
fast gradient-recalled echo sequence (TE: MinFull, FA: 300, FOV: 20 cm, Thickness: 5mm, 
Matrix: 256 x 128, rBW: 31.2 kHz).  The sequence generated phase maps and the structural 
images for 20 cardiac phases.   
Structural Images: Coronal T1-weighted spoiled gradient-recalled echo (SPGR) images 
covering the whole brain were acquired (124 slices with Matrix: 256 × 192; Thickness: 1.5 mm 
and zero spacing, TE: min Full, TR: 25 ms, FOV: 24 x 18 cm, rBW: 16 kHz).     
5.6.3 Image Processing & data analysis  
Image Reconstruction: EPI images were constructed off-line from the raw k-space data P-files 
using a reconstruction program written in C.  The reconstruction program converts the ramp-
sampled EPI data to a regular square matrix, sorts k-space lines and performs the Fourier 
Transformation of k-space data.   
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Image motion correction and segmentation: EPI and SPGR images were converted to 
the Analyze format for processing with Statistical Parametric Mapping (SPM2) (Wellcome 
Department of Imaging Neuroscience).   SPM2 image realignment corrected physiologic motion 
between acquisitions.  Non-overlapping volumes that normally appear on the superior slice (1st 
slice) or the inferior slice (the 19th slice) tend to be discarded in the realignment process.   The 
superior slice was typically discarded by us due to the lack of gray matter content.  The SPGR 
images were then segmented to get 256 × 256 gray matter, white matter, and CSF masks.  SPGR 
images were aligned to the mean images to determine the warping parameters.   The warping 
parameters were applied to the gray and white matter masks to obtain gray and white matter 
masks in the EPI images (64 x 64).   
Signal percentage differences: For each repetition, the signal difference was calculated 
voxel-by-voxel by the subtraction of the label image from its corresponding control image.  The 
signal difference and control image were averaged for all repetitions for improved SNR. The 
signal percentage difference image (∆M(t)/MC) was obtained by dividing the difference image by 
the control image.  The mean values of percentage differences for gray and white matter were 
fitted separately for left and right side of the brain by using a normal distribution function.  The 
fitting was used to get rid of the effects of intraluminal signals from the large vessels since a very 
small percentage of intraluminal signal may exist for postlabeling delay of 700 ms 54.  The 
residual MT measurement (S∆MT/MC) for each slice was calculated in the same manner as 
∆M(t)/MC.  The corrected signal percentage difference image ((∆M(t)- S∆MT)/MC) was obtained 
by subtracting the residual MT from the signal percentage difference image.   
BB1 maps: B1 map data were fitted on voxel-by-voxel basis to the three-parameter sine 
model by using a nonlinear least square algorithm, the three-parameter model is as follows: 
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)sin()( Ctbaty +=        (5.25) 
BB1 maps of all slices were calculated including the labeling plane (at the carotids) from the 
parameter C in Equation (5.25): 
BB1 = 0.146/π × C/90  × F      (5.26) 0
where F is 430 and 30.50 for label and control respectively. 
T1 maps: T1 map data were fitted on a voxel-by-voxel basis to the three-parameter model:  
1/)( Ttebaty −⋅+=        (5.27) 
Blood velocities of carotids: Carotids were identified from the phase contrast (PC) cine 
velocimetry maps and the blood velocities of carotids were calculated as a function of cardiac 
phase.  The blood velocities of left and right carotids were calculated, respectively, by averaging 
the corresponding velocities from different cardiac phases.    
Tissue-to-arterial ratio correction: MT effects due to off-resonance RF saturation were 
calculated by Equation (3.4), which takes the B1 map and the off-resonance frequency of each 
slice as input parameters.  The tissue-to-arterial blood magnetization ratio was calibrated by 
Equation (5.15).   
Labeling inversion efficiency:  The inversion efficiencies effα  in the left and right 
internal carotid arteries were calculated for each subject based on B1 maps and blood velocities 
at the label plane by Equation (4.5).   
Convolution kIs(t):  The theory of interslice convolution function was introduced in 
Section 5.5.2.  Polynomial fits were performed on CASL difference signals to filter out extreme 
values.  We determined the maxima of the polynomial fit instead of calculating the maxima 
directly from the CASL difference signals.  The value of Equation (5.20) at t = tz + τ needs to be 
calculated to calibrate the convolution kIs(t).  The calculation of the value requires the value of 
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T1b and T1t.  T1b was calculated based on the individual hematocrit.  T1t was calculated as the 
average T1 of gray matter T1 map.   
CBF map: Each perfusion map was obtained from Equation (5.12) by using the 
corrected signal percentage difference map (∆M(t)-S∆MT)/MC, tissue-to-arterial ratio (MC/Ma0), 
labeling inversion efficiency ( effα ) and convolution k(t).  A representative brain perfusion is 
shown in Figure 5.7.  Only gray matter perfusion was used for the CBF analysis because of the 
low perfusion SNR and the long tracer arrival time of white matter. 
 
 
Figure 5.7. Representative CBF maps from one subject for image slices 3 through 18. 
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5.7 SENSITIVITY OF PERFUSION AND ΔM SIGNAL TO PARAMETERS 
By combining Equation (5.12) and (5.17), we have 
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    (5.28) 
The perfusion signal depends on the parameters tz, , T'1tT 1b, αeff,  Λ. The inaccuracies of the 
parameters will propagate to produce errors in the perfusion values.  The relative error in 
perfusion was calculated using the Equation (5.28) by varying each parameter by a certain 
percentage.  The assumed values are based on the average value from our subjects: tz = 1.15 s, T1t 
= 1.06 s, T1b = 1.41 s, αeff = 0.83, Λ = 1.2. 
The propagated error in the perfusion measurement for each parameter is shown in Figure 
5.8.  For the acquisition time 4.6 s, the parameters must be known to the following accuracy: tz: 
5.8%, T1t: 5.5%, T1b: 6.6%, α: 5.1%, Λ: 5%, while for the measurement time 5 s, the parameters 
must be known to the following accuracy: tz: 18.6%; T1t: 4.9%; T1b: 5.6%; α: 5.1%; Λ: 5% for 
less than 5% error ( an acceptable limit) in perfusion measurements in gray matter.  The 
inversion efficiency α and Λ yield large errors (5%) regardless of the measurement time.  It is 
important to accurately determine α and Λ because they have a large effect on the perfusion 
measurements. The effect in the parameters T1t, T1b and tz varies with the measurement times.  
As the longer delay is inserted before the acquisitions, the perfusion is more sensitive to T1t and 
T1b variations, but less sensitive to tz variations. 
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Figure 5.8. Propagation errors in perfusion measurements to parameters: tz, T1t, T1b, α, Λ. 
Acquisition time is (a) 4.6 s and (b) 5 s.    
 
To compare the sensitivity of the CASL perfusion signal to errors in tz, T1t and T1b, the 
slope of ΔM with respect to these parameters was calculated using a relatively large range of tz 
and acquisition time t.  The ratio of change in ΔM to 0.1 s error in the corresponding parameters 
was displayed as a function of tz (Figure 5.9).  The ΔM signal is more susceptible to T1b 
variations and less susceptible to T1t variations as the tissue takes a longer time to arrive in the 
tissue.  The change in susceptibility due to the difference in arrival time is because the labeled 
blood tracer takes longer to enter into the tissue in the longer arrival time than in the shorter 
arrival time.   
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Figure 5.9. Sensitivity of ΔM to parameters tz, T1t, T1b as a function of tz. Acquisition time is (a) 
4.6 s and (b) 5 s. 
The ratio of change in ΔM to 0.1 s error in the corresponding parameters was displayed 
as a function of the acquisition time t (Figure 5.10).  The ΔM signal is less susceptible to the 
arrival time tz as the longer delay is inserted before the image acquisition.  The image must be 
acquired early (i.e., before all the blood tracers arrive in the imaging volume) to measure the 
blood tracer arrival time during the CASL experiment.    
 
Figure 5.10. Sensitivity of ΔM to parameters tz, T1t, T1b as a function of t.  
5.8 SUMMARY OF CASL PERFUSION MODEL  
We summarize our research achievements for the CASL perfusion model by analyzing the 
previous issues in CASL in Table 5.5.  We improved the perfusion quantification by inserting a 
short postlabeling delay, modeling off-resonance effects & residual off-resonance saturation 
effects, measuring the individual inversion efficiency, estimating the arrival time, verifying the 
exchange model, and optimizing the acquisition order.  
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There are limitations to our perfusion quantification.  First, as we indicated in the section 
5.5.4, more accurate perfusion measurements requires knowing the arrival times at the voxel 
level.  However, the SNR in difference images only allow us to calculate the cluster-wise arrival 
time map.  Second, the evidence of exchange means that we have an admixture of partially-
saturated macromolecules and chemical exchange.  There is no literature addressing these 
perturbations.  The perturbations complicate the kinetics.  The effects of chemical exchange are 
not considered in our CASL perfusion model, the effects are not addressed in other CASL 
models either.  
Table 5.5. Summary of CASL perfusion issues, our achievements and significance. 
   
Topics Issues from Previous 
Studies 
Research Achievements Significance 
Increased perfusion 
signal amplitude and 
SNR; time cost is 
reduced to almost half; 
whole brain in one 
acquisition reduced 
possible motion; 
Increased complexity of 
quantification. 
Postlabeling 
Delay 
Used long delay: reduces 
the signal amplitude and 
SNR, time cost is large, 
need two 8-minute 
acquisitions to cover the 
brain, and is limited by 
tracer T1 relaxation.  
Recent 3D-acquisition 
technique takes lesser 
time, but very motion 
sensitive.   
Used shortened delay: 
only need one 
acquisition to cover the 
whole brain.   
 
MT Effects 
& Residual 
Off-resonance 
Saturation 
Effects 
Assumed negligible 
residual off-resonance 
saturation effects. 
 
Established a dual-
Lorentzian MT model 
to fit the experimental 
data and model the 
residual effects from in 
vivo measurements.  
Apply models to correct 
individual data sets 
based on their 
experimental conditions 
(B1, label distance)  
See Chapter 3. 
MT, residual off-
resonance saturation, 
and nonadiabatic effects 
vary between subjects 
and experiments.  These 
effects can be 
significant especially 
for short postlabeling 
delays.   
Inversion 
Efficiency 
Assumed that it is 
constant.   
Established an 
analytical model and 
validated with the 
experiments.  Use the 
model to measure it for 
Significantly varies 
between subjects and 
experiments.  Offer the 
researcher the ability to 
correct the perfusion 
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each subject. 
See Chapter 4.  
quantification due to the 
variance of clinical 
conditions.       
Arrival Time Assumed the inserted 
postlabeling delay is long 
enough for the labeling 
blood to be delivered to 
the imaging slice.  
Measuring the arrival 
directly doubles the 
acquisition time. 
Measured the arrival 
time indirectly for each 
individual subject.   
Get the arrival time of 
each individual subject 
measured at the mean 
time.  Avoid wasted 
time after tracer arrival 
(early arrivals of tracer) 
or insufficient 
postlabeling delay (e.g. 
for diseased subjects)  
Acquisition 
Order 
From inferior to superior  From superior to 
inferior.   
Keep the blood tracer 
intact and alleviate the 
off-resonance saturation 
effects and crosstalk.    
Exchange vs. 
no-exchange 
model   
Use no-exchange model 
without validation. 
Use the interslice signal 
to verify whether the 
blood tracer exchange 
occurs or not. 
Capture the kinetic 
model more accurately 
and improve the 
perfusion quantification. 
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6.0  IMPACT OF IMAGE REGISTRATION ON PERFUSION ANALYSIS 
6.1 INTRODUCTION   
Brain perfusion is an important hemodynamic parameter.  The changes of perfusion in the 
development of Alzheimer ’s disease (AD) is crucial for the detection of early makers.  Most of 
the studies used a conventional region of interest (ROI) to evaluate regional changes.  The ROI 
technique is not always automated and might be intrinsically prone to error because of operator a 
priori assumptions and subjective choice.  The ROI analysis may lack sensitivity because the 
regional changes within the defined ROI are diluted when averaged across the ROI 123.   
Voxel-based morphometry (VBM) makes no assumption on the topography of regional 
changes, and compares changes at the voxel level to overcome the insensitivity of the ROI 
approach.  VBM is an effective approach to obtain an even-handed and global assessment of 
perfusion changes throughout the brain.  Voxel-based morphometry (VBM) involves spatial 
registration of images into a common stereotactic space, voxel-wise comparisons, and 
biostatistical analysis 124.  Spatial registration transforms the brain volume from each subject to 
the same stereotactic volume referred herein as the reference volume to correct for anatomical 
variability.  Biostatistical results are based on spatial registration methods.  Therefore, it is 
essential to assess the impact of spatial registration approaches on the biostatistical analysis of 
cerebral blood flow when VBM is applied to perfusion MRI. 
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 Spatial registration of elderly brains is a challenging issue.  Whole brain volume and fine 
cortical structures have large variability between individuals that may change at different atrophy 
rates as people age.  Different brain image voxels may deform or warp to varying degrees during 
the brain registration.  The deformation variability across cortical structures requires an accurate 
registration method to match the cortical structures between each individual brain and the 
reference volume.  A poor registration method will bias group comparisons.  Therefore, the 
performance of spatial registration on elderly brains has an important effect on group 
comparisons when applied to functional imaging. 
A variety of software registration packages are widely used to process images at brain 
imaging laboratories.  The most popular registration components for brain image analysis are 
statistical parametric mapping (SPM) 14, 123, 125-133 and automated image registration (AIR) 134, 135.  
SPM uses a geometric transformation model with low-dimensional discrete cosine 
transformation (DCT) basis functions; while AIR uses a polynomial basis functions as its 
transformation model.  The registrations of both SPM and AIR primarily model the low-
frequency deformation and ignore the high-frequency (i.e., high-spatial resolution) information.  
The spatial registration methods of SPM or AIR do not attempt to match every cortical feature, 
but merely correct for global brain shape differences 124. 
A fully deformable model (FDM) was developed with higher degrees of freedom for 
deformation.  FDM combines piecewise-linear and dense voxel-by-voxel geometric 
transformation models, and computes the displacement of each voxel with minimal constraints 65.  
FDM has the potential precision to match each cortical feature with substantial fine-scale 
deformation.  FDM was shown more accurate than affine linear methods at hippocampus 
segmentation in AD patients 136.  FDM also demonstrated a more reliable mean blood 
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oxygenation-dependent contrast (BOLD) functional MRI (fMRI) signal in the young subjects’ 
right hippocampus and right anterior cingulate cortex 137.  In these studies, FDM was more 
accurate than affine methods for segmenting two cortical structures in the subject space and 
improving structural and functional MRI signals in those two region-of-interests (ROI).   
No studies to-date have compared the performance of FDM and SPM/AIR registration 
methods for the correspondence of cortical structures from the subject to the reference space or 
assessed the impact of the registration methods on the voxel-by-voxel group analysis of elderly 
brain functional imaging including perfusion MRI (pMRI).  Therefore, we conducted 
quantitative comparisons to: 1) investigate the accuracy between SPM/AIR and FDM 
registrations regarding the correspondence of brain anatomical regions from the individual brain 
with hand-drawn ground-truth regions in the reference volume; and 2) globally assess the effects 
of registration methods on the biostatistical analysis of pMRI of elderly brains. 
6.2 THEORETICAL FORMULATION 
6.2.1 Problem formulation 
Given a 3-dimensional subject volume f, a reference volume g, and a perfusion volume p which 
is aligned with f, where f(x, y, z), g(x, y, z) and p(x, y, z) represent the image intensity at the voxel 
location [x, y, z], respectively. Our goal is to estimate the parameters of a geometric 
transformation which optimize the match between the subject volume f and the reference volume 
g, and then use the resultant transformation to relate the perfusion volume p to q.  The reference 
volume g and subject volume f are related to each other by the following model: 
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   εβα += )),,(()),,(( zyxgszyxtf      (6.1) 
The geometric transformation model tα transforms voxel locations in the reference 
volume to voxel locations in the subject volume; its behavior is dependent on a parameter of 
vector α.  In the case of affine geometric transformation, α will have entries for a translation, 
scaling and rotation along three Cartesian axes.  The intensity transformation model sβ is needed 
to accommodate the signal difference between the subject volume and reference.  The simplest 
case is that the intensity transformation is a linear scaling of signal intensity, for which β has 
only one entry, i.e. scaling factor.  ε is the error term.  In our perfusion transformation problem, 
we first estimate parameters α and β by optimization techniques, and then return an estimate q of 
q by applying p to t
~
α: 
)),,((),,(~ zyxtpzyxq α=        (6.2) 
6.2.2 Registration methods 
The registration methods are essentially an optimization problem.  The objective of the 
optimization is to determine the geometric transformation model tα and the intensity 
transformation model sβ for which the cost function c(tα, sβ) is minimized.  The simplest case for 
the cost function c(tα, sβ) is the sum of squared differences between the model and the reference 
volume: 
     ∑ −=
i
iiiiii zyxgszyxtfstc
2))),,(()),,(((),( βαβα (6.3) 
where (xi, yi, zi) represents the coordinates of the ith sampled point (to reduce the computation 
cost, not all image voxels are sampled).  Usually, there are many entries in α and β, yet an 
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exhaustive search through the whole parameter space is impossible.  An iterative search is 
normally used to modify the parameters for each iterative step.   
AIR: The first stage of AIR estimates a 12-paramter affine geometric transformation and 
a single scaling parameter for the intensity transformation.  That is,  and ]1,,,[),,( zyxAzyxt =α
),,()),,(( zyxgzyxgs ⋅= ββ .  The 12-parameter estimation of A and scalar β is done using a 
Gauss-Newton algorithm.  For the second stage, the basis functions of the geometric 
transformation model are a polynomial function of degree M.  The geometric transformation 
model 138 is represented by: 
∑∑∑
= = =
⋅=
M
i
M
j
M
k
kji
ijkijkijk zyxbbbzyxt
0 0 0
321 ],,[),,(α      (6.4) 
The coefficients bijk are the geometric transformation parameters, and are estimated by a  
Gaussian-Newton optimization procedure.  The sampled points are chosen as every K-by-K-by-
Kth voxel.   
SPM: The first stage of SPM also estimates a 12-parameter affine geometric 
transformation and single scaling parameter for the intensity transformation model as in AIR.  In 
the second stage, the geometric transformation model 139 adopts the basis function of discrete 
cosine transformation (DCT) as its basis function.  i.e. 
∑
=
⋅=
M
i
iiii zyxcbbbzyxt
0
321 ),,(],,[),,(α     (6.5) 
The coefficients bi are the geometric transformation parameters, and the functions ci(x,y,z) are 
the basis functions of the DCT.  The parameter estimation of both stages uses a Gaussian-
Newton algorithm.  The sampled points are chosen as every K-by-K-by-Kth voxel as in AIR.   
FDM: The first stage of FDM 65 estimates the parameters of an affine geometric 
transformation as in AIR and SPM.  The second stage is a piecewise-linear model, which takes 
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the estimated parameters from the first stage as a starting point.  In the piecewise-linear 
transformation, a set of control points [xi, yi, zi] is chosen and displacements of the control points 
[∆xi, ∆yi, ∆zi] are estimated.  The control points are located on a 3D rectangular grid that covers 
the reference volume.  The method first estimates displacements for a 2×2×2 grid of control 
points, and uses these displacements as the starting points to estimate displacements of 3×3×3 
grid of control points, and so on by the Levenburg-Marquardt method.  Each voxel point [x, y, z] 
in the reference volume is bounded by eight control points: [xl, yl, zl], [xh, yl, zl], [xl, yh, zl], [xl, yl, 
zh], [xh, yh, zl], [xl, yh, zh], [xh, yl, zh], [xh, yh, zh].  The piecewise-linear geometric transformation of 
each voxel is a trilinear interpolation of the displacements of the control points that bound it.  
That is,          (6.6) 
])1(,)1(,)1([],,[),,( hzlzhylyhxlx zzyyxxzyxzyxt Δ⋅−+Δ⋅Δ⋅−+Δ⋅Δ⋅−+Δ⋅+= ααααααα w
here )/()( lhhx xxxx −−=α , )/()( lhhy yyyy −−=α and )/()( lhhz zzzz −−=α .   
The third stage is a dense voxel-by-voxel transformation, which takes the estimated parameters 
from the second stage as a starting point.  For the transformation stage, the displacements [∆x, ∆y, 
∆z] of each voxel [x, y, z] in the atlas volume are the parameters to estimate.  i.e. 
],,[],,[),,( zyxzyxzyxt ΔΔΔ+=α       (6.7) 
The displacements can be estimated by a first-order Taylor expansion of Equation (6.1) by 
replacing tα by Equation (6.7).  The displacements only depend on the volume g and sβ(g), and 
their gradients, and can be computed iteratively at each voxel until the algorithm converges.   
FDM’s intensity transformation model is a linear function, i.e. .  The 
parameters, a and b, are estimated from the simple heuristic that the mean and variance of the 
intensity distribution of the reference volume should match those of the subject volume.  The 
sample points are chosen for a piecewise-linear stage as a random selection of K voxels.   
bgags +⋅=)(β
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In summary, the basis function phases of AIR, SPM, and the piecewise-linear phase of 
FDM are referred as “semi-deformable” methods since their transformations do vary spatially 
but in a gradual, constrained, low-dimensional way.  While the dense voxel-by-voxel phase of 
FDM was called as a “fully-deformable” method due to its fully unconstrained geometric 
transformation.  An example showing the use of these techniques to register a pair of images is 
shown in Figure 6.1 140.  In other words, FDM uses more degrees of freedom to geometrically 
deform the subject volume to match the reference volume.   
Geometric
Transformation 
Chen Fully-
Deformable 
Chen Semi-
Deformable 
SPM Semi-
Deformable 
AIR Semi-
Deformable AIR/SPM Affine 
Subject image Reference image
 
Figure 6.1.  Example deformations produced by fully deformable, semi-deformable, and affine 
registration techniques.  The subject volume is registered to the reference volume using the 
corresponding algorithm.  The colored dots show the geometric positions of voxels in the shown 
slice of the moving image before and after deformation by each of the methods.  The 
transformations produced by the AIR affine method and the SPM affine method were almost 
identical.   
 
The deformations from SPM/AIR are restricted to the lowest spatial frequencies of the 
basis function, and so high-frequency deformations cannot be modeled.  Therefore, these 
nonlinear registration methods do not have the potential precision compared to methods with 
more degrees of freedom.  This indicates that SPM/AIR is unsuitable for attempting fine matches 
between fine cortical structures.  The constrained registrations from SPM/AIR assume that the 
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reference resembles a warped version of the subject volume.  However, the most commonly 
available reference is based on the young healthy brains.  Most of the cortical structures in 
elderly brains (especially diseased ones) shrink at different rates, and the ventricles are enlarged 
compared to younger brains.  Hence a fully-deformable, high-quality registration technique is 
necessary to compensate for the changing rate of different cortical structures so that the choice of 
the reference volume does not bias the registration result.  The registration methods of SPM/AIR 
may not be adequate to match fine cortical structures from different subjects based on the above 
reasons. 
6.3 SUBJECTS AND METHODS 
6.3.1 Database of Subjects 
The Pittsburgh Cardiovascular Health Study (CHS) Cognition Study was a population study, 
conducted in 2002/03 to determine the incidence of dementia and MCI.  These participants were 
evaluated for cognitive functions and classified as a probable Alzheimer’s disease (AD) 141, 
probable mild cognitive impairment (MCI) 121, or normal cognitive control.  One hundred eighty 
eight participants (referred herein as the subject database) had an MRI of the brain in 2002-03.   
6.3.2 MR imaging 
All data were acquired using a 1.5 T GE Signa system (Milwaukee, WI, LX) after each subject 
provided informed consent either directly or by their caregiver and passed the Society of 
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Magnetic Resonance Imaging standardized MRI screenings.  Coronal T1-weighted spoiled 
gradient-recalled echo (SPGR) volume covering the whole brain were acquired (124 slices with 
Matrix: 256 × 192; Thickness: 1.5 mm and zero spacing, TE: min Full, TR: 25 ms, FOV: 24 x 18 
cm, rBW: 16 kHz).  The SPGR volumes were regrided into 240 × 186 × 180 matrix with voxel 
size 1 × 1 × 1 mm3.  For the quantitative perfusion map, blood flow velocities, perfusion rates 
and T1 relaxation times were measured in each subjects using phase contrast (PC) Cine, multi-
slice CASL, and saturation recovery MRI, respectively.  Multi-slice CASL used Alternating 
Single and Double adiabatic inversions (ASD) 61(3.7 s pulse train at 92% duty cycle) and ramp-
sampled echo-plane imaging (EPI) to acquire 19 contiguous axial slices (64×64 matrix, 20cm 
field-of-view, 5 mm slice thickness, 0 spacing, 21 ms echo time (i.e., minimum full), 76 kHz 
effective receiver bandwidth, 1 s acquisition time, 700 ms transit delay, 900 flip angle, 50 signal 
averages).  Images were acquired sequentially from superior to inferior brain to avoid RF 
perturbation of the endogenous tracer as it moved superiorly into the brain and to minimize 
intensity discontinuities associated with interleaved acquisitions.  The inversion efficiencies in 
the internal carotid arteries were calculated for each subject based on B1 maps and phase contrast 
(PC) cine velocimetry at the label plane 142. 
6.3.3 Registration Methods 
In this section, we will compare the registration methods between SPM2 and FDM.  We chose 
SPM over AIR for this comparison due to the former’s increased popularity in medical image 
processing.   
 
 
103
  
6.3.3.1 Qualitative evaluation of registration accuracy   
A subject was randomly selected from the subject database to evaluate the accuracy of the two 
registration methods qualitatively.  We chose two cortical structures (hippocampus and 
thalamus) for comparisons.  We registered the reference volume colin27 (a standard high-
resolution reference volume, the averaged MRI brain volume from 27 scans of the Colin brain 
143) to the subject SPGR volume, and used the resultant geometric transformation parameters (for 
SPM2 and FDM respectively) to transfer the hippocampus and thalamus masks from the 
reference volume to the subject volume.  The resultant hippocampus and thalamus masks were 
overlaid on the subject volume (in Figure 6.2).  The hippocampus detected from SPM 
registration is shifted up from its true anatomical position, and the thalamus is mislocated within 
the ventricle.  However, both regions detected from FDM are located correctly in their 
anatomical regions.  Therefore, FDM was more accurate for delineating fine cortical structures 
than SPM2’s registration method in this example.   
 
Figure 6.2.  Comparison of automatic ROI detection from SPM2 (top row) and from locally 
FDM (bottom row) for the left hippocampus (A) and left thalamus (B).  ROIs are shown 
projected onto the individual’s space (SPGRs).  Using SPM2, the left hippocampus is shifted up 
from its true anatomical position while the thalamus is erroneously located within the ventricles.    
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6.3.3.2 Quantitative assessment of accuracy of registration methods 
Ten subjects (mean age 82 ± 3.4: 4 normal controls, 3 MCI subjects, 3 AD subjects) were 
randomly selected from the subject database.  The 10 SPGR volumes were cropped to remove 
the extracranial regions using the Brain Extraction Tool (BET) of the FSL software package 
(Oxford Center for Functional Magnetic Resonance Imaging, Oxford University, UK).  We 
chose the standard Montreal Neurological Institute (MNI) brain colin27 (with voxel size 1 × 1 × 
1 mm3) 144 as the reference volume since the colin27 carries high-resolution anatomical brain 
structures.  In the interest of time, five regions (left posterior cingulate gyrus, left cuneus & 
calcarine, left hippocampus, right thalamus and right putamen) were selected because 1) those 
structures are biologically important in AD or healthy aging, and 2) the hippocampus and the 
posterior cingulate gyrus are suspected regions of atrophy and neurological change for AD 14, 20, 
34, 145.  Both the left side and the right side of the cortical structures were randomly selected to 
avoid the biased evaluation of registration methods in favor of only one side of the brain.   
The right thalamus and right putamen were traced in axial views; the left posterior 
cingulate gyrus, left cuneus & calcarine and left hippocampus were traced in sagittal views.  The 
five regions were manually traced for both the reference volume and ten elderly subject SPGR 
volumes under the supervision of a licensed neurologist.  The manually traced regions served as 
ground-truth region masks (each region mask is a binary 3D volume in which voxels labeled as 
the region had a value of 1).  The region tracing program was written in MATLAB.     
All 10 cropped brain SPGR volumes were normalized to the reference volume using 
SPM2 and FDM.  The warping parameters of each subject from the registration were used to 
warp the five region masks of the subject to the reference space for SPM2 and FDM, 
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respectively.  Two normalized region masks were obtained using: 1) SPM2 and 2) FDM for each 
region mask of each subject (Fig. 6.3).   
We used the overlap ratio to evaluate the agreement between normalized region masks 
from each method and the ground-truth region masks of the reference volume.  Let normalized 
region mask  be the set of voxels labeled as the cortical structure j (j = 1, …, 5) of the ith (i = 
1,…, 10) subject from the registration method k (k=1, 2.  1 stands for SPM, 2 for FDM), and the 
ground-truth region mask be the voxels labeled as cortical structure j of the reference volume.  
The overlap ratio of cortical structure j of ith subject from the method k was quantified as:  
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 The range of the overlap ratio is 0 to 1.  The overlap ratios evaluate how well the normalized 
region masks overlap with the ground-truth region masks of the reference volume.  The higher 
the ratio, the better the overlap. 
We also calculated the overall overlap ratio from the 10 subjects for each cortical 
structure j to assess the ability of the methods in removing the anatomical variability.  The 
overall overlap ratio was defined as the percentage of voxels that are shared between all subjects 
for each cortical structure and registration method: 
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6.3.3.3 Effects of registration methods on biostatistical analysis of pMRI 
Forty-five subjects were selected from the subject database (Table 6.1 shows demographic 
information for the three study groups).  These subjects had an optimal CASL MRI with no 
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exclusionary criteria: radiological evidence of structural or vascular central nervous system 
(CNS) lesions, history of strokes, or head trauma encephalopathy; evidence of large disparity in 
blood flow between hemispheres; poor arterial labeling efficiency or execution, excessive patient 
motion as evidenced in the structural images; excessive image artifact; or consumption of 
caffeine within 8 hours prior to exam.  The 45 SPGR volumes were also cropped using BET to 
remove the extracranial regions.    
The 45 absolute perfusion (CBF) maps of gray matter were calculated using the tracer 
kinetic convolution model of CASL 74.  The gray matter CBF map of each subject was 
transformed to the cropped SPGR space of the subject by the coregistration algorithm of SPM2.   
The 45 cropped SPGR volumes were normalized to the reference volume colin27 using 
SPM2 and FDM.  The warping parameters of each subject from the registration were used to 
warp the corresponding brain gray matter perfusion map to the reference space.  Therefore, two 
normalized gray matter perfusion volumes were obtained for each subject using SPM2 and FDM, 
respectively (Fig. 6.3). 
We smoothed the two normalized gray matter CBF maps (from SPM2 and FDM) of each 
subject using the same 6 mm Gaussian kernel.  Kernel widths of up to 16mm are being used in 
the literature.  Smoothing increases statistical power. The less one smoothes, the less likely it is 
to obtain significant results.  However, the increased statistical power is in the cost of dramatic 
loss of spatial precision.  The worst case senerio is that you many observe the statistical 
significance in an area with no signal at all (e.g. white matter).  Six mm was chosen as the 
smoothing kernel width since this corresponds roughly to the cross sectional dimensions of the 
hippocampus and sensitized the analysis to difference at this spatial scale by the matched filter 
theorem.  Biostatistical analysis of the smoothed CBF maps were performed between groups: a) 
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normal controls and early AD subjects, b) MCI and early AD subjects, and c) normal controls 
and MCI subjects using a customized one-way ANOVA multiple comparison algorithm on a 
voxel-by-voxel basis written in MATLAB (MathWorks Inc.).  The customized algorithm 
permitted an ANOVA of those voxels with perfusion values that were morphometrically shared 
by a majority of subjects in each group to maximize the brain volume coverage.  Because of the 
variability of slice coverage, the algorithm made the voxels from most of the cortex analyzable in 
the ANOVA.  A two-tailed p-value of 0.02 was chosen for the voxel-by-voxel analysis to 
identify statistically significant differences between groups (referred as the difference maps).  
The difference maps were further masked using the brain volume mask (i.e.  all of the gray 
matter voxels that have valid perfusion data in a majority of subjects of each group) to avoid a 
smoothing artifact.  SPM subroutines were modified to overlay the masked difference maps to 
the surface section of colin27 brain. 
Clusters displayed on the colin27 brain were thresholded at a correct cluster-level of P < 
0.02.  The cluster-level correction was performed to guard against false positives from multiple 
comparisons.  The correction took into account the voxel-level threshold and the spatial extent of 
cluster 146.   
6.4 RESULTS 
Assessment of accuracy of registration methods: The comparisons of the five overlap ratios 
measured for SPM2 and FDM are shown in Fig. 6.4A.  For all regions, FDM gives a higher 
mean overlap ratio than SPM2.  Paired two-tailed t-tests were applied for the overlap ratios 
obtained from SPM2 vs FDM.  The result of the paired t-tests of five overlap ratios is shown in 
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Table 6.2.  The differences in overlap ratios of all five regions were statistically significant (with 
two-tailed p < 0.025), showing FDM transformed the corresponding anatomical cortical 
structures from the subject space to the reference space more accurately versus SPM2.  The 
overall overlap ratios from all 10 subjects for five cortical structures are shown in Fig. 6.4B.  For 
all five cortical structures, FDM gives a higher overall overlap ratio than SPM2: 12% higher for 
the left cuneus and at least 97% higher for the other four cortical structures.  Therefore FDM 
provided more precision to overlay the cortical structures between different subjects than SPM2. 
Effects of registration methods on biostatistical analysis of pMRI: The results of the 
CBF biostatistical analysis are illustrated in Fig 6.5.  Cluster-level statistics are shown in Table 
6.3.  With FDM, the total number of voxels with statistical significant change in perfusion is 
6112, 2.39 times greater than SPM2. FDM identified almost 3 times more clusters of statistical 
significance than SPM2 (FDM: 11 clusters vs. SPM2: 4 clusters). We also observed markedly 
larger sizes (40% or more) of statistically significant clusters than SPM2 for most clusters with 
the exception of normal controls vs.  MCI subjects.   
For normal controls vs.  MCIs, the left and right posterior cingulate area yielded one 
cluster in SPM.  The total size of the two separate clusters from FDM was still 5% larger than the 
one cluster from SPM, while the sizes of the right superior parietal lobe measured from FDM 
and SPM2 were almost equal.  Not only were small clusters of statistical significance from FDM 
registration not observed in SPM, but a large cluster (right posterior cingulate gyrus for normal 
controls vs.  AD subject, 1155 mm3) was also not detected in SPM2. 
 
 
109
  
6.5 DISCUSSION 
SPM/AIR only corrects for the global brain shape differences in term of the overall mathematical 
characteristics of these registration algorithms.  Their registration methods do not enforce a 
match between every brain cortical structure because they use only low frequency deformations.  
However, the goal of our quantitative perfusion analysis is to deform the subject volume so that 
each subject cortical structure aligns as well as possible with the reference cortical structure, 
regardless of how heavily each voxel of the subject volume needs to be deformed.  FDM is a 
method with a fully unconstrained condition of deformation. 
Our experimental results also verify the deformation degrees of these registration 
algorithms.  Figure 6.1 shows that FDM can account for substantial warps by increasing the 
volumes of some voxels and shinking the volumes of others.  Our results also demonstrate that 
the high-dimensional FDM algorithm is superior than SPM2 for transforming anatomical 
structures from the subject to reference space.  Previous studies showed that FDM segmented 
hippocampus and anterior cingulate gyrus more accurately. However, this result was based on 
the registration from the template to subject space.  We demonstrated not only better 
performance in the hippocampus registration, but better correspondence of other brain structures 
from the subject to template space in one unified measure. The overall higher overlap ratios from 
FDM than SPM2 show that FDM can correct for anatomical variability between subjects better 
than SPM2.  
The improved correction of anatomical variability achieved by FDM increases the 
biostatistical sensitivity of pMRI variations between different cognitive classification groups.  
FDM was shown to produce more reliable structural and functional MR signals in the ROIs 
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(hippocampus and anterior cingulate gyrus).  We demonstrate that FDM is more sensitive to 
CASL perfusion changes for different disease states than SPM2 throughout the cerebrum. 
The normalization package of the latest version of SPM (SPM5) reportedly uses a low-
dimensional algorithm.  Therefore, we expect SPM5 will yield similar normalization 
performance as SPM2 when compared to FDM.  Nevertheless, a quantitative comparison of 
these techniques is warranted. 
One issue is related to the normalization performance regarding to SPM2 and FDM.  We 
chose colin27 brain as our reference volume because the reference volume is a current standard 
high-resolution template and is widely accessible to the researchers.  The high-resolution 
template is important for the high performance of FDM since the high resolution contains the 
clear boundaries of cortical structures that assist to determine the displacement of each voxel.  
On the other hand, colin27 is a young brain template.  Therefore, the transformation from each 
elderly brain to the young template requires more deformation.  The high-resolution elderly 
template is in demand to be developed and the normalization performance based on the to-be-
developed template requires further investigation.  We would guess that FDM will have better 
performance than SPM in both registration accuracy and statistical sensitivity based on its higher 
degree of freedom relative to SPM, but it may not be as significant as what we reported here.                 
 
   
 
 
111
  
Cropped SPGR 
volume of subject i 
Reference 
volume   
Hand-drawn region 
j of cropped SPGR i 
Normalized region mask Nkij in 
the reference volume 
Warping parameters 
from method k for subject i 
Normalize by 
method  k
Apply
BET 
SPGR volume  
of subject i 
CBF map of subject 
i in cropped SPGR 
space  
Apply
Normalized CBF map of 
subject i from method k 
 
Figure 6.3.  Graphical illustration of registration methods in obtaining normalized region mask 
and normalized CBF maps. 
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Figure 6.4.  A) Mean overlap ratios and B) Overall overlap ratios of five cortical regions: left 
hippocampus (L Hippo), right putamen (R Putam), right thalamus (R Thala), left cuneus (L 
cuneu) and left posterior cingulated gyrus (L cingp) over 10 subjects by SPM and FDM.   
 
Table 6.1.  Characteristics of study Groups 
Characteristic Controls MCIs ADs 
# of Cases 16 14 15 
Age 82.4 ± 3.8 83.5 ± 3.4 83.0 ± 3.1 
Female/Male 5/11 4/10 6/9 
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3MSE 95.1 ± 4.7 89.1 ± 10.9 87.4 ± 9.5 
 
Table 6.2.  Statistical comparison of overlap ratios of five selected regions 
Regions Mean overlap of 
SPM2 
Mean overlap of 
FDM 
t-values two-tailed 
p-values 
Left  Hippocampus 0.5166 0.5881 -4.7154 0.0011 
Right Putamen 0.5811 0.7199 -3.7484 0.0046 
Right Thalamus 0.5706 0.7045 -4.5973 0.0013 
Left Cuneus 0.6046 0.6398 -2.7655 0.0219 
Left Posterior Cingulate 0.2288 0.4797 -7.2176 0.00005 
 
Figure 6.5. Comparison of statistically significant regions (white) between groups 
from SPM and FDM.  A) CBFcontrol > CBFMCI; B) CBFMCI > CBFAD;  
C) CBFcontrol > CBFAD. 
 
 
 
 
Table 6.3.  Comparison of Cluster-level statistics between groups from FDM and SPM.   
 Cluster Location Cluster size (mm3) & Cluster size (mm3)  
A A 
B
SPM FDM
B 
C C 
DD 
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corrected P-value 
from SPM 
& corrected P-value 
from FDM 
R posterior cingulate ext inf parietal 1024 0.0003 
L posterior cingulate ext inf parietal 
1383* 0.0001 
431 0.0060 
CBFcontrol 
> CBFMCI
R superior parietal 233 0.0179 236 0.0180 
L orbital 0 
0 
N/A 
N/A 
340 
249 
0.0096 
0.0170 
L superior parietal 0 N/A 254 0.0164 
CBFMCI > 
CBFAD
R thalamus 0 N/A 258 0.0171 
R posterior cingulate ext inf parietal 0 N/A 1155 0.0002 
L orbital 551 
0 
0.0042 
N/A 
793 
669 
0.0011 
0.0028 
CBFcontrol 
> CBFAD
L superior parietal 395 0.0116 703 0.0019 
* L posterior cingulate and R posterior cingulate became one cluster. 
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7.0  REGIONAL PERFUSION CHANGES IN MCI AND AD 
7.1 INTRODUCTION 
The majority of brain functional studies have been conducted in referral clinics26, 27, with 
subjects that have advanced disease, especially MCIs.  We know very little about CBF changes 
in MCI and early dementia in subjects from population cohorts.  Neuroimaging studies in these 
subjects, especially those in early disease stages, are extremely important since the severity of 
symptoms may not have reached the threshold that initiates a referral to specialists.  Therefore, 
neuroimaging of population cohorts provides an ideal opportunity to examine the incipient 
pathophysiological changes in AD, several years before they are enrolled in memory clinic 
imaging studies. 
The purpose of this chapter is to examine the CBF in subjects with incident dementia and 
MCI identified through a longitudinal epidemiological study: The Cardiovascular Health Study 
(CHS) Cognition Study.   
7.2 SUBJECTS 
The diagnoses of MCI and dementia were done by an Adjudication Committee that examined the 
longitudinal data, and neuropsychological, neurological, psychiatric, and systemic information.   
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The CHS Cognition study classified 145 subjects as demented, 141 as MCI, and 246 as normal in 
2002-03.  However, a total of 188 subjects had an MRI of the brain.  For the purpose of this 
study, we selected those subjects who had no MRI-identified vascular lesions in the brain, had an 
optimal CASL MRI, and had the diagnosis of either probable AD 141, probable MCI 121, or 
normal control.   
Additional exclusion criteria included: radiological evidence of structural CNS lesions 
(e.g., brain infarcts, CNS neoplasms, prior brain surgery), history of strokes or head trauma 
encephalopathy, consumption of caffeine within 8 hours prior to exam, inability to complete 
MRI exams, inability to segment images using semi-automated tools, placement of the labeling 
plane was not orthogonal to both carotid arteries and/or the difference between left and right 
carotid arterial mean velocities exceeded 20%, incorrect operation of the scan (by the 
technologists), excessive patient motion as evidenced in structural images, excessive image 
artifact (e.g., hair oil or dental implant), lost or corrupted data files, poor scanner performance 
(e.g. instability or noise).   
After applying the exclusion criteria, 38 Normals, 29 MCIs and 37 ADs were used for 
statistical analysis.   
7.3 METHODS 
Spatial registration: An EPI mean image for each subject was registered to the corresponding 
SPGR volume using SPM2.  Then the warping parameters were used to transform the gray 
matter rCBF maps for the subjects to the SPGR space.  SPGR volumes from different subjects 
were aligned to a standard colin27 brain by a fully deformable atrophy-corrected registration 
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method (see chapter 6 for details).  The SPGR volumes were used to determine the parameters 
for transforming the CBF maps to the standard space.   
7.3.1 Methodological enhancement of statistical analysis  
The SPM data processing package is popular for making statistical inferences in group 
comparisons about regional effects in neuroimaging data, and performing the spatial registration 
as mentioned in the chapter 6.  SPM combines the general linear model (GLM) and the theory of 
gaussian random field (GRF) to make statistical inferences 147.  The GLM is used to infer the 
activity at the voxel-level to the group comparisons.  To guard against false positives, a 
correction for multiple comparisons (i.e., comparisons over the voxels) must be made.  This is 
achieved using GRF theory.   
A hierarchy of tests are framed in terms of the level of inference (voxel-level, cluster-
level and set-level) 146.  These inferences have increasing power but decreasing spatial 
localization.  The cluster-level test is based on the probability of obtaining a cluster with k or 
more voxels, above a threshold u (i.e. the probability that one cluster, with k voxels or greater 
size, could happen by chance).  The probability takes into account both the significance threshold 
and the spatial extent of the cluster.  The set-level inferences are to assess the significance of 
distributed (rather than local) activations.   
However, all levels of inference of the SPM package require that all subjects have valid 
data for the voxels which are used to make statistical inferences.  In fact, it is almost impossible 
to get exactly the same slice coverage from the MRI unless the entire brain is acquired.  Even if 
the various heads are correctly positioned in the scanner parallel to B0 direction and the first slice 
starts from the same anatomical structure with same slice thickness and interslice spacing, the 
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image data will not end at the equivalent anatomical structure due to the variance of the brain 
longitudinal lengths (Fig. 7.1).  The heads of the research subjects may not be practically placed 
in the same fixed position.  The common brain area is shown from two subjects in Fig. 7.2 if the 
head is tilted in the scanner.  The common brain coverage area tends to be small from a large 
group of subjects since a large group of subjects will have cases in both Fig. 7.1 and Fig. 7.2.   
     
(c) (a) (b
Figure 7.1.  Illustration of brain coverage of two subjects who had their head parallel to B0 
direction and were scanned at the same anatomical structure (Corpus Callosum) but do not end at 
the same anatomical structure despite the same slice thickness (5 mm) and interslice spacing (0 
mm).  After spatial registration, the brain coverage of normalized subject 1 is described by the 
green box, while the brain coverage of normalized subject 2 is described by the red box.  
Therefore, normalized subject 1 does not yield the valid data in the blue area.  The common 
brain coverage area of the two subjects is the pink area. The example is exaggerated for 
illustrative purposes. 
 
 
(c) (b)(a)  
Figure 7.2.  Illustration of brain coverage of two subjects who tilted their head and were scanned 
at the same anatomical structure (Corpus Callosum) but do not end at the same anatomical 
 
 
119
  
structure despite the same slice thickness (5 mm) and interslice spacing (0 mm).  Their common 
brain coverage area is the pink area.   
 
However, the SPM data processing package is only valid for the tiny common brain 
coverage areas for all of the subjects.  Therefore, the data processing will not analyze large 
cortical regions.  One can choose to exclude some subjects whose brain data have less overlap 
with others.  However, researchers normally suffer with small samples.  Based on these 
considerations, we implemented the voxel-level statistical and cluster-level analysis in separate 
codes to optimally utilize the available data.   
The volume of the brain evaluated in this study is all of the gray matter voxels that have 
valid perfusion data in a majority of subjects (majority criteria: at least 19 subjects for normal 
controls, 15 for MCI subjects, and 19 for early AD subjects).  We refer to this volume as a brain 
volume mask.  The rCBF maps were smoothed using a 6 mm gaussian kernel.   
7.3.1.1 Voxel-level group analysis 
 The smoothed rCBF maps were tested for significant differences between: a) normal controls 
and early AD subjects, b) MCI and early AD subjects, and c) normal controls and MCI subjects 
using a customized one-way ANOVA multiple comparison algorithm on a voxel-by-voxel basis 
written in MATLAB (MathWorks Inc.).  The customized algorithm permitted an ANOVA of 
those voxels with rCBF values that were morphometrically shared by a majority of subjects in 
each to maximize the brain volume coverage.  Because of the variability of slice coverage, the 
algorithm made the voxels from most of the cortex analyzable in ANOVA.  A two-tailed p-value 
of 0.02 was chosen for the voxel-by-voxel analysis to identify significant differences between 
groups.  The significant difference maps were further masked using the brain volume mask to 
 
 
120
  
avoid a smoothing artifact.  SPM subroutines were modified to overlay the masked significant 
difference maps to the surface section of colin27 brain.   
7.3.1.2 Cluster-level group analysis 
Cluster searching: The t-statistics maps between group comparisons were thresholded by a t-
value corresponding to a two-tailed p-value of 0.02, so that the t-values with a corresponding p-
value of less than 0.02 were changed to zero.  From each thresholded t-statistics map, we first 
detected a nonzero voxel s as the starting point of a cluster in a scanning order (i.e. every 
coordinate is from 1 to its maximum value). Then the 3-dimensional map can be considered as a 
graph G = (V, E), where V is a set of vertices and E is a set of edges.  Here the vertices are all 
nonzero voxels, the edges connected with a vertex are hidden between the vertex and its all 
nonzero neighbors (totally 26 neighbors for each vertex), and the voxel s is the source.  The 
cluster-searching problem involves finding a connected graph from the source s, which can be 
performed using a classical breath-first-search or depth-first-search algorithm (we chose the 
breath-first-search algorithm).  After cluster-searching, we searched for the next starting point 
(source) for the next cluster until we completed all of the voxels.    
Algorithmically, we can represent the thresholded t-statistics map as a three-dimension 
matrix A.  I, J and K are the three-dimensional maximum indices, respectively.  The source 
vertex can be obtained by scanning matrix A from 1 to I, from 1 to J and from 1 to K and 
searching for the first nonzero vertex that is not in any cluster.  A Breadth-first-search algorithm 
148 from the source vertex was then utilized to find a cluster by taking nonzero voxels as vertices 
and all nonzero neighbors of each vertex as its adjacency list.   
Algorithm for cluster.   
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for i = 1 to I 
    for j = 1 to J 
 for k= 1 to K 
      do if  A(i ,j ,k) is not in a cluster 
   then A(i, j, k) is a source vertex s for a cluster.   
       Breadth-first-search from source vertex s.   
  end 
       end 
end  
 
The probability of a cluster: The probability that a cluster happens by chance (corrected 
cluster-level P value) was obtained by calling a SPM subroutine which takes a point list of 
voxels for the cluster, significance threshold, smoothness of image and degree of freedom as 
parameters.  The corrected cluster-level statistics yields a correction for multiple comparisons to 
guard against false positives. 
7.3.2 Volume-Of–Interest (VOI) analysis 
We further concentrated our VOIs on the statistically significant clusters (with cluster-level 
threshold P = 0.02).  The average rCBF for each VOI was obtained from the smoothed rCBF 
maps, which were masked with the corresponding gray matter masks in the standard colin27 
space.  Only those voxels with valid gray matter rCBF values were used in the quantification of 
rCBF for each VOI.  Subjects with less than 100 voxels in the VOI were excluded from the 
further two statistical analyses.  The analysis was carried out using MATLAB.   
ANCOVA Analysis: we further compared the group differences among the control 
group, the MCI group, and the AD group, by controlling for age, hypertension and gender risk 
factors using the one-way analysis of covariance (ANCOVA) model. The purpose of the 
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ANCOVA is to exclude the possibility that group differences that result from imbalance between 
the ages, hypertensions, and genders,  
Multivariate linear regression: a multivariate linear regression between the perfusion 
and 3MSE score, age, hypertension, gender was calculated from each cluster.  The F test was 
used to test for whether those variables (3MSE score, age, hypertension, gender) are significant 
predictors of the cluster perfusion.  If the F test showed the significance of the linear model, the 
t-test for the regression coefficient of 3MSE different than zero was calculated to assess the 
independent contribution of 3MSE after controlling the other variables. 
7.4 RESULTS 
The demographic characteristics of the subjects are shown in Table 7.1.  There were no 
statistically significant differences among groups in terms of age, gender, education level, and 
HRS scores.  The proportion of subjects carrying the APOE-4 allele was similar in the three 
groups.  AD subjects had lower 3MSE scores than MCI and normals.  There were no statistically 
significant global gray matter rCBF differences between groups.  However, we observed the 
statistically significant clusters from the cluster-level analyses.  Cluster-level statistics for the 
clusters (thresholded at a corrected cluster level of P < 0.02) are shown in Table 7.2.  The 
clusters were displayed on the three orthogonal surface of the colin27 brain, but the crosshairs 
were pointed at the clusters with corrected cluster level of P < 0.01 (Figure 7.3). 
MCI Group versus Control Group 
The comparison of the MCI group vs. the control group demonstrated significant clusters 
of hypoperfusion in the right inferior parietal lobe extending to the posterior cingulate gyrus 
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bilaterally (P = 0.0079; cluster size = 425) (Figure 7.3A), and significant clusters of 
hyperperfusion in the left hippocampus (P = 0.0002; cluster size = 1266) (Figure 7.3B), right 
hippocampus area (P = 0.0078; cluster size = 393) (Figure 7.3C), right caudate and putamen (P = 
0.0179; cluster size = 354), and left subcallosal lesion (P = 0.0186; cluster size = 256). 
 MCI Group versus early AD Group 
The early AD group had significant clusters of hypoperfusion in the left inferior parietal 
lobe (P = 0.0028; cluster size = 582) (Figure 7.3D), left inferior frontal lobe(P < 0.0001; cluster 
size = 2166) and left superior temporal lobe (P = 0.0028; cluster size = 536) (Figure 7.3E), left 
caudate (P = 0.0018; cluster size = 683) (Figure 7.3F), left orbital frontal lobe (P < 0.0001; 
cluster size = 1870) (Figure 7.3G), left thalamus (P = 0.0019; cluster size = 657) (Figure 7.3H), 
left hippocampus (Figure 7.3I), left superior frontal lobe (P = 0.0124; cluster size = 364), left 
superior parietal lobe (P = 0.0135; cluster size = 307), right superior temporal lobe (P = 0.0102; 
cluster size = 277), and left occipital lobe (P = 0.0102; cluster size = 336) compared to the MCI 
group.  There were no significant clusters of hyperperfusion observed for the AD group 
compared with the MCI group. 
Early AD Group versus Control Group 
The early AD groups had significant clusters of hypoperfusion in the right inferior 
parietal lobe extending to the posterior cingulate gyrus bilaterally (P < 0.0001; cluster size = 
2101) (Figure 7.3J), left superior parietal (P = 0.0001; cluster size = 1451) (Figure 7.3K), left 
orbital frontal lobe (P < 0.0001; cluster size = 2384) (Figure 7.3L) and left inferior frontal lobe 
(P = 0.0076; cluster size = 383) (Figure 7.3M), and a significant cluster of hyperperfusion in the 
right anterior cingulate gyrus (P = 0.0076; cluster size = 336) (Figure 7.3N). 
ANCOVA Analysis 
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The ANCOVA analysis was used to test for group differences after controlling for the 
potential confounding factors (age, hypertension, gender).  Three VOIs (right amygdala, left 
caudate nucleus, and left thalamus) lost the significance (with two-tailed p-value threshold 0.02) 
after controlling for those risk factors, indicating that these regions are affected by the risk 
factors.  The mean perfusion values (after accounting for the confounding factors) of the VOIs 
with significant group differences compared to the normal controls are shown in Table 7.3.  The 
VOIs of hyperperfusion (left hippocampus, left subcallosum, right caudate & putamen, and right 
anterior cingulate) remained significantly higher compared to the normal controls even after 
controlling for the risk factors. In order to describe the changing pattern of MCI and AD patients 
for the VOIs with respect to normal controls more clearly, we show the rCBF Z-scores of MCI 
and AD subjects relative to adjusted normal controls in Figure 7.4. 
Multivariant linear regression 
The multivariant linear regression was performed to test for the correlation of perfusion 
for each brain VOI with 3MSE score.  The perfusion values in the left inferior frontal lobe, left 
orbital frontal lobe, left superior frontal lobe, left superior parietal lobe, left superior temporal 
lobe, left & right posterior cingulate gyrus, right anterior cingulate gyrus were significantly 
correlated with 3MSE (Table 7.5).   
7.5 DISCUSSION 
We made a specific effort to exclude subjects with disease processes other than AD that may 
have affected cognition, which allowed us to examine the transition from normal to AD, and 
early phases of dementia in relative isolation.  The perfusion MRI analysis showed patterns of 
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both hypoperfusion and hyperperfusion of the MCI and early AD group.  Specifically for 
hypoperfusion, the MCI group had decreased CBF in the right inferior parietal lobe and posterior 
cingulate gyri compared to normal controls. The early AD group had decreased CBF in the 
parietal association cortices, posterior cingulate gyri, and frontal association cortices compared 
to the normal controls. The AD group had decreased CBF in the hippocampus, thalamus, 
caudate, tempoparietal cortices, frontal cortices, and occipital cortices compared to the MCI 
group.  The hypoperfusion brain regions involved were similar to those reported in FDG PET or 
HMO SPECT.  For hyperperfusion, the MCI group had increased CBF in the left hippocampus, 
left subcallosal lesion, right amygdala, and right caudate & putamen.  The early AD group had 
increased CBF in the right anterior cingulate gyrus.  The regional findings implied that a 
hemodynamic process at the capillary level accompanied the neurodegenerative process, as 
indicated by the areas of reduced rCBF.   
There was hypoperfusion of the right inferior parietal lobe and posterior cingulate gyri in 
the MCI group compared to the normal control group.  The regions were the regions that affected 
in the AD group.  However, the AD group did not have significant hypoperfusion in the right 
inferior parietal region relative to the MCI group.  The lack of regional coherence in the AD 
versus the MCI group suggested that the posterior cingulate gyrus and right parietal lobe that 
affected by MCI group was prior to the onset of clinical AD.  This result is consistent with that 
of a previous pulsed arterial spin labeling MR study 27.  Researchers have shown that the 
posterior cingulate gyrus is one of the earliest structures to be affected in AD 15, 16, 18-20.  The 
posterior cingulated gyrus can be abnormal in MCI cases, and some studies have found that the 
posterior cingulate gyrus is a strong predictor of conversion from MCI to AD 15, 16, 18, 20.   
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The decreased CBF with AD subjects in the parietal association cortices, posterior 
cingulate gyri, and frontal association cortices is consistent with PET and SPECT studies 149-151.  
This finding is also consistent with the progressive pattern observed in the cingulate gyri and 
temporoparietal cortices with milder AD and frontal cortices involved with more advanced AD 13, 
152. These results are also consistent with previous pulsed arterial spin-labeling MR study 
involving subjects with AD, but we observed more hypoperfusion regions due to our increased 
brain coverage. 
An ANCOVA analysis was performed to determine whether the hyperperfusion exists 
after controlling for the risk factors (age, hypertension, sex).  We found that the regions of 
hyperperfusion remain significant, suggesting that the regional hyperperfusion we observed is 
independent of those risk factors.  The hyperperfusion findings demonstate hyperemia in the left 
hippocampus, right amygdala, right anterior cingulate gyrus, left subcallosm and right caudate & 
putamen, indicating the presence of a compensatory mechanism.  The results of the correlation 
analysis showed that some regions are significantly correlated with 3MSE.  It is worth noting 
that the right anterior cingulate gyrus appears negatively correlated with rCBF, suggesting the 
existence of an active compensatory mechanism.   
Neurons, microglia, and blood vessels are an integrated unit, and any alteration of this 
system can lead to brain dysfunction 153-155.  The fact that our cognitively impaired subjects had 
both increased and decreased rCBF in different regions relative to controls indicate that the 
vascular process associated with AD is dynamic and complex.  Although functional 
neuroimaging studies have shown decreased rCBF and glucose metabolism in AD subjects, it is 
difficult to determine which occurs first, the vascular phenomenon or the neurodegenerative 
process.    
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The increased cortical CBF in MCI and early AD is consistent with pathological studies 
that show the presence of compensatory mechanisms in the brains of dementia cases.  Choline 
acetyltransferase and acetylcholinesterase activity were reported to be increased (in the 
hippocampus and frontal lobes) 156 or normal 157 in MCI and early AD.   Cerebral 
acetylcholinesterase activity is diminished in AD cases, but its severity did not correlate with 
abnormal glucose metabolism 158.   
The increased rCBF extended to the subcallosal region, which is rich in cholinergic 
neurons 159 and is affected in AD 160.  The cingulate gyrus thus appears to be a pivotal structure 
where pathology and compensatory mechanisms are inter-related.  It has connections with all 
heteromodal association areas and is involved in memory processes and in the modulation of 
behavior, emotions, and autonomic responses 161-163.  
Although the hippocampus is one of the areas most affected by AD neurofibrillary 
pathology 164, 165, we found that that CBF was increased in MCI compared to early AD, 
suggesting that the compensatory mechanisms in the hippocampus were more pronounced in the 
MCI stage than in early AD.  This is consistent with previous reports of increased choline 
acetyltransferase and acetylcholinesterase activity 156 in MCI and early AD.  In addition, 
functional neuroimaging studies (PET and SPECT) have found that hippocampal glucose 
metabolism can be preserved in early AD 32, 166, 167.  However, our results may be difficult to 
compare with these studies, since coupling of glucose metabolism and blood flow has not been 
confirmed in MCI and early AD.  
Taken together, our data suggest an early dysfunction in the Papez circuit (i.e., mesial 
temporal lobe, thalamus, anterior and posterior cingulate gyrus) 168 in early AD and MCI.  AD 
pathology is present in the thalamus 169, and PET studies have found an association between 
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episodic memory and activation of the hippocampus, thalamus, and cingulate gyrus of AD 
subjects 170, 171.  More recently, longitudinal MRI studies have shown that the mesial temporal 
lobe, thalamus, orbitofrontal cortex, and inferior parietal cortex lost more volume over time in a 
selected group of MCI subjects 172.  This is important because the inter-related set of structures is 
critically involved in memory and emotional regulation.   
The presence of both increases and decreases in CBF indicates a dynamic process 
between vascular (and likely cellular) compensatory mechanisms and AD pathology that appears 
to be more pronounced in the MCI state, i.e., prior to some threshold of neuropathology beyond 
which such compensation is not possible.  The understanding of these compensatory processes is 
essential for the development of both primary and secondary prevention treatments.   
Table 7.1.  Demographic characteristics 
 Control Early AD  MCI Χ2/F-ratio 
Number of subjects 38 37 29  
Age 82.78 + 3.54 
 
83.68 + 3.50 
 
82.73 + 3.95 1.06 
Education level 
(>high school) 
15 (75%) 13 (59%) 8 (53%) 1.94 
Male/Female 13/25 13/18 12/11 1.93 
Caucasians 17 (85%) 16 (73%) 14 (100%) 2.78 
3MSE 95.24 + 4.48 85.16 + 9.46 91.10 + 8.59 9.78* 
HRS 1.1 + .9 1.0 + 1.7 .9 + 1.2 .10 
APOE-4 allele 4 (21%) 8 (40%) 4 (27%) 1.63 
*ANOVA: Control and MCI different from AD (p< 0.001) 
Abbreviations: AD: Alzheimer’s disease; MCI: Mild Cognitive Impairment; 3MSE: Modified 
Mini-Mental State Examination; HRS: Hachinski Rating Scale.   
 
Table 7.2.  Summary of cluster-level statistics for decreased and increased CBF in Control, MCI and Early 
AD subjects 
 
Group Analysis Cluster location Cluster-level 
corrected p-value 
Cluster 
size 
Control > MCI L/R posterior cingulate, right inferior parietal 0.0079 425 
MCI > Control L hippocampus 
R hippocampus area 
R caudate & putamen 
0.0002 
0.0078 
0.0179 
1266 
393 
354 
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L subcallosm 0.0186 256 
MCI > AD L hippocampus 
L inferior frontal 
L orbital frontal 
L caudate 
L thalamus 
L inferior parietal 
L superior temporal 
R superior temporal 
L occipital 
L superior frontal 
L superior parietal 
< 0.0001 
< 0.0001 
< 0.0001 
0.0018 
0.0019 
0.0028 
0.0028 
0.0102 
0.0102 
0.0124 
0.0135 
3211 
2166 
1870 
683 
657 
582 
536 
277 
336 
364 
307 
AD > MCI NO   
Control > AD L orbital frontal 
L/R posterior cingulate, inferior parietal 
L superior parietal 
L inferior parietal 
< 0.0001 
< 0.0001 
0.0001 
0.0076 
2384 
2101 
1451 
383 
AD > Control R anterior cingulate 0.0076 336 
 
Table 7.3.  The mean CBF values of Control, MCI, and Early AD subjects after controlling the age, 
hypertension and gender effects.  Black font stands for the significant change of CBF compared to normal controls.   
 
REGION Control perfusion  MCI perfusion AD perfusion 
L & R posterior cingulate 53.4231 40.6653 40.9568 
R caudate & putamen 37.0577 47.6090 42.3857 
L subcallosm 35.3047 51.5062 35.9145 
L hippocampus 37.4982 53.6585 37.3389 
R hippocampus 36.6203 48.8715 40.1613 
43.1191 L inferior parietal lobe 56.6975 58.1019
57.8757 R anterior cingulate 40.8668 48.0527
31.3015 L superior parietal lobe 44.4516 40.9650
32.1100 L inferior frontal lobe 44.6551 41.2890
36.3601 L orbital frontal lobe 51.8297 50.5894
 
Blood flow values are expressed as milliliters per 100g tissue per minute [ml/(100g·min)].  
  
 
Table 7.4.  Significant correlations between cluster perfusion and 3MSE.   
 
REGION 3MSE coefficient Two-tailed p value 
L inferior frontal lobe 0.4801 0.0047 
L orbital frontal lobe 0.4227 0.0027 
L superior frontal lobe 0.3899 0.0098 
L superior parietal lobe 0.4571 0.0057 
L superior temporal lobe 0.4719 0.0061 
L & R posterior cingulate gyrus 0.5525 0.0030 
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R anterior cingulate gyrus -0.6943 0.0056 
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Figure 7.3. Statistically significant changes in regional CBF by ANOVA (p < 0.02) are 
overlaid in color on the top of a surface section of the colin27 brain.   A) CBFControl > 
CBFMCI at L & R post cingulate, B) CBFMCI > CBFControl at L hippocampus, C) CBFMCI > 
CBFControl at R hippocampus area, D) CBFMCI > CBFAD at L inf parietal,  E) CBFMCI > CBFAD at 
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L inf frontal & L sup temporal, F) CBFMCI > CBFAD at L caudate, G) CBFMCI > CBFAD at L 
orbital frontal, H) CBFMCI > CBFAD at L thalamus, I) CBFMCI > CBFAD at L hippocampus, J) 
CBFControl > CBFAD  at L/R post cingulate, K) CBFControl > CBFAD at sup parietal, L) CBFControl > 
CBFAD  at L orbital frontal, M) CBFControl > CBFAD  at inf frontal N) CBFAD > CBFControl at R 
anterior cingulate.  The color scale ranges from yellow (highest positive t-score) to red (lowest 
positive t-score).  
 
 
Z score relative to the adjusted control
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
LH LS RC RAC
Regions
Z 
sc
or
e
MCI
AD
LSP            LIP            BP          LST           LO 
 
 
Figure 7.4.  Comparison of standard Z-score of CBFs of MCI and AD subjects compared with 
normal controls after adjusting the risk factors for the VOIs identified from cluster-based 
analysis. Error Bars represent standard error from the mean (SEM). (LH = left hippocampus; LS 
= left subcallosal area; RC = right caudate and putamen; RAC = right anterior cingulate; LSP = 
left superior parietal; LIP = left inferior parietal; BP = Bilateral posterior cingulate; LST = left 
superior temporal; LO = left orbital frontal). 
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8.0  RISK FACTOR OF HYPERTENSION TO AD 
8.1 INTRODUCTION 
Hypertension (HTN) is frequent in elderly subjects; 30-40% prevalence in subjects age 65 or 
higher 173-176.  HTN has a significant impact on cardiovascular functions 177, and in cerebral 
structures, with the subsequent cognitive deterioration 178-181.  The most common explanation for 
the effect of HTN on cognition is that it increases the risk of cerebrovascular disease (CVD) 182, 
183.  Long-term HTN can cause vascular hypertrophy and microvascular remodeling by 
promoting arteriosclerosis in large vessels and lypohyalinosis in penetrating arterioles, with 
subsequent regional cerebral blood flow (rCBF) dysfunction 184-186, which could lead to strokes 
and white matter disease.  HTN was found to be a risk factor for cognitive decline 178-181, and for 
Alzheimer's disease (AD) 179, 187.  HTN causes a CNS vulnerability state that leads to cognitive 
deficits mainly through CVD.  However, HTN also appears to be a risk factor for AD.  
Therefore, it is crucial to understand the pathophysiology of HTN in cognitively normal controls, 
MCI and AD subjects.   
Studies conducted in middle-aged cognitively normal subjects with HTN showed a 
pattern of reduced rCBF and compensation using positron emission tomography (PET) 188.  
When engaged in memory tasks, hypertensive subjects had less activation than normotensives in 
the middle posterior watershed area, parietal lobes, and thalamus.  Interestingly, hypertensive 
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subjects with normal performance in memory tasks had increased CBF in the 
amygdala/hippocampus area.  Functional MRI studies have shown that there was a correlation 
between activation in the anterior cingulate gyrus, insula, thalamus, and periacueductal grey 
matter and measures of blood pressure when cognitively normal hypertense subjects performed 
the Stroop test 189.   
Volumetric MRI studies have shown that elevated systolic pressures in untreated 
hypertensive and cognitively normal subjects (mean age 61.3 years) correlated with decreased 
gray matter volumes in superior frontal, anterior cingulate, and middle temporal gyri 190.  In 
addition, the gray matter volume was associated with memory and executive function tests, and 
non-treated midlife blood pressure was associated with decreased hippocampal volume 30 years 
later 191.  These studies suggested that HTN can alter brain structure and rCBF beyond the 
expected cerebral regions localized at the end of the tree of the perforant arteries.  These limbic 
and paralimbic areas are critical for higher cognitive functions, and are targeted by AD 
pathology.  Therefore, the purpose of this study is to investigate the rCBF in cognitively normal 
subjects, identified through a population-based study, using continuous arterial spin-labeled MRI 
(CASL-MRI).  We hypothesize that the rCBF of hypertensive subjects will be altered at the 
capillary level in multiple brain regions, reflecting a vulnerability state caused by HTN. 
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8.2 MATERIAL AND METHODS  
8.2.1 CHS Cognition study 
The Pittsburgh Cardiovascular Health Study Cognition Study (CHS-CS) is a continuation of the 
CHS Dementia Study, and it was conducted in 2002/03 to determine the incidence of dementia 
and mild cognitively impaired (MCI) in a population of normal and MCI subjects identified in 
1998/99 in the CHS-CS in Pittsburgh.  Of the 927 participants examined in 1998-99, a total of 
532 normal and MCI subjects were available for study in 2002/03.  All subjects had complete 
neurological and neuropsychological examinations in 1998-99, and an MRI of the brain in 1992-
94, and 449 had a repeat MRI in 1998-99.  The characteristics of the total CHS cohort, and the 
Pittsburgh CHS-CS have been described previously 121, 192, as well as the details concerning the 
longitudinal follow-up of the CHS participants 121, 122.  All participants completed neurological, 
neuropsychological examinations in 1998-99, and in 2002-03. 
Subjects 
The CHS-CS is conducting an MRI of the brain for all subjects who convert from Normal 
to MCI, Normal to dementia, or MCI to dementia.  In addition, we are performing MRI of the 
brain to a group of 25-30 controls per year.  Of the 188 subjects who had an MRI of the brain in 
2002-04, we selected 38 controls, 29 MCI and 37 AD subjects for this study.  These participants 
had an optimal CASL MRI with no MRI-identified vascular lesions in the brain.  Additional 
exclusion criteria to maximize case reliability and validity were: radiological evidence of 
structural CNS lesions (e.g., brain infarcts, CNS neoplasms, prior brain surgery) or history of 
strokes or head trauma encephalopathy, consumption of caffeine within 8 hours prior to exam, 
inability to segment images using semi-automated tools, placement of the labeling plane was not 
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orthogonal to both carotid arteries and/or the difference between left and right carotid arterial 
mean velocities exceeded 20% of the mean, excessive patient motion as evidenced in structural 
images, or excessive image artifact (e.g., hair oil or dental implant).   
Clinical examination 
Neurological exam: The neurological exam included a brief mental status examination, as 
well as cranial nerve testing, motor tone, abnormal movements, strength, deep tendon reflexes, 
release signs, plantar response and clonus, cerebellar testing, primary sensory testing, gait, and 
postural stability.  The examiner also completed the Unified Parkinson’s Disease Rating Scale 
(UPDRS) 193 and the Hachinski Ischemic Scale (HRS) 194.    
Psychiatric examination: Symptoms of depression were measured with the modified 
version of the Center for Epidemiology Studies Depression Scale (CES-D) 10-item version 195 
and additional behavioral symptoms were measured with the Neuropsychiatric Inventory (NPI). 
Neurpsychological exam: All participants were assessed with the following cognitive 
measures: Premorbid intelligence: the American version of the National Reading test (AMNART) 
196, Raven’s Colored Progressive Matrices 197, Memory: California Verbal Learning Test (CVLT) 
198, Rey-Osterreith figure, Language: Boston Naming test 199, Verbal fluency test, 
Visuoperceptual/visuoconstructional: Block design (from the Wechsler Adult Intelligence Scale-
revised) 200, Copy of a geometric figure, and Executive functions: Stroop test, Digit Spans 200, 
Baddeley & Papagno Divided Attention Task 201, and the Motor: Grooved Pegboard Test 202.  
Total time of the neuropsychological battery was 2 hours. 
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8.2.2 CASL MRI & Image Processing 
The details of MRI data acquisitions protocol and image processing are shown in Section 
5.6.  Absolute rCBF maps of gray matter were generated for each individual subject. 
8.2.3 Statistics  
An EPI mean image for each subject was registered to the corresponding SPGR image using 
SPM2.  Then the warping parameters were used to transform the gray matter rCBF maps for the 
subjects to the SPGR space.  SPGR images from different subjects were aligned to a standard 
colin27 brain by a fully deformable atrophy-corrected registration method 65.  The SPGR images 
were used to determine the parameters for transforming the CBF maps to the standard space.  
The volume of the brain evaluated in this study was all the gray matter voxels that have valid 
perfusion data in a majority of subjects, and we refer to this as a brain volume mask.  The rCBF 
maps were smoothed using a 6 mm gaussian kernel.   
The smoothed rCBF maps were tested for significant differences between hypertensive 
and normo-tensive subgroup within normal controls, MCI subjects, and AD subjects.  Due to 
variability in slice coverage between subjects, some voxels in the standardized space contained 
rCBF measurements.  Therefore, a customized t-test algorithm was written in MATLAB 
(MathWorks Inc.) to test differences in rCBF between normotensives and hypertensives on a 
voxel-by-voxel basis.  The customized algorithm permitted t-tests of only those voxels in which 
rCBF was measured in a majority of subjects to maximize the brain volume coverage.  By 
permitting the analysis of voxels in which only a subset of rCBF measurements were available, 
the algorithm allowed the analysis to include voxels from most of the cortex.  A two-tailed p-
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value of 0.02 was chosen for the voxel-by-voxel analysis to identify significant differences 
between groups.  The significant difference maps were further masked using a brain volume 
mask to avoid a smoothing artifact.  The masked significant difference maps were displayed on 
the surface section of colin27 brain by modifying SPM subroutines.  Clusters displayed on 
colin27 brain were thresholded at a correct cluster-level of P < 0.01 146.  The cluster-level 
correction was performed to guard against false positives from multiple comparisons.  The 
correction took into account the voxel-level threshold, the size and shape of cluster.   
8.3 RESULTS 
The demographic characteristics of the subjects are shown in Table 8.1.  There were no 
statistically significant differences among groups in terms of age, gender, education level. AD 
subjects had lower 3MSE scores than MCI and Normal controls.  Demographic and clinical 
characteristics of cognitively normal subjects are shown in Table 8.2.  There were more subjects 
with HTN using convertase II inhibitors and diuretics than those without.  There were no 
statistical differences in terms of age, gender, education level, Modified Mini-Mental State 
Examination 203 score, heart disease, diabetes mellitus, and other medication intake (beta-
blockers, calcium channel blockers, other vasodilators). 
 
 CASL MRI 
There was no hyperperfusion observed for hypertensive subgroup compared with normo-
tensive subgroup within each group (normal controls, MCI subjects, or AD subjects). 
Hypertensive normal controls vs. normo-tensive normal controls 
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The comparisons of hypertensive normal controls versus normo-tensive normal controls 
demonstrated significant clusters of hypoperfusion in the anterior cingulate gyrus (Fig 8.1A), 
inferior parietal lobe (Fig 8.1B), inferior frontal lobe and putamen (Fig 8.1C) bilaterally, left 
superior frontal lobe, left orbital frontal lobe, left hippocampus (Fig 8.1C) and superior parietal 
(Cluster-level P > 0.01, not shown).  Cluster-level statistics for all clusters are shown in Table 
8.3.   
Hypertensive MCIs vs. normo-tensive MCIs 
No significant clusters of hypoperfusion were seen in the hypertensive MCIs versus 
normo-tensive MCIs. 
 Hypertensive ADs vs. normo-tensive ADs 
The comparisons of the hypertensive ADs versus. normo-tensive ADs showed significant 
clusters in the putamen bilaterally, left inferior frontal lobe together with superior temporal lobe 
(Fig  8.1D), left hippocampus and left middle temporal lobe (Cluster-level P > 0.01, not shown). 
8.4 DISCUSSION 
We only observed hypoperfusion for the subgroup with hypertension compared with the 
subgroup without hypertension.  We found that compensatory hyperemia (e.g. anterior cingulate 
gyrus) in MCI and AD subjects along with decreased perfusion in specific brain regions in this 
cohort.  The presence of hypertension appears to moderate the increase in blood flow, suggesting 
at least one mechanism for vascular risk in dementia. Hypoperfusion was most evident in normal 
subjects, suggesting that vascular damage occurs well before the onset of dementia symptoms.  
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These findings showed that rCBF, at the capillary level, is affected in normal elderly 
subjects with HTN, not only in the subcortical regions, but also in limbic and paralimbic 
structures, even when they are receiving the proper anti-hypertensive treatment.  However, it 
seems that the effect of HTN is attenuated after the onset of the pathological cognitive process.  
These findings are consistent with previous observations of  the association between HTN and 
hippocampal and amygdala atrophy 191, and with the notion that HTN can affect cerebral 
structures that are targeted by AD pathology 188, 189, increasing the vulnerability of hypertensive 
subjects to develop AD. 
Our findings showed diminished rCBF in the frontal (orbitofrontal cortex and cingulate 
gyrus), temporal, and parietal cortices, and subcortical regions (striatum) in elderly subjects with 
HTN.  These findings suggested that HTN can alter brain structure and rCBF beyond the 
expected cerebral regions localized at the end of the tree of the perforant arteries in subcortical 
regions (striatum).  This is consistent with previous studies conducted in non-demented patients 
with HTN that showed that diminished cerebrovascular dilative response to physiological stimuli 
188, 189, and a pattern of reduced rCBF and compensation in middle age subjects with HTN using 
PET.  Furthermore, volumetric MRI studies have shown that elevated systolic in untreated 
hypertensive, and cognitively normal, subjects (mean age 61.3 years) correlated with gray matter 
volumes in superior frontal, anterior cingulate, and middle temporal gyri 190.   
Long-term HTN can cause significant structural vascular damage to large vessels and 
microcirculation, with subsequent rCBF dysfunction 184-186.  Damage to the vascular endotelium 
is the earliest and most critical pathophysiological process of the CVD associated with HTN; as 
shown in subjects with juvenile HTN.  However, the complexity and heterogeneity of the effect 
of HTN on the vascular endothelium is not fully understood, especially the vulnerability of the 
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microcirculation of specific cortical areas to HTN.  Moreover, the relationship between these 
HTN-related vascular factors and neurodegeneration is unknown.  The increased vascular 
production of superoxide dismutase 204-206, which leads to inactivation of NO-dependent 
vasodilatation, appear to play a critical role in the HTN vascular damage.  These vascular 
processes can alter the glutamate-mediated [Ca+] neuronal-to-astrocyte control of the 
microcirculation 207, 208, which may explain the relationship between decreased rCBF in 
heteromodal association areas in subjects with HTN.  Recent findings, in normal subjects,  have 
shown that there is an astrocyte-mediated Ca+ rise in parenchimal arterioles as a response to 
neuronal activity 208, and that cortical areas with increased synaptic activity, such as the 
heteromodal association areas, have increased vulnerability to AD pathology 209.  Taken together, 
these studies indicated that neurons, astrocytes, and microcirculation are closely interrelated, and 
damage to the vascular endothelium may cause neuronal dysfunction, especially in areas of 
increased synaptic activity. 
Finally, our findings are consistent with the notion that HTN can contribute to cognitive 
deficits, in the absence of radiological (CT- or MRI-identified) infarcts, or clinical strokes 178, 179.  
In addition, they are relevant to the hypothesis that CVD can modulate AD clinical manifestation 
210, 211 by expressing the clinical symptoms of dementia with fewer AD pathological changes, and 
that hypertension plays a critical role in this process 212.   
This study is limited by the small number of subjects, and by the lack of information 
about duration of antihypertensive medication.  It was shown that antihypertensive treatments 
diminished the risk of dementia 213, 214, and they can modify structural brain changes 215.  The 
relationship between CASL MRI in hypertensive patients and incident dementia needs to be 
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examined.  This will allow us to identify a rCBF pattern that may predict dementia in healthy 
individuals with HTN. 
 
Table 8.1.  Subjects Characteristics with and without hypertension 
Class  Hypertensive Normotensive 
Number of subjects 16 22 
Male/Female 6/10 7/15 
Age 83.5 + 3.1 82.2 + 3.7 
Normal 
3MSE 94.4 + 4.7 95.8 + 4.2 
Number of subjects 11 18 
Male/Female 81.8 + 4.6 83.2 + 3.4 
Age 7/4 5/13 
MCI 
3MSE 92.5 + 5.9 90.2 + 9.9 
Number of subjects 18 19 
Male/Female 6/12 7/12 
Age 83.8 + 3.6 83.5 + 3.4 
AD 
3MSE 83.4 + 10.1 86.7 + 8.7 
 
 
 
 
Table 8.2. Demographic and clinical characteristics of cognitively normal subjects with and without 
hypertension 
 Hypertensive Normotensive χ2/ t-test p-value 
Number of  Subjects 16 22   
Age 83.5 + 3.1 82.2 + 3.7 -1.09 .28 
Education level (%) 
(>high school) 
10 (62.5) 16 (73) .44 .50 
Race: Whites (%) 11 (69) 20 (91) 3.02 .08 
Male/Female 6/10 7/15 .13 .71 
3MSE 94.4 + 4.7 95.8 + 4.2 .93 .35 
Heart Disease* (%) 1 (6) 4 (18) 1.54 .28 
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Diabetes Mellitus** (%) 1 (6) 2 (9) .10 .74 
Convertase II inhibitors (%) 8 (50) 0 (0) 13.9 <.001 
Beta Blockers 4 (25) 3 (14) .79 .37 
Calcium Channel Blocker (%) 6 (37.5) 6 (27) .44 .50 
Diuretics (%) 10 (62.5) 1 (4.5) 15.2 <.001 
Other vasodilators (%) 3 (18) 2 (9) .75 .38 
* History of angina, or Myocardial infarction, ** by American Diabetes Association. 
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Table 8.3.  Summary of Cluster-level statistics for hypoperfusion clusters 
  Region Cluster p-value Custer size 
Normal L anterior cingulate 
L sup frontal 
L inf frontal & L Putamen & L hippo 
R inf frontal 
R putamen 
R anterior cingulate 
L sup parietal 
L inf parietal 
R inf parietal 
L middle temporal 
L orbital frontal 
0.0000 
0.0000 
0.0000 
0.0002 
0.0000 
0.0000 
0.0125 
0.0000 
0.0064 
0.0001 
0.0031 
4763 
2238 
12099 
1207 
1589 
2166 
312 
3092 
467 
1356 
605 
MCI NO     
AD L inf frontal & superior temporal 
L middle temporal 
L putamen 
R putamen 
R thalamus 
L hippocampus 
0.0000 
0.0177 
0.0028 
0.0016 
0.0180 
0.0261 
2488 
258 
495 
642 
220 
201 
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A 
B 
C 
D 
 
Figure 8.1.  Statistically significant regional CBF decreases in hypertensive subjects compared 
with normo-tensive subjects by t-test (cluster-level P < 0.01) are overlaid in color on the top of a 
surface section of the colin27 brain.  A) Anterior cingulate gyrus CBFhyper_normal < CBFnormo_normal; 
B) Posterior cingulate gyrus CBFhyper_normal < CBFnormo_normal; C) Bilateral putamen, left superior 
frontal lobe, left orbital frontal lobe, left hippocampus CBFhyper_normal < CBFnormo_normal.  D) 
Bilateral putamen, left inferior frontal lobe and superior temporal lobe CBFhyper_AD > 
CBFnormo_AD The color scale ranges from yellow (highest positive t-score) to red (lowest positive 
t-score).   
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9.0  SUMMARY AND FUTURE WORK 
Individual brain perfusion map was measured by a noninvasive technique: continuous arterial 
spin labeling (CASL).  CASL techniques use off-resonance RF pulses to invert flowing arterial 
water (1H proton) spins in the carotids of the neck.  However, the RF pulses produce significant 
off-resonance saturation effects (MT effects).  A dual-Lorentzian model was established to 
characterize the MT effects in CASL. The labeling region tends to lie in the inhomogeneous 
region in the scanner, so the individual inversion efficiency may very significantly between 
subjects.  An analytical model was established to calculate the individual inversion efficiency 
and also verified by the in vivo experiments.  Quantification of perfusion map was improved by 
incorporating short postlabeling delay, MT effects, individual inversion efficiency, individual 
arrival time and superior-to-inferior acquisition. 
Spatial normalization transforms the brain volume from each subject to the same 
reference volume to correct for anatomical variability.  From the quantitative comparison of two 
normalization algorithms (statistical parametric mapping (SPM2) vs. fully deformable model 
(FDM)), FDM increased anatomical normalization accuracy and thus improved the biostatistical 
group comparison of pMRI (perfusion MRI) compared with SPM2.  Therefore, FDM was 
applied to transform the individual brain perfusion map to the reference volume. 
A group of population subjects from cognitive healthy study (CHS) were used to evaluate 
the perfusion changes among normal controls, mild cognitive impairments (MCIs) and early 
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Alzheimer’s disease (ADs).  First, voxel-level statistical comparison of perfusion was performed 
by customized one-way ANOVA. The voxels in which at least half of subjects have valid 
perfusion data in each group were counted in the ANOVA analyses.  Second, cluster-level 
analysis was performed to correct for false positives in the voxel-level comparison. Third, the 
statistically significant clusters were targeted to evaluate the group difference by controlling the 
risk factors.  The effects of hypertension on the CBF within each group (normal controls, MCIs, 
or ADs) were investigated by voxel-level and cluster-level statistics.  
We observed not only the decreased cerebral blood flow (CBF), but also the increased 
CBF.  Moreover, the regions with increased CBF remain significant even after the risk factors 
are controlled.  The regional findings imply a compensatory mechanism, at the capillary level, 
accompanied the neurodegenerative process.  For the effects of hypertension, only hypoperfusion 
was observed for the subgroup with hypertension compared to the subgroup without 
hypertension.  The presence of hypertension appears to moderate the increase in blood flow, 
suggesting one mechanism for vascular risk in AD.  Hypoperfusion was most evident in normal 
controls suggesting that vascular damage occurs well before the Onset of AD symptoms. 
The perfusion techniques, registration techniques, and statistical tools that developed in 
the thesis can be used to study the longitudinal perfusion changes and predict the potential 
population with high risk to develop the Alzheimer’s disease.  These techniques can be applied 
to study the perfusion changes and risk factors for other brain diseases (such as Lewis body 
disease, Stroke, Parkinson disease), and detect the drug effects of any potential drugs.  These 
techniques can be adopted to investigate the perfusion of other human organs (such as kidney, 
liver). 
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APPENDIX A GLOSSARY 
Bloch equations: Equations of motion for the magnetization vector in the presence of magnetic 
field. 
 
Echo-planar imaging: Ultra-fast imaging technique that fills whole two-dimensional k-space 
data from a single data acquisition. 
 
Flip angle: Degree of magnetization vector rotated by an RF pulse relative to the direction of the 
static magnetic field. 
 
Full saturation: A state in which the directions of spins are random, so that the net 
magnetization is zero. 
 
Gradient echo: Echo signal generated by dephasing and rephasing a transverse magnetization 
via changing the gradient direction.   
 
On-resonance: A state in which the frequency of an excitation RF field is same as the Larmor 
frequency of spins. 
   
Off-resonance: A state in which the frequency of an excitation RF field is different from the 
Larmor frequency of spins. 
 
Pulse sequences: A diagram showing that when and how long RF and/or gradient pulses are 
applied to a spin system. 
 
Partial saturation: A state in which the net magnetization is nonzero, by applying repeated RF 
pulses in times on the order of or shorter than T1. 
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APPENDIX B ABBREVIATION 
AIF  Artery input function 
AD  Alzheimer’s disease 
AFP  Adiabatic fast passage 
AIR  Automated image registration 
AM  Amplitude modulated 
ANCOVA Analysis of covariance 
ANOVA Analysis of variance 
APDI  Alternating proximal and distal irradiation 
ASD  Alternating single and double adiabatic inversion 
BET  Brain Extraction Tool 
BOLD  Blood oxygenation-dependent contrast 
CASL  Continuous arterial spin labeling 
CBF  Cerebral blood flow 
CHS  Cognitive healthy study 
CNS  Central nerve system 
CW  Continuous Wave 
CVD  Cerebrovascular disease 
CT  Computed tomography 
DAI  Double adiabatic inversion 
DCT  Discrete cosine transformation 
DSC  Dynamic susceptibility contrast 
EPI  Echo-planar imaging 
FDA  Food and Drug Administration 
FDM  Fully deformable model 
fMRI  Functional magnetic resonance imaging 
FSL  FMRIB Software Library 
GLM  General linear model 
GRF  Gaussian random field 
HTN  Hypertension 
IDL  Interactive Data Language 
IRB  Institutional Review Board 
MCI   Mild cognitive impairment 
MNI  Montreal Neurological Institute 
MRI   Magnetic resonance imaging 
MT   Magnetization transfer 
NMR  Nuclear magnetic resoance 
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PC  Phase contrast 
PET   Positron emission tomography 
pMRI  Perfusion magnetic resonance imaging 
RF  Radiofrequency 
rms  Root-mean-square 
rCBF  Regional cerebral blood flow 
rBW  Receiver bandwidth 
ROI  Region of interest 
SAI  Single adiabatic inversion 
SAR  Specific absorption rate 
SNR  Signal-noise-ratio 
SPDI  Simultaneous proximal and distal irradiation 
SPET  Single photon emission computed tomography 
SPGR  Spoiled gradient-recalled echo 
SPM  Statistical parametric mapping 
TE   Time of echo 
TR  Time of repetition 
VBM  Voxel-based morphometry 
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